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Diastereomeric Effects in DNA Binding – Biological and 
Biophysical Studies on Ruthenium Complexes 
ANNA K. F. MÅRTENSSON 
Department of Chemistry and Chemical Engineering 
Chalmers University of Technology 
ABSTRACT 
Organic molecules, such as glucose and amino acids, are most often chiral. This means 
that their mirror-images are different, in the same way a left and a right hand are 
different from each other. For example, the DNA double helix in its standard form twists 
like a right-handed screw. Therefore, when chiral DNAǦbinding ligands interacts with 
DNA the effect will depend on their handedness – that is, the interactions will be 
diastereomeric. Hence, it is essential to always consider the effects chirality may have 
on ligand-DNA interactions when developing new DNAǦtargeting drugs. By 
improving properties such as binding affinity and sequence selectivity, many 
adverse effects present in currently available treatments could be avoided. Therefore, 
to have efficient methods for evaluating ligand-DNA binding properties would greatly 
simplify the search for potential therapeutic candidates.  
The key focus in this thesis is the binding interactions between DNA and a group of DNA 
intercalating ruthenium complexes. It is demonstrated using spectroscopic and 
calorimetric methods that both chirality and small changes in the molecular structure of 
the complex can have significant impact on the binding properties of the complex. 
Furthermore, a general algorithm used for thermodynamically characterize the ligand-
DNA binding interactions is presented as a simplified method for fitting binding models 
to complex systems. From both photophysical and calorimetric results it is evident that 
cooperativity between neighboring bound ligands has a huge impact on the overall 
binding interactions between ruthenium complexes and DNA and must be taken into 
account in order to find a satisfactory fit of a theoretical binding model. Finally, 
ruthenium complexes are shown in vitro to have a high antimicrobial activity comparable 
to clinically available antibiotics and it is again evident that chirality have a strong 
influence on the binding properties of the complex. As a continuance to the promising 
antimicrobial results, an alternative type of antibiotic is presented in the concluding 
remarks as a possible counteract to the ongoing and growing problem of multi-resistant 
bacteria.   
KEYWORDS: DNA, ruthenium, intercalation, enantiomer, diastereomeric, kinetics, 
spectroscopy, calorimetry, neighbor interaction, antimicrobial activity      
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1 INTRODUCTION 
The cell is the basic unit of life. We all have them. They are the building blocks of every 
living organism, but each cell is on its own an isolated system capable of replication, 
growth and metabolism. From the smallest bacterium to higher order multicellular 
organisms, all cells share certain features: ribosomes; where proteins are produced, the 
plasma membrane; a selective barrier separating the cell from the surrounding 
environment, and the cytoplasm; the material within the plasma membrane. These are 
all essential components of the cell, but the most central of all is the carrier of all genetic 
information of that cell, deoxyribonucleic acid, more commonly known as DNA. DNA is 
often referred to as the blueprint of life. Although only a metaphor, this would imply that 
DNA is something prescriptive and static. Nothing could be farther from the truth. 
Although composed of merely four simple building units, DNA is a multi-dimensional, 
complex, and dynamic molecule that is ever-changing and ever-adapting. It is responsible 
for the growth, functioning and reproduction of a living organism. Quite simply, DNA is 
what make us who we are.  
Every day something bad happens to your DNA. At a rate of several thousand errors per 
day, DNA is damaged by a vast number of causes. It could be environmental, such as 
exposure to ultra-violet light, or endogenous, such as an oxidative attack from normal 
metabolic byproducts. Should the integrity and availability of essential information of 
the genome be lost, the cell can no longer function normally. Fortunately, the cell has 
developed several DNA repair mechanisms that is implemented depending on the nature 
of the damage, so most of the time the damage is harmless. Sometimes, however, the DNA 
repair mechanism fails, and the cell may enter a state of unregulated cell division, 
resulting in cancer. Ironically, cancer is often effectively treated with DNA-damaging 
drugs. However, an ongoing problem with cancer-treating drugs are their non-specificity 
towards cancerous cells. Healthy tissues sharing the high proliferation rate characteristic 
of many types of cancers will often suffer the same damaging effects of the treatment 
resulting in nasty side effects.  
Other diseases dependent on cellular division such as bacterial infections could also be 
treated by DNA-targeting drugs. Many attempts have already been made to develop 
effective treatments targeting bacterial DNA, but the reoccurring problem of non-
specificity results in the drug being deemed to cytotoxic for the host. Interestingly, many 
of them were instead developed (quite successfully) as anti-cancer drugs. However, 
pathogenic bacterial strains are becoming more and more resistant to available 
antibiotics so it is much needed (now more than ever) that new antibiotics with 
alternative targets, such as bacterial DNA, are found.   
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Large biological molecules, such as DNA and proteins, are really just long chains of 
simpler building blocks molecules (nucleotides for DNA and amino acids for proteins). 
These building block molecules are chiral, meaning that they could in theory exist 
naturally as 50:50 racemic mixtures. However, both nucleotides and amino acids occur 
in nature as single enantiomers. Consequently, the DNA structure itself is chiral and 
exists as a single enantiomer, a right-handed helix. Any interactions between the DNA 
molecule and another chiral molecule will therefore be diastereomeric. Hence, in 
medicine, any drug with a chiral center and with a chiral target should be given as a single 
enantiomer, as the different enantiomers will interact differently with the chiral 
molecule in the body. 
Fifty years after their discovery, in the 80s, ruthenium(II) polypyridyl complexes were 
proposed to bind to DNA by inserting one of its ligands between the DNA base pairs in a 
binding mode called intercalation. The search for stronger binding affinity and 
enantioselectivity, combined with the interesting photophysical properties of 
ruthenium(II) polypyridyl complexes,  prompted a synthesis cascade of intercalating 
complexes with the hopes of developing a new DNA targeting drug or probe. Even so, 
there is still much that is unknown of the underlying mechanisms behind the ligand-DNA 
interactions. Factors such as the chirality of the complex or substitution groups on the 
ancillary and intercalating ligands not only affect the binding between the DNA strand 
and the ruthenium complex, but also the interactions between bound complexes in close 
proximity of each other. Only when the kinetics behind the ligand-DNA binding is fully 
understood and hence (more importantly), predictable, effective DNA-binding 
pharmacotherapeutics can be developed.  
In this thesis, I will explore how ruthenium complexes may influence each other’s binding 
interactions to DNA and how seemingly small molecular differences such as chirality and 
the addition of substitution groups can have significantly affect the binding properties of 
the complex. I will furthermore demonstrate how satisfactory model fitting can be 
achieved using quite simple methods, regardless the complexity of the binding system 
investigated. 
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2 BACKGROUND 
This thesis has a main theme of the binding interactions between small molecules and 
DNA using ruthenium complexes as model compounds. This chapter focuses on 
providing a basic understanding to why DNA is an attractive drug target, the properties 
of ruthenium complexes and how they interact with DNA, emphasizing the influences of 
molecular structure and chirality to binding affinity. Lastly, the fundamental concepts of 
cellular uptake mechanisms and the potential of developing ruthenium complexes as a 
new family of antibiotics will be addressed.   
2.1 Structure and Functional Role of DNA 
Deoxynucleic acid, or DNA, is a molecule that carries all genetic information of all known 
living organisms (with the exception of viruses that, rather than being “alive”, are free 
forms of DNA or RNA that cannot replicate on their own). The reading out of this 
information tells every cell which proteins to build, and where and when to build them. 
The proteins, in turn, are the building blocks of the living organism. In order to develop 
DNA-binding molecules with improved properties, such as binding affinity and sequence 
selectivity, the basic structure of DNA must first be understood. 
DNA is a long polymer consisting of two helical strands coiled around the same axis, 
where the 5’ end of one strand is paired with the 3’ end of its complementary strand, 
forming an anti-parallel double helix. Each strand is composed of the same repetitive unit 
called a nucleotide, consisting of a deoxyribose sugar with a nitrogenous nucleobase 
bound to one side and a phosphate group bound to the other side (Fig. 2.1 (left)). The 
nucleotides are covalently linked to each other with alternating sugar-phosphate 
residues, forming the DNA backbone. The nucleobase can either be a double-ringed 
structure (purine) or a single-ringed structure (pyrimidine). There are in total four 
available nucleobases: adenine (A) (a purine), cytosine (C) (a pyrimidine), guanine (G) 
(a purine) and thymine (T) (a pyrimidine). The nucleobases are hydrophobic, hence they 
point inwards protecting themselves from the aqueous environment. Together with the 
nucleobases on the opposite strand, they form pairs bound together by hydrogen bonds. 
Each base pair is formed from two complementary nucleotides (purine with pyrimidine). 
In accordance to Chargaff’s rules, A always pairs with T and C always with G (Fig. 
2.1(right)).1-3    
There are three different conformations of the DNA double helix: A-, B- and Z-form (Fig. 
2.2). The most common form, present in most DNA at neutral pH and physiological 
conditions, is the B-form. This is the classic right-handed double helical structure, first 
proposed by James D. Watson and Francis Crick in 1953,4 where the grooves formed by 
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between the backbones of the helix have equal depths, but two different widths. Their 
names, the major and minor groove, reflect their difference in size. The A-form is also a 
right-handed double helix, but is thicker with a shorter distance between the base pairs, 
due to a different conformation of the deoxyribose sugar ring. In contrast to the B-form, 
the base pairs are not perpendicular to the helix axis, but more displaced from the central 
axis and closer to the major groove. The result is a ribbon-like helix with a more open 
cylindrical core. This conformation is found in nature mainly in RNA-RNA duplexes, but 
also in DNA-RNA hybrids. It can also appear in dehydrated DNA samples used in 
crystallographic experiments. The third conformation, the Z-form, has a strikingly 
different left-handed helical structure. Z-DNA is formed by stretches of alternating 
purines and pyrimidines, e.g. GCGCGC, especially in negatively supercoiled DNA 
(underwound DNA).  
DNA has two major functions, both crucial for the survival of an organism. The first 
function is coding for proteins, where the genetic code is translated to a language of 
amino acids – the building blocks of proteins. Proteins play many critical roles in the 
body, including repair and maintenance, chemical reactions, and transportation of 
molecules. Indeed, with the exception of water, proteins are the most abundant 
substance found in an organism. The second function of DNA is replication; the ability to 
copy itself is vital for the reproduction and growth of an organism. As DNA plays such a 
critical role for cellular growth and reproductivity of an organism, malignant conditions 
dependent on uncontrolled cell division, such as cancer and infectious diseases, are often 
treated (quite successfully) with DNA-targeting drugs. However, while there are already 
effective treatments available that eradicate cancerous and bacterial cells though various 
Figure 2.1 A simplified illustration showing the anti-parallel structure of a small 
part of DNA (left) and molecular structure of the four nucleobases connected via 
hydrogen bonding (right). 
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DNA-damaging mechanisms, the specificity is still so poor that healthy cells are also 
affected. The challenge lies in finding new therapeutics with a more sequence-specific 
DNA binding affinity.       
2.2 Non-Covalent Binding Interactions with DNA 
In principle, there are six modes for reversible (noncovalent) binding of molecules with 
the DNA double helix: electrostatic attractions with the anionic sugar-phosphate 
backbone of DNA, interactions with the DNA major groove, interactions with the DNA 
minor groove, intercalation between base pairs via the DNA major groove, intercalation 
between base pairs via the DNA minor groove, and a threading intercalation mode (Fig. 
2.3).  
For groove binders, the major groove is generally reserved for proteins composed of 
DNA-binding domains as it exposes more functional groups that identify a base pair. 
Minor groove binding ligands are typically composed of several aromatic rings connected 
by bonds that possess torsional freedom. As a result, minor groove binders generally 
adopt a characteristic curved shape that is isohelical with the target groove. Minor 
groove binders generally exhibit a binding preference for A-T base pairs due to favorable 
hydrophobic contacts, the more well-known examples of this being the synthetic dyes 
DAPI5 and Hoechst6-7. In addition, sequence selectivity is easier to achieve compared to 
intercalators, as groove binders can recognize a longer base sequence. Minor groove 
Figure 2.2 A-, B- and Z-form of a 16 base pair DNA double helix. 
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binders are usually preferred for fluorescent staining of the DNA in, for example, 
microscopy as they do not cause structural distortions of the DNA, in contrast to 
intercalating ligands. 
Intercalating ligands typically possess flat, heteroaromatic ring systems capable of 
inserting between two adjacent base pairs in a double helix. The ligand-DNA complex is 
stabilized by π-π stacking interactions between the ligand and the DNA bases 
surrounding it. Also, cationic compounds stabilize the ligand-DNA interactions as there 
is an additional electrostatic attraction between the positive charge of the ligand and the 
negative charge of the phosphate backbone groups. Intercalation causes several 
distortions of the DNA backbone, e.g. lengthening of the DNA polymer and some 
unwinding. Conformational changes in the DNA polymer initiated by the first binding 
event will mediate the binding of additional ligands, i.e. cooperative binding. In addition, 
these structural changes can readily be used as a reliable diagnostic tool for this binding 
mode. Intercalating ligands can interfere with the recognition and function of DNA 
associated proteins and hence slow down or even inhibit replication and transcription 
processes. 
A more unusual DNA-binding mode is threading intercalation, associated with molecules 
containing an aromatic ring system with bulky substituents on opposite ends, much like 
a dumbbell shape. A well-known example is the naturally occurring antibiotic 
nogalamycin.8 For both binding and dissociation to occur, one of the bulky substituents 
must pass through the base pair stack. The resulting bound state leaves the flat middle 
part intercalated between the base pairs and the bulky substituents located one in each 
groove. Obviously, the large molecular thickness of the bulky substituents requires some 
Figure 2.3 Schematic illustration of 
possible non-covalent binding modes 
between small molecules and DNA. 
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base pair dissociation (i.e. partial breakage of the DNA double helix) for penetration to 
occur. Such a process will effectively result in kinetic inertness and a higher stabilization 
of the ligand-DNA complex not seen in those formed from conventional intercalators. The 
reduced dissociation rate associated with a threading intercalation binding mode have 
been shown to be important for cytotoxic activity9,  making these types of molecules very 
attractive as potential new DNA-binding drugs.   
2.3 General Properties of Metallointercalators 
Metallointercalators refer to positively charged transition metal complexes that contain 
planar, heterocyclic, aromatic ligands with at least one of the ligands capable of DNA 
intercalation. Most metallointercalators, with very few exceptions, share a few 
characteristics important for their functionality. They are coordinately saturated making 
them kinetically inert which, in turn, give the metal complexes a much desired stability. 
They are either d6 octahedral or d8 square-planar, thus exhibiting a rigid or mostly rigid 
three-dimensional structure, also an important property since excessive fluxionality 
could negatively affect DNA-sequence recognition. It is also possible for the 
stereochemistry of the metal complex to provide specificity. The metal center serves as 
an anchor, and its stability enables interchangeability of the ligands, thus the DNA-
binding and recognition properties of the complex can be varied quite easily. Finally, 
most of the complexes are photochemically or photophysically active thanks to the 
transition metal center, thus extending the potential use of metallointercalators to more 
than just a passive molecular recognition agents. As a result, metallointercalators can be 
used in various capabilities, such as fluorescent markers10, DNA foot-printing agents11-12 
and electrochemical probes13. 
2.4 Ruthenium(II) Polypyridyl Complexes as DNA Intercalators  
The first clues suggesting interactions between inert metal complexes and DNA can be 
traced back as far as the 1950s, in the work of F.P. Dwyer and coworkers where simple 
tris(chelate) complexes of Ru(II) and Ni(II) were found to have antimicrobial and 
antiviral activities.14-17 Even this early, an enantioselective biological activity could be 
observed in some cases. It was, however, not until the 1980s that the binding interactions 
between ruthenium complexes and DNA were described. These earliest studies focused 
on tris(phenanthroline) complexes of several transition metals18-19, among which 
ruthenium20-22, indicating the DNA-binding mode for Ru(phen)32+ to be partial 
intercalation of a phenanthroline (phen) ligand into the helix in the major groove23-24. 
These early studies suggested that ruthenium(II) polypyridyl complexes of the general 
form Ru(L)2(IL)2+ (L = ancillary ligand and IL = intercalating ligand) interact with DNA 
via intercalation of one of the ligands between the base pairs. Furthermore, depending 
on the type of ligand coordinated, the mode and strength of the DNA interaction could be 
modified. This initiated a search for ruthenium complexes with improved DNA-binding 
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as well as photophysical properties, the most famous examples probably being the light-
switch complexes, Ru(bpy)2dppz2+ and Ru(phen)2dppz2+, so named for becoming  
completely quenched in aqueous solution but become brightly luminescent upon 
intercalation into DNA.25-28 This effect is considered to be caused by hydrogen bonding 
of the aqueous environment to the phenazine nitrogens of the dppz ligand, leading the 
emissive 3MLCT state (located on the dppz ligand) to be effectively quenched.29-30 That it 
is the dppz ligand in tri-bidentate complexes that intercalates between the base pairs has 
been established by both spectroscopic and biophysical methods, with the most recent 
examples being a series of X-ray crystallography studies by Hall and coworkers.31-33 Once 
intercalated, the dppz ligand is shielded from the surrounding solvent and hydrogen 
bonding is made more difficult. The “light-switch effect” aside, the increased overlap 
between the extended phenazine rings of the dppz ligand and the aromatic nucleobases 
significantly improved DNA-binding affinity.25 As even seemingly small changes in the 
structures of both the ancillary as well as the intercalating ligands may tune the 
photophysical properties of the complex, numerous variations of dppz-ruthenium-
centered complexes have been reported, with the aim of improving both DNA-binding 
strength and DNA sequence selectivity.  
The octahedral coordination geometry that comes from coordinating three bidentate 
ligands to the ruthenium ion leads to a structure much like a three-winged propeller 
structure (Fig. 2.4). A propeller can either have a right-handed (Δ) or a left-handed (Λ) 
configuration, resulting in a chiral ruthenium complex able to exist in two enantiomeric 
forms, which are non-superimposable mirror images of each other. DNA, being a right-
handed double helix in its most naturally occurring B-form, is consequently also a chiral 
molecule and will interact differently with the Δ- respectively Λ-enantiomer, as 
numerous studies have already demonstrated.21, 34-41  
Figure 2.4 The Λ- (left) and Δ-enantiomer (right) of Ru(phen)32+. 
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If instead a tridentate moiety is coordinated to the ruthenium ion, a plane of symmetry 
is introduced and there will no longer be a stereocentre at the ruthenium ion and the 
complex will thus not be chiral. This eliminates the need for resolving racemic mixtures 
into pure enantiomeric forms. However, in contrast to the well-studied light-switch 
complexes and their derivatives, complexes with a tridentate moiety such as tpy have 
generally very small quantum yields at room temperature.42-43 As a result the interest for 
intercalating ruthenium complexes with a tridentate moiety has been much lower. 
However, this type of intercalating ruthenium complex has a single free coordination site 
left available, enabling a fine-tuning of its DNA-binding properties.  
As mentioned above, threading intercalation is an unusual binding form with a 
significantly slower association and dissociation rates when binding to DNA. Binuclear 
ruthenium(II) polypyridyl complexes of the form μ-bidppz(L)4Ru24+ (L = phen or bpy) 
were found to bind with extremely high affinities to DNA through a binding mode later 
identified as threading intercalation.37, 44-45 Not only do these ruthenium complexes have 
extremely slow kinetics, even in comparison with other synthetic threading 
intercalators, but they also possess light-switch properties. In combination, the 
threading process can be easily studied using only conventional spectroscopic 
techniques. Our group has previously shown both μ-bidppz(phen)4Ru24+ and μ-
bidppz(bpy)4Ru24+ to be kinetically selective towards long AT-rich sequences of DNA.46-
47 Later studies on binuclear ruthenium complexes with structural modifications on the 
bridging ligand showed the same selectivity.48-49 This property could potentially be 
exploited for targeting genomes with AT-rich DNA, for example the Mycoplasma 
species50, which are endosymbiotic bacteria, and the malaria parasite Plasmodium 
falciparium51. 
2.5 Cellular Uptake of Ruthenium Complexes 
In order to reach the DNA in a living cell, a compound must be able to penetrate a series 
of barriers, one of the first being the cell membrane. Composed primarily by a lipid 
bilayer of phospholipids containing a variety of proteins and lipids, the cell membrane 
regulates the uptake (and expulsion) of compounds. The organization of the lipid bilayer, 
which is composed of a hydrophilic head group attached to hydrophobic chains, provides 
a hydrophobic interior of the membrane. As a result, a large and/or hydrophilic 
compound will have more difficulty permeating the membrane via passive diffusion. 
Such compound would instead require a transport mechanism or endocytosis, both 
tightly regulated by different membrane proteins and receptors. Often the cell 
membrane is permeabilized during the initial assessment of a compound. While the 
barrier is removed to allow free passage into the cytosol, the internal structure of the cell 
remains intact (although non-viable). This provides information of the compound’s 
intracellular targets as well as what photophysical properties that might be present.  
10 
The 3MLCT light-switch properties of Ru(L)2dppz2+systems greatly simplifies the 
assessment of cellular uptake and localization within the cell. Initial studies by the Barton 
group indicated passive diffusion as the uptake mechanism and hence a strong 
dependence on the hydrophobicity of the ancillary ligands.52-53 This comes as no greater 
surprise, considering the largeness and positive charge of these types of Ru complexes, 
making them relatively hydrophilic. While mononuclear ruthenium(II) polypyridyl 
complexes appear to rely on passive diffusion as the transport mechanism, binuclear 
complexes enter the cell via active transport, using both endocytic and non-endocytic 
pathways, depending on the structure of the complex. Again not surprisingly, as the sheer 
size of such a complex would greatly diminish its ability to enter the cell through passive 
diffusion. Complexes entering the cell through an endocytic drug delivery mechanism 
appear to have limited nuclear staining when compared to those transported through 
the cell membrane in a non-endocytic way.54 Complexes that enter the cell through 
endocytosis appear instead to be trapped in the endosomes55 or transported to the 
mitochondria56. Evidently, the initial transport mechanism chosen to surpass the first 
obstacle for the complex heavily influences what the final destination will be, making it 
even more important for the uptake properties of the complex to be fully understood. 
While it is already well-established that the chirality of a complex have great impact on 
its DNA-binding properties, should a complex need to enter a cell through non-endocytic 
active transport, it is likely that the chirality would also influence the ability to permeate 
the cell membrane in the first place, emphasizing the importance of using enantiopure 
complexes when assessing cellular uptake. 
2.6 Morphology of Prokaryotic Cells 
Cells are regarded as the basic building blocks of life and all living organisms can be 
broadly classified either as prokaryotes or as eukaryotes, depending on the fundamental 
structure of their cells (Fig. 2.5). Prokaryotes are subsequently divided into two groups: 
bacteria and archaea, while all other groups of living organisms are eukaryotes. In 
contrast to eukaryotic cells, the more primitive prokaryotic cell lack a cell nucleus (which 
holds genetic material) as well as any other membrane-encased organelles. Although 
prokaryotic cells do not contain a cell nucleus, its genetic material is still located in a 
discrete region in the cytoplasm called the nucleoid. Unlike the linear DNA of eukaryotes, 
bacterial DNA consists typically of a single circular chromosome. Many bacteria also 
contain one or more plasmids, which are small circular DNA molecules. These can readily 
be picked up from the surrounding environment (transformation) or by direct contact 
from other bacteria (conjugation). 
All plasmids have their own “Origin of replication” – a stretch of DNA making the plasmid 
capable of copy themselves independently of the bacterial chromosome, resulting 
sometimes in hundreds of copies within one bacterial cell. The plasmids contain only a 
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few genes that are helpful for the cell in particular stressful situations, such as exposure 
to an antibiotic.  
All cells have a plasma membrane, acting as a protective barrier separating the internal 
content of the cell from the surrounding environment. In addition, almost all prokaryotes 
have a chemically complex cell wall outside of the plasma membrane, separated from it 
by a periplasmic space. Bacteria can, in broad terms, have two types of cell walls and can 
hence be classified into two groups of bacterial species: Gram-positive or Gram-negative. 
The names refer to the bacteria’s ability to retain the color of the Gram stain: originally 
devised by Danish bacteriologist Hans Christian Gram in 1882 (published 1884)57 and is 
considered one of the most important staining techniques in microbiology. While Gram-
positive bacteria have a thick homogeneous cell wall with several layers made of 
peptidoglycan and teichoic acids, Gram-negative cell walls are much thinner with only a 
few layers of peptidoglycan. An additional outer membrane consisting of 
lipopolysaccharides and lipoproteins surrounds the cell wall. Because of the multiple 
layers, the outer covering of a Gram-negative bacteria is near-impossible to penetrate 
and the reason to why Gram-negative pathogens are much harder in general to 
successfully treat with antibiotics compared to Gram-positive.58-59 Its protective qualities 
can be compared to those of a bullet-proof west. Depending on the charge and shape of 
the antibiotic some are able to traverse the outer lipid layer via porin proteins.60-61 
However, these transport proteins can change their properties through mutations,62-64 
thus increasing the risk of the bacterial strain developing antibiotic resistance.  
Gram-negative Escherichia coli and Gram-positive Bacillus subtilis are both frequently 
used as model organisms in microbiology and both have had their entire genome 
sequenced.65-66 E. coli is rod-shaped and most commonly found in the lower intestines of 
warm-blooded organisms. Most strains are harmless and part of the normal gut flora. B. 
subtilis is also rod-shaped and most commonly found in the upper layers of soil, but is 
also considered to be a part of the normal human gut flora. B. subtilis is one of the best 
Figure 2.5 Simplified illustration showing the fundamental differences in basic 
structure between a eukaryotic cell (left) and a prokaryotic cell (right). Note that 
their relative size is not accurate as prokaryotic cells are much smaller (0.1-5.0
μm in diameter) compared to eukaryotic cells (10-100 μm in diameter). 
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studied Gram-positive bacterium and is often considered as the Gram-positive 
equivalent of E. coli (in terms of popularity).  
2.7 Antibiotics and Multidrug Resistant Pathogens 
Antibiotics such as we know them were first introduced into clinical practice in the 
1940s, after the initial observation made by Alexander Fleming 12 years prior of the 
antimicrobial activity of the mold Penicillium67. This marked the beginning of the “golden 
era” of antibiotics and the discovery of several other antibiotic classes followed. Initially, 
these first types of antibiotics were so efficient in treating pathogenic bacteria so that 
infectious diseases were believed to eventually be wiped out completely, but it soon 
became clear that bacteria could become resistant to them. For a while, a continuous flow 
of new antibiotics alleviated this problem, but in recent years this flow has significantly 
slowed down. As a consequence, the prevalence of antibiotic-resistant bacteria, in 
particular multidrug resistant pathogens, have rapidly risen.68-69 Apart from preventing 
the antibiotic from entering the cell, the bacteria may also alter its antibiotic target, or 
directly destroy or modify antibiotics, thus resisting their effect (Fig. 2.6).70-71 Most types 
of antibiotics clinically available today target the same limited set of bacterial 
components, usually by either disrupting the bacterial cellular wall or inhibiting protein 
synthesis of the bacterial cell.72-73 While bacterial-exclusive targets decreases the risk of 
adverse side effects from the treatment, it also increases the risk of antibiotic resistance. 
In addition, most “new” antibiotics that are coming onto the market are merely variants 
of existing drugs, with the risk that resistance mechanisms have already (at least in part) 
developed.74 Only quinolones, another family of antibiotics, target bacterial DNA by 
preventing it from unwinding and duplicating.75 This is however not done by direct 
interaction with bacterial DNA, but by targeting either the bacterial DNA gyrase or the 
topoisomerase enzyme.  
Figure 2.6 Summary of common antibiotic-resistance mechanisms. 
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While many DNA-binding compounds have proven to have a strong antibiotic activity, 
the lack of specificity towards bacterial DNA have deemed all too cytotoxic against the 
host. Indeed, many potential antibiotics where instead developed as anticancer 
treatments, with the most famous example probably being actinomycin D.76 Bacterial 
DNA is still an attractive target, provided that specificity to bacterial cells can be 
established, either by cellular uptake or by specific affinity towards bacterial DNA.77 
Ruthenium(II) polypyridyl complexes possess many of the sought-after qualities in an 
antibiotic, being water soluble, coordinately saturated and inert to substitution. In 
addition, their properties can be easily modulated in order to increase specificity 
towards bacterial targets. Despite this, as well as the pioneering work of Dwyer and 
coworkers, there has not been any major interest in testing ruthenium(II) polypyridyl 
complexes for their antimicrobial activity until recently. While these studies show 
promising results78-79, with the exception of Li and Keene et al.80-86, they only test racemic 
complexes thus not taking into consideration any potential enantiomeric difference in 
antimicrobial activity.       
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3 METHODS 
The focus in this thesis has been on how the molecular structure of ruthenium(II) 
polypyridyl complexes affects DNA-binding properties such as binding affinity and 
interactions between neighboring bound ligands. This has been done by using various 
spectroscopic techniques, evaluating the binding orientation and binding constants to 
both ctDNA and AT-DNA. With the development of a general algorithm for the global 
fitting of ligand-DNA interactions, it has also been possible to find appropriate binding 
models for intercalative dppz complexes based on experimental isothermal titration 
calorimetry (ITC) data. Finally, the antimicrobial activity and mode of action of both 
mono- and binuclear complexes are thoroughly investigated using metal susceptibility 
assays as well as fluorescence confocal microscopy. Below follows a brief description of 
the techniques used in this project as well as some fundamental concepts explained.            
3.1 Synthesis of a Terpyridine-Based Ruthenium Complex 
The octahedral structure of tris-bidentate ruthenium-centered complexes results in the 
existence of two enantiomeric forms, the right-handed Δ-form and the left-handed Λ-
form. By instead coordinating a tridentate ligand to the ruthenium ion the metal loses its 
stereocentre, thus making the molecule achiral. This eliminates the need for separating 
the Δ and Λ racemic mixtures characteristic of tris-bidentate systems. In addition, a 
Figure 3.1 Synthetic route for Ru(tpy)(py)dppz2+ 
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ruthenium complex with dppz as the intercalating ligand together with a tridentate 
ligand will have a single free coordination site left free on the ruthenium ion, enabling a 
fine-tuning of the ligand-DNA interactions not possible in the tris-bidentate systems. In 
Paper I, the tridentate ligand terpyridine (tpy) was coordinated to a dppz-ruthenium-
centered complex. For the purpose of comparison, a single pyridine ring was attached to 
the remaining single coordination site, making the resulting complex an achiral 
structural isomer of the chiral Ru(bpy)2dppz2+ (the original “light-switch” complex). The 
synthetic route is summarized in Fig. 3.1 and is a modified version of the method 
previously described by Zhou et al. and Leising et al.87-88 
3.2 Exploring the Photophysical Properties of Ru Complexes 
Light is a kind of electromagnetic radiation, which is a type of energy consisting of both 
an electric (E) and magnetic (B) component. Both components oscillate a sinusoidal wave 
pattern in perpendicular directions relative to each other and to the direction of 
propagation (k). When molecules interact with light (carried by photons) so that they are 
excited from their ground state to higher electronic states, the light is said to be absorbed. 
For absorption to occur, the incident light has to have the same energy as the difference 
in energy between the ground state and the excited state of the absorbing molecule. A 
molecule, or part of a molecule, that can be excited and absorb light is called a 
chromophore. This energy difference depends not only on the structure of the absorbing 
chromophore but also on its surrounding environment. This means the absorption of a 
molecule will change when bound to DNA as the environment will be different compared 
to when the molecule is free in solution. It is therefore possible to utilize a variety of  
spectroscopic techniques where the extent of absorption is measured as a function of 
wavelength (inversely related to the energy of the light).  
Ultraviolet-visible (UV-vis) absorption spectroscopy (also known as spectro-
photometry) is one of the simplest but also one of the most versatile spectroscopic 
techniques used for study molecules and the interactions between molecules. Organic 
compounds with multiple bonds such as C=C, C=O or C=N often have a strong in the UV-
vis portions of the light spectrum so measurements are normally done in the 200-800 
nm interval. In a typical experiment, the spectrophotometer will direct light of a specific 
wavelength on the sample, and the absorbance is measured as the log of the ratio of the 
incident light and the transmitted light. The intensity of the transmitted light will depend 
on the number of absorbing molecules in the light beam. As a result, the absorption of a 
sample will be linearly proportional to the molar concentration of the sample tube: 
ܣሺߣሻ ൌ  ቀூబூ౐ቁ ൌ ߝሺߣሻ݈ܿሺͳሻ  
where A(λ) is the absorbance at wavelength λ, I0 is the intensity of the incident light, IT is 
the intensity of the transmitted light, ε is the molar extinction coefficient, c is the molar 
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concentration of the sample and l is the path length of the light beam (length of the 
sample tube). 
Once excited, the molecule may return to the ground state (S0) by both radiative and non-
radiative pathways. Some energy is rapidly lost to vibrational relaxation (heat) in a 
process called internal conversion, leaving the excited molecule in the lowest level of the 
first excited state (S1). From there, the molecule may fall to one of the sub-levels of the 
ground state, whilst emitting a photon with energy equivalent to the energy difference 
of the transition. This process is termed fluorescence. The energy of fluorescent photons 
is always less than that of the exciting photons, meaning that the emission wavelength 
will be longer compared to the absorbing wavelength. Another path that a molecule may 
take in the dissipation of energy is called intersystem crossing. This is also a non-
radiative path but in contrast to internal conversion, which does not involve a change of 
spin multiplicity, intersystem crossing is the conversion of an excited singlet state to an 
excited triplet state (T1). This is a forbidden transition, hence it should not happen if only 
electronic selection rules applied. However, by coupling vibrational factors into the 
selections rules, the transition becomes more allowed, yet it is still a much slower 
process compared to fluorescence. From the excited triplet state, the molecule can fall 
back to the singlet ground state via a radiative transition called phosphorescence. Like 
intersystem crossing, this process is spin-forbidden and hence also very slow. There are 
other, non-radiative transitions from excited state to ground state that compete with 
Figure 3.2 Jabłoński diagram illustrating energy levels and the transitions
between different electronic states. Non-radiative transitions are represented by
dashed arrows, radiative transitions by solid arrows.   
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fluorescence as the molecule relaxes back to the ground state. Such transitions are 
energy transfer between molecules through molecular collisions, and quenching where 
energy is transferred between molecules trough overlap in absorption and fluorescence 
spectrums. This explains why many molecules are not fluorescent or phosphorescent. All 
these possible electronic transitions are often summarized in a Jabłoński diagram (Fig. 
3.2).  
3.3 DNA-Binding Orientation Determined by Linear Dichroism 
When light is absorbed by a chromophore there is an interaction between the electric 
field of the light and the local charges on the chromophore, yielding an oscillating charge 
displacement. This displacement is represented by the transition dipole moment. The 
more parallel the orientation of the electric field of the light is to that of the transition 
dipole moment, the more effective is the charge displacement resulting in stronger 
absorption.89-90 By keeping the transition dipole moment of a chromophore constant, its 
absorption of linearly polarized light will depend solely on the direction of the 
polarization. The difference in absorption between two perpendicularly polarized light 
beams is called the linear dichroism (LD): 
 ൌ ܣȁȁ െ ܣୄሺʹሻ 
where Aıı and A٣ are the absorption of the polarized light parallel and perpendicular to a 
macroscopic orientation axis, respectively. For a randomly oriented sample, such as DNA 
polymers in solution, introducing an orientation during the experiment requires some 
kind of external force. There are several means available, but the most convenient 
Figure 3.3 Schematic illustration of the Couette flow cell with radial incident light
linearly polarized in XY (as shown) or XZ plane. Also showing are the direction of 
the electric field E, the magnetic field B and the propagation direction k.    
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method for orientation of long polymers such as DNA is the Couette flow cell orientation 
system.91 Only small amounts of sample is required and the constant recirculation of the 
sample enable many repeat measurements thus decreasing the effect of background 
noise. A schematic illustration of the Couette cell is shown in Fig. 3.3. The sample is 
inserted into the narrow gap between two quartz cylinders. By rotating one of the 
cylinders, a shear flow gradient is created in-between the cylinders that causes the long 
DNA polymer to align in the flow direction. Only molecules long enough to align in the 
sample will exhibit a LD signal. Unbound ruthenium complexes are too small to be 
properly oriented, hence only ruthenium complexes bound to an oriented DNA polymer 
will give rise to a LD signal. 
Assuming the helix axis of the flow-oriented DNA as the orientation axis, LD signals >0 
would indicate the transition dipole moment responsible for that signal to be oriented 
closer to parallel to the DNA polymer helix axis.89-90 A LD signal <0 would thus indicate a 
more perpendicular orientation. In DNA, only the nucleic bases contribute to absorption 
at wavelengths >200 nm. Since the bases are almost perpendicular to the DNA helix axis, 
their transition moments will be oriented perpendicular to the orientation axis in flow-
oriented DNA. Using the same principle, LD spectroscopy can be used to obtain the 
orientation of ligand-DNA interactions, provided that the polarization direction of a 
transition dipole moment within the ligand is known.92 
Using the reduced linear dichroism, LDr, which is the LD divided by the isotropic 
absorption (Aiso), it is possible to determine the angle between a specific transition dipole 
moment (transition i) and the orientation axis provided that the transitions are non-
overlapping: 
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where θi is the angle between the transition dipole moment and the orientation axis of 
the molecular system, γ is the ratio of the optical path-length of the absorption 
measurement to that of the LD measurement, and S is the orientation factor which 
describes the degree of orientation of a sample (S=1 means perfect orientation of the 
sample, whereas S=0 means random orientation). Should the magnitude of S increase 
due to some change in the system (such as the introduction of a DNA-binding molecule) 
the DNA has become more oriented and consequently the LD signal becomes stronger. 
This increase is usually caused by the DNA polymer becoming elongated or stiffened or 
both. 
However, in most cases, and also for ruthenium(II) polypyridyl complexes, electronic 
transitions overlap over the whole range of the spectrum. In such cases, Aiso of each 
sample can be regarded as a sum of component spectral envelopes ei of the absorption 
bands of all transition dipole moments: 
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The LD spectrum will then be the weighted sum of the weights wi of the same component 
spectral envelopes: 
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In cases where a single component spectral envelope ei dominates the absorption 
spectrum, e.g. as seen for the absorption band of B-DNA at around 260 nm, the LDr curve 
will be more or less constant and take the value wi. The angle θi for the in-plane polarized 
nucleobase transitions at this absorption band is close to 90°, hence the orientation 
factor S0 for ligand-free DNA can be calculated from the LDr values as follows: 
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However, the absorption spectra of ruthenium(II) polypyridyl complexes are composed 
of several different electronic transitions which substantially overlap each other. As a 
consequent, the LDr curve will vary strongly with wavelength, making it not possible to 
directly determine the LDr of each individual transition dipole moment. Instead, the 
experimental Aiso and LD spectrum for a ruthenium complex may be divided into 
separate absorption bands, one for each polarization direction. This was done in Paper 
I, where we analyzed the LD data of Ru(tpy)(py)dppz2+ in the presence of calf thymus 
DNA (ctDNA) using the TEM method.38, 93 where a system of a two component envelope 
spectra, with distinct characteristic absorption band features and distinct weights, make 
it possible to combine Eqs. (4) and (5) into a matrix system:      
ሾ܉܊ሿ ൤ͳ ݓଵͳ ݓଶ൨
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where a, b, e1 and e2 are column vectors corresponding to the Aiso, LD and the two 
components envelope spectra, respectively. When varying the weights w1 and w2 in Eq. 
(7) the characteristic features of component e1 will visibly vanish in component e2, and
vice versa.
The angular orientation can be determined only if the orientation factor S is known. If a 
ligand strongly binds to DNA, has significant absorbance at wavelengths above the DNA 
absorption range (>300 nm) and invariant binding geometry and absorption spectrum 
(within a known range of [ligand]/[DNA] ratios), S can readily be obtained as follows: 
Let column vectors L1 and L2 be two LD spectra with different [ligand]/[DNA] ratios and 
L0 be the LD spectrum of a sample with DNA only. The three columns are linearly 
dependent if the DNA and bound ligand spectral profiles are invariant with the 
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[ligand]/[DNA] ratios, thus scalars α and β can be found so that αL1 + βL2 = L0. Let M = 
[L1 L2] and x = [α; β] in matrix notation: 
ۻܠ ൌ ۺ૙ሺͺሻ 
Solving Eq. (8) by a least square projection gives α and β: 
ሺۻ܂ۻሻିଵۻ܂ۺ૙ ൌ ܠሺͻሻ 
If a ligand binds strongly to DNA it is assumed that no added complex will remain 
unbound in a DNA solution (within reasonable concentrations). Therefore, the DNA 
concentration can be considered equal in the three samples and the vectors can be 
written as: 
ۺ૙ ൌ ߛܵ଴܌ۺ૚ ൌ ߛ ଵܵሺ܌ ൅ ܿଵ܊ሻۺ૛ ൌ ߛܵଶሺ܌ ൅ ܿଶ܊ሻሺͳͲሻ 
where (with γ = 1), d is the LD spectrum at perfect orientation of DNA only, b is the LD 
spectrum at perfect orientation of bound complex at unit concentration, and c1 and c2 are 
the two known complex concentrations. At wavelengths >300 nm d will be zero and if b 
is non-zero, so by inserting Eq. (10) in (8) the following two equations are obtained: 
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Since γS0 can be evaluated from Eq. (11) it is possible to obtain S1 and S2 from known 
quantities: 
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3.4 Ligand-DNA Interactions Studied Using Circular Dichroism 
Circular dichroism (CD) spectroscopy is, like linear dichroism, based on the differences 
in absorbance of polarized light. In contrast to linear polarized light where the electric 
field vector oscillated only in one plane, circularly polarized light occur when the electric 
field vector rotates around the propagation axis while maintaining constant magnitude. 
As the radiation propagates the electric field vector traces out a helix in space, which can 
be either left-handed or right-handed. CD is defined as the difference in absorbance 
between left- and right-handed polarized light:      
ሺȟܣሻ ൌ ܣ୐ െ ܣୖሺͳ͵ሻ 
where AL and AR are the observed absorbance of left- and right-handed polarized light, 
respectively. As Eq. 13 indicates, a circular dichroism signal can be positive or negative, 
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depending on left-handed circularly polarized light is absorbed to a greater (positive) or 
lesser (negative) extent than right-handed circularly polarized light. Achiral 
chromophores absorb left- and right-handed circularly polarized light in the same extent, 
hence the CD signal would be zero. If, on the other hand, the chromophore is chiral or 
perturbed by a chiral environment, the differential absorption would result in different 
amplitudes of left- and right-handed circularly polarized light. As previously mentioned, 
many ruthenium complexes are chiral and would exhibit CD signals on their own. The 
same goes for the DNA polymer, being a right-handed helix. Binding to DNA, both chiral 
and achiral molecules can result in a new CD signal not otherwise present, the induced 
CD, due to interactions between the transition dipole moments of the bound molecule 
and the nucleobases.90 The distances and angles between the interacting transition 
dipole moments will dictate the magnitude and sign of the induced CD signal. Therefore, 
similar binding geometries are expected to result in similar patterns in the induced CD 
signal.  
3.5 Metal Susceptibility Assay for Testing Antimicrobial Activity 
When evaluating a substance’s potential usage as an antibiotic, the minimum inhibitory 
concentration (MIC) and the minimum bactericidal concentration (MBC) are normally 
determined at an early stage, as it provides quantitative data useful when predicting 
necessary tissue and blood levels for an antibiotic to be effective. MIC is defined as the 
lowest concentration of a compound that inhibits visual growth of an organism; the MBC 
is defined as the lowest concentration of a compound required to kill a particular 
bacterial strain.  
Figure 3.4 Experimental setup of the metal susceptibility assay for the 
determination of MIC and MBC of an antibiotic.  
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In Paper V, we used a modified version of the MBEC high-throughput assay94 in order to 
determine the antibiotic activity of enantiopure Ru(phen)2dppz2+and μ-(11,11’-
bidppz)(phen)4Ru24+ to a Gram-positive and a Gram-negative bacterial strain. The 
method (summarized in Fig. 3.4) allows for both MIC and MBC to be determined in a 
single experiment. In a typical experimental setup, frozen stocks of bacterial strains are 
streaked out on Luria-Bertani (LB) agar to obtain a subculture. After overnight 
incubation, a single colony is picked and suspended in LB medium to grow for 3-4 hours, 
after which the suspension is diluted 100-fold. Serial dilutions of the ruthenium 
complexes are set up on a 96-well microtiter plate followed by the diluted bacteria 
suspension. After overnight growth, the MIC values are determined by reading the 
optical density (OD) at 650 nm of the plate. In order to obtain the MBC values, the Ru-
bacteria suspensions are diluted 101-108 fold and spot plated on LB agar plates. After an 
appropriate growing period (depending on the growth rate of the bacterial strain) the 
colonies are counted and CFU/mL (colony-forming units) is determined: 
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If no colonies are formed at a certain concentration, that concentration is determined as 
the MBC value for that bacterial strain.  
3.6 Bacterial DNA Intercalation Visualized by Confocal Microscopy  
For a ruthenium complex to function as a DNA interacting antibiotic it must first and 
foremost be able to reach the DNA in live bacterial cells. Emissive molecules such as 
(many) ruthenium complexes can easily be located inside cells using fluorescence 
confocal microscopy, which is done in Paper V. Here, bacterial cells were incubated with 
enantiopure Ru(phen)2dppz2+ and then washed and fixated using formaldehyde. Thanks 
to the well-established light-switch effect of Ru(phen)2dppz2+, the uptake and DNA 
intercalation of the complex could be visualized. 
In regular fluorescence microscopy the sample is completely illuminated by the 
excitation light, so all of the sample is fluorescing at the same time. Because of this, there 
will be a background haze in the resulting image. By adding a pinhole in front of the 
detector, only the light originating from an in-focus plane will freely pass the pinhole, 
while light coming from the out-of-focus planes will effectively be blocked out.95 Usually 
a laser provides the excitation light (in order to get high enough intensities). The laser 
light passes through a second pinhole, is reflected by a dichroic mirror, and focused by a 
microscope objective to a small spot in the sample. The dichroic mirror reflects light of a 
shorter wavelength while transmitting that of a longer wavelength. The image is then 
built up by a computer connected to the detector, one pixel at a time. By scanning several 
thin sections of the sample while rejecting out-of-focus light, a very clean three-
dimensional image can be obtained. 
24 
 
3.7 Ligand-DNA Thermodynamics and Isothermal Titration Calorimetry 
Often referred to as the “gold standard” for quantitative measurements of bio-molecular 
interactions, isothermal titration calorimetry (ITC) is a high-precision tool for studying 
the binding interactions between a ligand and a macromolecule. It is also the only direct 
thermodynamic method that enables a full thermodynamic characterization of the 
interaction (stoichiometry, enthalpy, entropy of binding, and association constant) after 
a single titration experiment.96-98 In a typical experiment (Fig. 3.5), a solution of the 
macromolecule is placed in the sample cell of the calorimeter. The ligand is then titrated 
in aliquots using an automated precision syringe lowered into the sample cell. A paddle 
at the end of the syringe stirs the content of the sample in order to ensure rapid mixing 
of the reactants. After each addition, the heat released or absorbed in the sample cell is 
measured with respect to a reference cell of the same volume. The heat change (ΔT) is 
expressed as the electrical power (μcal s-1) required to maintain a constant temperature 
in the sample cell and the reference cell. The integrated heat flow from each injection Qi 
corresponds to the enthalpy change ΔH from the interaction between ligand and 
macromolecule: 
௜ܳ ൌ ȟሾܮ௜ሿୠ୭୳୬ୢ ൈ ୡܸୣ୪୪ሺͳͷሻ 
where Δ[Li]bound x Vcell corresponds to the molar increase of bound ligand with each 
injection.  
Figure 3.5 Left: Schematic of the ITC cells and injection syringe. Right: 
Representative raw data from an ITC experiment showing the standard sigmoidal
shape typical of independent non-cooperative binding. 
25 
 
In the simplest of scenarios, where the binding sites of the macromolecule are 
independent of each other and the binding of the ligand is non-cooperative, nearly all 
injected ligand will bind to the macromolecule in the beginning of the titration, as nearly 
all binding sites are available. As the titration progresses, more and more binding sites 
will become occupied resulting in only a fraction of injected ligand able to bind to the 
now saturated macromolecule. Since the integrated heat is proportional to the total 
binding enthalpy of each injection, the ITC curve will have a sigmoidal shape. The small 
heat changes registered at the end of the titration are caused by the heat of ligand dilution 
and other nonspecific effects. Usually these are corrected for by performing a blank 
titration of ligand into buffer. In some cases, however, the heat of dilution is too large to 
simply be corrected by a blank titration. A large dilution heat could simply be caused by 
buffer mismatch, where the buffer composition (including pH) of the cell and syringe 
samples are different. This can be easily adverted by matching the buffers using co-
dialysis prior to the measurements. A second possible cause for large dilution heats is 
dissociation, where the high concentration in the syringe causes the ligands to form 
oligomers (for example dimers), which dissociate upon injection (i.e. dilution). This is an 
equilibrium process by itself and cannot simply be subtracted from the ITC curve by a 
blank titration. In Paper III a model is described that explicitly takes into account the 
ligand oligomerization equilibrium, as well as the external aggregation of further ligands 
on already saturated DNA at the end of the titration.  
3.8 Binding Isotherms and Model Fitting 
As stated above, in the simplest systems the binding sites on the macromolecule are 
independent of each other and the ligand binding is non-cooperative, resulting in a 
sigmoidal shaped curve. In such cases the curvature of the ITC profile depends on the 
binding constant K and the total number of binding sites. While proteins and short 
oligonucleotides often have independent and isolated binding sites, the DNA used in the 
experiments presented here consist of long polymers of binding sites, which overlap each 
other when occupied by bulky ligands (such as DNA-binding ruthenium complexes). In 
addition, neighboring bound ligands may affect each other by either cooperative or anti-
cooperative interactions, which gives rise to an interaction enthalpy Δh in addition to the 
intrinsic binding enthalpy ΔH. The classical McGhee and von Hippel model, which was 
presented in 1974, treats DNA as a one-dimensional infinite lattice of which the subunits 
are the identical binding sites.99 The model accounts for both nearest-neighbor 
interactions as well as bound ligands covering more than one binding site. In Paper I a 
non-unity cooperativity parameter y was introduced together with two other adjustable 
parameters: the thermodynamic binding constant K and the binding site coverage 
parameter n. Knowing the total concentration of binding sites [B]tot (i.e. base pairs) and 
DNA-ligand [L]tot (i.e. ruthenium complex) for each step of the titration, the mass-balance 
equations can be solved by guessing values for K, n and y, which are then optimized by 
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iteration using a Newton-Raphson procedure as previously described by Lincoln 
(1998)100 and Andersson et al. (2013)39 and briefly summarized below. 
By using a variant of the formulation by Chen101, where the lattice of bound ligand is seen 
as a heteropolymer of N+1 types of elementary units i (i = 0, 1…N). While unit 0 is the 
bare binding site unit, the other N elementary units i are composed of ni consecutive 
binding sites of varying lengths. The binding potential xi for elementary unit i is a function 
of the intrinsic binding constant Ki (the binding equilibrium constant in the absence of 
neighbor interactions) and the free ligand concentrations; for a simple 1:1 case xi = 
Ki[Li]free. The binding density θi is defined as the ratio between the concentrations of 
bound ligand of type i and the total concentration of binding sites. Thus, for the 1:1 case, 
xi and θi should satisfy the mass balance: 
ሾܮ௜ሿ୲୭୲ ൌ ሾܮ௜ሿ୤୰ୣୣ ൅ ሾܮ௜ሿୠ୭୳୬ୢ ൌ ܭ௜ି ଵݔ௜ ൅ ሾܤሿ୲୭୲ߠ௜ሺͳ͸ሻ 
θi gives the probability of finding a ligand of type i bound to a randomly chosen binding 
site. When moving in one direction along the DNA strand there is a conditional 
probability, denoted pij, that given a binding site occupied by a bound ligand of type i, it 
is followed by a bound ligand of type j.  
As a result, the change in the concentration for each titration step can be obtained and 
ΔH and Δh calculated from a least-square fit to the experimental data. Finally the error 
between the simulated and the experimental ITC data is minimized by varying K, y and 
n.  
The algorithm employed in Paper I, although efficient, is limited by its complexity and 
has never had any wide-spread use. In addition, it is limited to describe interactions 
between 1:1 binding site:ligand equilibria. Therefore, a much simplified and “user-
friendly” algorithm was developed in Paper II and implemented further in Paper III and 
Paper IV. This algorithm can be implemented to any type of biopolymer with a long chain 
of repeating binding sites, regardless of the complexity of the binding system. The new 
algorithm avoids the tedious nested iteration procedures of the previous algorithm, since 
it takes advantage of the fact that both the free and bound ligand concentrations can be 
simply and uniquely determined by any positive vector r. 
The matrix algebra involved in the fitting of a generalized binding model to ITC-data 
might appear daunting to the reader at first glance. Therefore, the remaining part of this 
chapter will take a closer look on the classical McGhee and von Hippel model by giving 
an example of the model fitting of the binding of a single ligand, hence characterized by 
a single variable r. The interactions between neighboring elementary units are written 
as a set of non-negative cooperativity constants yij and are elements of the cooperativity 
matrix Y = [yij], i, j = 0, 1, …N. Here, the binding is set to be non-cooperative (y = 1), hence 
the matrix is written as:  
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܇ ൌ ൤ͳ ͳͳ ݕ൨ሺͳ͹ሻ  
From Eq. (8) in Paper II we have: 
ݏ଴ ൌ ሺͳ ൅ ݎሻିଵݏଵ ൌ ሺͳ ൅ ݕݎሻିଵሺͳͺሻ 
where si are the elements of the N + 1 vector s.  
From Eq. (9) in Paper II we can write the stochastic matrix P as such: 
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From Eqs. (12) and (18) in Paper II we get: 
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In order to keep it simple, for the purpose of illustration, the binding system will be 
assumed to not have any binding site overlap (n = 1) and the binding will be non-
cooperative (y = 1). Hence, Eqs. (20) and (21) can be simplified to: 
ݔ ൌ ݎሺʹʹሻ 
ߠ ൌ ݎͳ ൅ ݎሺʹ͵ሻ 
ܮ଴ ൌ ݔܭିଵ ൅ ܤ଴ߠ ൌ
ݎ
ܭ ൅
ݎܤ଴
ͳ ൅ ݎሺʹͶሻ 
Derivation with respect to r gives: 
ܮ଴
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ܭሺͳ ൅ ݎሻଶ ሺʹͷሻ 
For this simple case (n = 1 and y = 1), the mass balance equation (24) can be rearranged 
into an equation quadratic in r: 
ݎଶ ൅ ሾͳ ൅ ܭሺܤ଴ െ ܮ଴ሻሿݎ െ ܭܮ଴ ൌ Ͳሺʹ͸ሻ 
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Hence: 
ݎ ൌ െͳ ൅ ܭሺܤ଴ െ ܮ଴ሻʹ ൅ ඨቆ
ͳ ൅ ܭሺܤ଴ െ ܮ଴ሻ
ʹ ቇ
ଶ
൅ ܭܮ଴ሺʹ͹ሻ 
The enthalpy changes monitored during an ITC experiment comes from the 
concentration differences occurring when small additions of ligand is titrated into the 
macromolecule solution. If the additions are very small and the dilution heat is small 
enough to be neglected, it is possible to make an approximation of the concentration 
differences per mole added ligand by the derivative of the concentration with respect to 
total ligand concentration. In order to model the ITC curve with the changes in 
concentration of both total bound ligand and neighboring bound ligand, we need the 
derivatives with respect to r of θ and of θP11, respectively. 
Using this model to calculate an ITC-curve will give a linear combination of these two 
functions, which are weighted by the enthalpy of binding and the enthalpy of nearest-
neighbor interaction, respectively. The following three figures (Fig. 3.6, 3.7 and 3.8) will 
demonstrate example titrations on how the shape of these functions are affected by the 
different binding model parameters: the first figure show the effect on the curve with the 
intrinsic binding constant K; the second figure shows the effect on the shape of the curve 
with a non-unity cooperativity parameter y; lastly the third shows the effect of changing 
the binding site size n. Note that in all examples, the ligand is assumed to cover two base 
pairs (nearest neighbor exclusion, as commonly observed for most small intercalating 
ligands). That means that should the binding be infinitely strong, all binding sites would 
be occupied (saturation) at ratio L0/[base pairs] = 0.5. 
As demonstrated by the examples below, this correlation of K, y and n is important to 
have in mind when comparing fits of different binding models to ITC data. 
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Example 1 (Fig. 3.6) 
Here the ligand is assumed to bind only to one type of base pair of an alternating DNA 
lattice, hence the binding sites does not overlap and n = 1. Note that the ligand binding 
curve has the shape of the classical sigmoidal ITC isotherm, with sharper edges closer to 
the saturation ratio as K increases. A lower K leads to the interaction curve peaking 
before the saturation ratio. However, if the binding constant K increases, the peak moves 
closer towards the saturation ratio 0.5. In addition, the initial part of the interaction 
curve becomes more linear with a higher K value.    
 
 
  K n y 
Black 0.2 1 1 
Red 1 1 1 
Blue 5 1 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Left: Example titration showing the effects of an increasing intrinsic 
binding constant K on the binding curve (solid line) and interaction curve (dashed 
line) of the ligand-DNA interactions; Right: Table summarizing the different 
binding model parameters for each curve.  
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Example 2 (Fig. 3.7) 
Here we see the effect of introducing cooperativity. For anti-cooperative binding (y < 1), 
the initial part of the interaction curve is concave, while for cooperative binding (y > 1) 
it is convex due to the facilitated binding of additional ligands. By setting Ky2 = 1 the plots 
will be more similar at high loading (from ratio 0.5 and over), which facilitates 
comparison of the plots. At ratios > 0.5 the DNA lattice is so saturated that further binding 
will in most probability result in nearest-neighbor interactions.   
 
  
 
 K n y 
Black 0.1 1 3.16 
Red 1 1 1 
Blue 10 1 0.316 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Left: Example titration showing the effects on the binding curve (solid
line) and interaction curve (dashed line) by introducing a cooperativity binding 
parameter y to the ligand-DNA system; Right: Table summarizing the different 
binding model parameters for each curve.  
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Example 3 (Fig. 3.8) 
Here we assume one binding site on every base pair and n = 2. This means that gaps 
between bound ligands on the binding lite lattice could be as small as 1 base pair wide. 
As ligands still cover more than 1 base pair when bound, the nearest-neighbor exclusion 
rule still apply. Consequently, some gaps between bound ligands will be too small fit an 
additional ligand and the number of available binding sites decreases more rapidly as the 
titration progresses (see Fig. 3.9 for comparison of the two models). Hence the concave 
shape of the initial interaction curve. A second consequence of the faster decrease of 
available binding sites is that the saturation of the lattice is slowed down, which can be 
observed at the end of the interaction curve. This can partly be compensated for by 
increasing y and decreasing K as shown by the least-square fit (blue) in Fig. 3.8.  
  
 
 K n y 
Black 1 2 1 
Red 1 1 1 
Blue 0.338 2 2.91 
 
 
 
 
 
 
Figure 3.9 Schematic illustration comparing the two lattice models of the DNA-
ligand system with n = 2 (top) or n = 1 (bottom). When n = 2 some gaps will be too 
narrow for any additional ligands to be able to bind (as each ligand cover more 
than one base pair), therefore there will be a steeper decrease of available binding
sites as the titration progresses compared to when n = 1. 
Figure 3.8 Left: Example titration showing the effect of assuming the binding site 
size n = 2 instead of 1 on the binding curve (solid line) and interaction curve 
(dashed line) and how this effect can be compensated for by increasing the 
cooperativity and decreasing the binding constant; Right: Table summarizing the 
different binding model parameters for each curve.  
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4 RESULTS AND DISCUSSION 
The aim of this thesis is to investigate how the binding affinity of ruthenium(II) 
polypyridyl complexes to DNA is correlated to the molecular structure and how this 
affinity can be affected by slight changes of said structure. Factors such as chirality and 
the addition of substituent groups to the intercalating ligand will be addressed. In 
addition, the influence that complexes have on their neighbors when bound to DNA will 
also be shown to have a significant impact on the overall ligand-DNA interactions. 
Ruthenium(II) polypyridyl complexes have previously shown a strong antimicrobial 
activity, which will be further explored in this thesis. By predicting the outcome of 
modulating these factors, using binding models to fit experimental data, the development 
of ruthenium complexes as DNA-binding antibiotic can be further explored. In this 
chapter the results of Paper I-V, which are included in this thesis, will be presented and 
discussed. 
Paper I initiates the exploration of heterochiral cooperativity and introduces new 
techniques in LD resolution and ITC model fitting. Paper II follows with an improvement 
of the binding model algorithm. This is applied to competitive ITC experiments, where 
enantiomers of intercalating ruthenium complexes compete for DNA binding sites, and 
allows the systematic study of the diastereomeric interactions between bound 
complexes. Paper III then investigates the possible effects of altering the intercalating 
ligand by methyl substitution and shows how non-constant heat of dilution can be 
accounted for. Paper IV further demonstrates the improved model fitting algorithm 
when combining competitive titration experiments with luminescence titration data. 
Finally, Paper V, moves the project to a more biological setting where the antimicrobial 
activity of DNA-binding ruthenium complexes is evaluated with DNA-binding confirmed 
as the antimicrobial mode of action.  
4.1 The Binding Geometry of Ru(terpyridine)(pyridine)dppz2+ 
The discovery of the original “light-switch” complexes lead to a huge interest in dppz-
ruthenium complexes with an octahedral tris-bidentate structure and numerous 
structural variations have been reported ever since. It has already been well-established 
that these types of complexes bind to DNA by intercalation of the dppz ligand between 
the base pairs, and that the binding affinity can be tuned by modulation of the ancillary 
ligands.28, 31-32, 38-39 Should the tri-bidentate system be replaced by a dppz-ruthenium 
complex carrying a tridentate ligand, such as terpyridine (tpy), a single free coordination 
site on the metal is left free, allowing for additional fine-tuning of the complex in a 
manner not possible for the tris-bidentate systems. Furthermore, the lack of a 
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stereocentre at the metal results in an achiral complex, thus eliminating the need of 
separating the Δ and Λ racemic mixtures characteristic of tris-bidentate systems. 
Complexes carrying the tridentate tpy ligand have in general a very low quantum yield 
in room temperature and as a result the interest in these types of structures have not 
been as intense compared to the brightly luminescent bpy and phen complexes. 
Consequently, the binding geometry of tpy-based complexes has not yet been fully 
determined. Our group have previously shown the influence tris-bidentate complexes 
have on each other when intercalated in close proximity of each other on the DNA 
polymer; they can either inhibit (anti-cooperative) or facilitate (cooperative) additional 
complexes binding.39 Here, the same approach was used for finding the most likely 
binding model for Ru(tpy)(py)dppz2+ (Ru-tpy). A series of spectrophotometric and 
calorimetric measurements were carried out and analyzed using the classical McGhee-
von Hippel cooperative binding model99 in order to find the best global fit. As a 
comparison we used the original “light-switch” complex Ru(bpy)2dppz2+ (Ru-bpy) which, 
in addition to having its binding interactions with DNA much more evaluated, is the chiral 
structural isomer of Ru-tpy. 
Ru-tpy, being achiral, will not show a proper induced CD (ICD) signal unless bound to a 
chiral molecule, such as DNA. We could observe a negative ICD band in the long-axis 
polarized tpy band at 300 nm for Ru-tpy, much similar to the negative ICD band seen at 
290 nm for their long-axis bpy band of both Δ- and Λ-Ru-bpy, as could be expected for 
electronic transitions positioned in the minor groove close to parallel to the helix axis. 
Figure 4.1 Resolved spectra of the x and y (red) and the z (blue) polarized 
absorption bands of Ru-tpy bound to ct-DNA. The Y-axis units are ε/(1000 M-1cm-1).
The arrows on the molecular structure of the complex show the direction of the x
and z transition moments. 
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In correlation to the observations made with absorption and CD, the linear dichroism 
(LD) spectra for Ru-tpy were found to be almost invariant with the binding ratio, which 
allowed us to determine the orientation factor S and to quantitatively analyze the angular 
binding geometry. By varying weight values w1 and w2 in Eq. (7) until the dppz band at 
375 nm vanished in component e1 and the sharp tpy band at 310 nm vanished in 
component e2, it was possible to resolve the LD spectrum of Ru-tpy into its x, y and z 
components (Fig. 4.1). The results showed the tpy long-axis (z) to be aligned parallel and 
the dppz long-axis (x) perpendicular to the DNA helix axis, consistent with the dppz 
ligand being inserted between the base pairs.  
The calorimetric titration of Ru-tpy resulted in non-classical isothermal titration 
calorimetry (ITC) curves similar to those of Ru(L)2dppz2+ (L = bpy or phen) as previously 
reported by Andersson et al. (2013).39 In comparison to Δ- and Λ-Ru-bpy, Ru-tpy showed 
an ITC-profile most similar to the latter (Fig. 4.2). The ITC data for Ru-tpy was excellently 
globally fitted with the classical McGhee-von Hippel cooperative binding model. The 
parameters and derived thermodynamic data are summarized in Table 4.1. Contrary to 
previous results, where a satisfactory global fit to both luminescence and ITC data for 
Ru(L)2dppz2+ complexes required two binding geometries (perpendicular and polar), the 
experimental data (ITC and absorption titration) of Ru-bpy and Ru-tpy could both be 
Figure 4.2 ITC profiles with fitted traces for the binding of Ru-tpy (blue circles), 
Δ-Ru-bpy (green triangles), and Λ-Ru-bpy (red triangles) to AT-DNA in 150 mM 
aqueous solution at 20, 25, and 30°C. Symbols indicate the normalized heat 
absorbed or evolved upon sequential injections (2 μL) of complex into the 206 μL 
cell containing the DNA. The data has been corrected for heat of complex dilution.
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fitted using a much simpler model, where only one distinct binding geometry is assumed 
with a single cooperativity parameter y. 
Table 4.1 Binding constant K, cooperativity parameter y, and binding sites n that gave the best fit to 
experimental data, and the derived thermodynamic parameters for the intrinsic binding at 20°C.   
Sample K1 y n ΔHb2 ΔHnn2 ΔCpb3 
Ru-tpy 1 2.8 2.0 3.0 -10.2 -680 
Δ-Ru-bpy 0.9 1 2.2 4.3 -6.9 -800 
Λ-Ru-bpy 0.06 5.5 2.3 7.2 -17.6 -560 
1) K/106M-1  2) ΔH°/kJ mol-1  3) ΔCp/J mol-1K-1 
Even though a simple single binding geometry model is sufficient to fit the experimental 
data for Ru-tpy, due to the lack of two-fold symmetry, two types of neighbor interactions 
are possible: either the neighboring tpy ligands of two consecutive complexes are 
oriented toward the same strand (TSS) or toward alternating strands (TAS). We found that 
the TSS model was the most consistent with the single binding geometry model since it 
only had one type of intermolecular contact (similar to that of alternating bound Δ and 
Λ-Ru-bpy). However, the y-values of the corresponding Δ-Δ and Λ-Λ interactions were 
similar enough in magnitude to suggest that the TAS model also is relevant. 
4.2 Competitive ITC Demonstrating a General Binding Isotherm Algorithm 
While ITC is a powerful tool for direct thermodynamic profiling of binding interactions, 
currently available analysis software is in general limited to binding systems with non-
interactive binding sites, unable to adequately include cooperative or anti-cooperative 
behavior between bound ligands. The algorithm utilized in Paper I, while taking binding 
site interactions into account, is too complex for any wide-spread usage. In order to 
facilitate the search for new and improved pharmaceutical treatments, it is vital to be 
able to evaluate the binding properties of new molecules in a quick and effective manner. 
The general algorithm developed in Paper II allows for the fitting of lattice binding 
models of a wide variety of complexity levels. While this algorithm is general enough to 
be utilized for modelling ligand binding to any type of linear biopolymers, the most 
frequent usage would probably be for studying the binding interactions between ligands 
to the closely spaced binding sites of DNA. Therefore, as a practical example, the 
competitive binding interactions between the two enantiomers of Ru(bpy)2dppz2+ and 
poly(dAdT)2 is analyzed using this new algorithm in Paper II.  
Here 5 models are evaluated, schematically summarized as lattice models in Fig. 4.3. 
Model 1 is the classical model, where each lattice subunit is one base pair (and the 
binding site coverage parameter n is expected to be close to 2) and assumes all 
intercalation pockets to be equal. In Model 2 and 3 the lattice subunit is instead taken to 
be 2 base pairs (and n = 1). While Model 2 assumes a strict TA (or AT) selectivity, this 
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selectivity is relaxed in Model 3 for Δ which is then able to bind in either of the 
intercalation pockets 1 or 2 of the lattice subunit. Model 1-3 take both intrinsic (ΔH°b) 
and neighbor interaction (ΔH°ab) reaction enthalpies into consideration. In contrast, 
Model 4 and 5 assumes two binding modes for each enantiomer, and considers only 
intrinsic reaction enthalpies. In Model 4, the two binding modes are modelled as two 
independent binding sites with the fraction of base pairs for each binding site as a freely 
adjustable parameter. However, it is possible to construct a mathematically equivalent 
lattice model if the fractions of the two binding sites have the same value, as depicted in 
Model 4*. In Model 5, the two binding modes are set to alternating in consecutive 
sequences, thus only interacting with neighbors of different binding mode.   
Upon evaluation of the different binding models, it was not possible to produce any 
reasonable global fit without including a cooperativity parameter. In addition, Model 4 
and 5, which do not consider any neighbor enthalpy, require significantly more fitting 
parameters in order to produce acceptable fits. 
As a large number of fitting parameters could easily reduce the physical relevance of any 
best-fit values, a binding model with a satisfactory global fit with the smallest number of 
adjustable parameters is the most desirable outcome. Therefore, to understand the 
binding interactions of the system presented here, it is absolutely necessary to include 
the interactions between bound ligands in close proximity of each other. Furthermore, 
previous X-ray structure results showing 5´-TA-3´selectivity for Λ-Ru-bpy suggest that it 
is incorrect to treat all intercalation pockets identically, as is assumed in Model 1. The 
best fit was produced in Model 3, with a strict TA selectivity for Λ-Ru-bpy but with that 
selectivity relaxed for Δ-Ru-bpy. Model 3 gives the lowest RMSD of all models 
investigated and even with the binding and enthalpy parameters constrained to be the 
Figure 4.3 Schematic illustration summarizing the 5 proposed lattice models of 
the ligand-DNA binding interactions.  
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same for the two base pair steps (total number of fitting parameters 7 + 5 = 12) the RMSD 
is only slightly increased. The best fit value of the yΔΔ cooperativity parameter was found 
to be close to one, and defining yΔΔ = 1 (thus fitting only 6+5 parameters) increased the 
RMSD by less than 0.5%. The excellent fit of the (6+5) parameter Model 3 to the 
integrated peaks of the experimental ITC data is shown in Fig. 4.4.  
Model 3 gave a lower intrinsic binding constant K and higher cooperativity for Λ-Ru-bpy 
than for Δ-Ru-bpy. A simple allosteric explanation for this would be the seemingly less 
good steric fit in the groove compared to the Δ-enantiomer, resulting in an extra free 
energy penalty when Λ is forced to widen the groove. This is in turn payed back when the 
second Λ-enantiomer intercalates to an already widened groove. This does not, however, 
fully explain the hetero-chiral cooperativity observed since the better fitting, non-
cooperative Δ-enantiomer should not need to widen the groove. It is likely that ligand-
ligand interactions also make a significant contribution. Three types of arrangements of 
the close-by bipyridine moieties of neighboring Ru-bpy are possible: ΔΔ: face to face; ΛΛ: 
Figure 4.4 ITC profiles with fitted traces of (6+5) parameter Model 3 for the 
binding of the Δ- and ΛǦRu-bpy to AT-DNA alone (left) followed by a second 
titration of opposite enantiomer to already complex-saturated AT-DNA (right) in 
150 mM NaCl aqueous solution at 25°C. Symbols (Δ: green; Λ: red) indicate the 
normalized integrated heat absorbed or evolved upon sequential 2 μL injections 
of complex (~470 μM) into the 206 μL cell containing the DNA (~300 μM 
nucleotides). 
38 
edge to edge; ΔΛ: face to edge. These arrangements are expected to       be essentially 
different with regard to interactions such as pi-stacking and electrostatic repulsion 
(enthalpic effects) but also water solvation and counter ion distribution (enthropic 
effects).    
4.3 Methyl Substitution Groups and the Effects on Ligand-DNA Enthalpy 
The introduction of small changes into the molecular structure of the ruthenium 
complex, it might be possible to modify the DNAbinding affinity and specificity. Added 
methyl substituents on the intercalating dppz ligand of the enantiomers of the parent 
complex Ru(phen)2dppz2+ will have steric consequences on the complex, possibly with 
altered ligand-DNA binding motifs. While previous studies suggest that methyl 
substituents do indeed alter the binding properties of intercalative ruthenium 
complexes,28, 102-103 the underlying binding kinetics are still much left unexplored. By 
utilizing the general algorithm developed and demonstrated in Paper II, we seek to 
thermodynamically characterize the DNA-binding of Ru(phen)2dppz2+ with methyl 
groups substituted in the 10-position or in the 11,12-position of the dppz moiety using 
ITC experimental data. The complexes are denoted 1, 2 and 3, respectively (Fig 4.5).  
The raw ITC data show that while all complexes have a non-constant heat of dilution, it 
is small for complex 1 but very prominent for the methylated complexes 2 and 3. The 
added methyl substituents results in an increased hydrophobicity of complex 2 and 3 
that, in turn, causes a more prominent self-aggregation of dimer/trimer structures in 
free ligand solution.  In addition, at the end of the titration when most binding sites on 
the DNA strand are occupied, complex 2 and 3 both show intense endothermal heat 
peaks in comparison to the parent complex 1. To account for this additional equilibrium 
process aside from the ligand-DNA interactions, we have here considered both the 
heat of aggregation from the highly-concentrated free ligand solution, as well as an 
external ligand binding to saturated DNA. Therefore, a ligand solution 
oligomerization equilibrium m L Æ Lm has been incorporated into the mass balance. In 
addition, to account for the prominent endothermal heat change upon DNA 
saturation each intercalating ligand is assumed to be able to become an external 
binding site for an additional ligand. This is characterized by an external binding 
constant Kext.  
Fig. 4.6 summarizes the best global fit to the integrated peaks of the raw data of all 
complexes. As previous linear dichroism studies do not indicate any major differences 
in binding geometry between complex 1, 2 and 3,103 the intercalation equilibrium 
constants K and neighbor interaction parameters y were assumed identical for each set 
of enantiomers, leaving only the binding site coverage parameter n to vary freely. 
Allowing K and y to vary freely gave only a slightly lower nRMSD (6.4% compared to 
7.3%) indicating that the assumption of similar binding affinity parameters for each set 
of enantiomers to have been correct. Interestingly, the Λ-enantiomers consistently all 
have larger binding site coverage parameter n compared to Δ, with the difference being 
most prominent for complex 2. 
In general, the differences in enthalpy values due to methyl substitution were small (less 
than 4 kJ mol-1), with the much more exothermic intercalation for the Δ-enantiomer of 2 
compared to 1 being the most significant exception. The most prominent differences 
between the complexes are shown in Table 4.2. 
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Figure 4.6 ITC profiles with fitted traces for 
the titrations of the Δ-enantiomers (top left) 
and the Λ-enantiomers (top right) to 
poly(dAdT)2. Colors (blue: 1; red: 2; green: 3)
indicate the normalized heat absorbed or 
evolved upon 2 μL injections of complex (~590 
μM) into the 206 μL cell containing the DNA 
(~320 μM). Bottom right graph shows the 
averaged titration of both enantiomers into 
pure buffer. All titrations were performed in 
150 mM NaCl aqueous solution at 25°C.  
Figure 4.5 Structures of ruthenium complexes Ru(phen)2dppz2+ (1),
Ru(phen)2dppzCH32+ (2) and Ru(phen)2dppz(CH3)22+ (3).  
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Table 4.2 Changes in enthalpy values due to methyl substitution (in kJ mol-1) 
Complex Δ(ΔH°KΔ) Δ(ΔH°yΔ) Δ(ΔH°KΛ) Δ(ΔH°yΛ) 
2 -11.6 +3.4 -1.6 -1.1 
3 -0.8 +3.3 +4.3 -2.6 
 
In order for a binding model to be of practical use, the number of fitting parameters must 
be limited. Even with the additional heat of dilution added in the analysis, we have shown 
here that the model does not have to become overly-complicated.   
4.4 Model Fitting of Ru(phen)2dppz2+ Demonstrating Diastereomeric Crowding 
Tris-bidentate ruthenium complexes of the general form Ru(L)2dppz2+ exhibit almost 
invariably biexponential excited-state emission decays when bound to DNA. This has 
previously been assigned to two distinct binding geometries, with the shorter lifetime 
attributed to a centered intercalation geometry and the longer lifetime to a more canted 
geometry. However, photophysical results have shown that upon DNA-binding of the 
enantiomers of Ru(phen)2dppz2+ the fractions of short and long lifetimes are strongly 
dependent on salt concentration and, in particular, temperature, which cannot be 
satisfactory explained using this old model.104 By using the simplified algorithm 
(introduced in Paper II) to analyze ITC data in a competitive setting, the aim of Paper IV 
is to find an improved binding model for Ru-phen that also accounts for the excited-state 
populations of the complex. 
Here, two models are compared: in Model A the ligand-ligand interaction energy is 
assumed to be additive and independent of the environment while in Model B (Fig. 4.7) 
it is possible for the ligand-ligand interaction energies to be different for ligands at the 
ends and in the middle of a sequence of consecutively bound ligands. In the more 
complicated Model B the ligands are modelled as 4 different elementary units (two 
canted, unsymmetrical units a and b, which only occur to the left and right, respectively, 
of a ligand neighbor while having one empty binding site on the other side (end binding); 
two symmetrical units: c, which only occur “sandwiched” in between a ligand sequence 
(interior binding), and d, only occurring without any neighboring ligands (isolated 
binding)).  
The best fit for model B was obtained when assuming ligand binding exclusively at either 
the AT/AT or TA/TA steps. In addition, setting the binding site coverage parameter n to 
be exactly 1 did not significantly affect the residual norm. The best global fit to the 
integrated peaks of the raw data (see Paper IV) using Model B is shown in Fig 4.8.  
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Figure 4.; ITC profiles with fitted traces of Model B for the titrations of ΔǦ and Λ-
Ru-phen to AT-DNA alone (left) followed by a second titration of opposite 
enantiomer to already ligand-saturated AT-DNA (right). Also shown is the ITC 
profile for rac-Ru-phen titrated to AT-DNA alone. Symbols (Δ: green; Λ: red; rac: 
blue) indicate the normalized integrated heat absorbed or evolved upon 19 
sequential 2 μL injections of the complex (~550 μM) into the 206 μL cell containing 
the DNA (~408 μM nucleotides). All titrations were performed in 150 mM NaCl 
aqueous solution at 25°C. 
Figure 4.ͽ Schematic illustration of the proposed lattice Model B with the 
4 different element units and their possible ligand-DNA interactions. 
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A summary of the best global fit for the binding of the different categories of Model B is 
presented in Table 4.3. The enthalpy ΔH° parameter values for the outer binding mode 
to saturated DNA and the formation of dimer in solution are also presented. Pronounced 
diastereomeric differences for the bound Ru-phen enantiomers can be seen in all 
categories, reflecting the differences in the factors discussed below. For Δ-Ru-phen, 
fitting the αshort data105 assigns the short lifetime almost exclusively to interior and 
isolated elementary units, while the long lifetime is assigned to the end ligands. In 
contrast, the long lifetime of Λ-Ru-phen is mostly contributed from the interior ligands. 
Rather than directly associating each lifetime with a distinct binding geometry, each 
intercalated complex should instead be regarded as being in equilibrium with a short and 
long lifetime state. This equilibrium of lifetimes may then be affected by nearest-
neighbor ligands and consequently also much more affected by the surrounding 
environment. 
Table 4.3 The best global fit of Model B to experimental ITC data (enthalpy parameter values ΔH°/kJ 
mol-1) and αshort data105 (coefficients c). 
outera isolated end interior end, mix interior, mix dimer 
ITCb
Δ +0.4 -0.7 -0.6 -24.5 -7.4 -21.3 -24.1
Λ +0.8 -4.4 -17.3 -14.3
αshortc
Δ 0.89 0.07 1.00 
Λ 0.91 0.65 0.11 
aAssuming Kouter = 100     bEnthalpy parameter values (ΔH°/kJ mol-1)    ccoefficients c 
In contrast to the global fitting of the competitive ITC data of Ru(bpy)2dppz2+ binding to 
poly(dAdT)2 (Paper II), the addition of the phenanthroline B-ring of the ancillary ligands 
of Ru-phen results in increased steric crowding of the intercalated complexes. 
Consequently, Ru-phen is much more affected by diastereomeric differences in the 
attractive and repulsive intermolecular contacts, in particular upon full lattice saturation. 
Table 4.4 summarizes the best global fit parameters of Model B. When bound to the DNA 
lattice, Δ showed a modest cooperativity in the a-b dimer configuration but was 
essentially non-cooperative when bound as an isolated trimer a-c-b. In addition, Δ 
showed strong anti-cooperativity for the c-c arrangement, indicating an inert reluctance 
for expanding to larger a-c-c-b arrangements.  For Λ, the isolated dimer a-b interaction 
was also anti-cooperative.  
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Table 4.4 Binding parameter values from global fitting of Model B to ITC data. 
K/106 n yab yac ycc 
Δ 13.7 1.00 2.70 1.12 0.07 
Λ 3.71 1.00 0.45 0.93 0.25 
Δ-Λ 0.70 1.26 0.19 
dimer 2.9E-4 
The prominent diastereomeric influence from neighboring bound ligands is reflected in 
the values of the cooperativity y parameters, which can be seen as combinations of both 
attractive and repulsive factors, the most important being: 
1. Electrostatic repulsion of neighboring positive cations.
2. Repulsion caused by inter-complex steric clashes.
3. Attraction due to hydrophobic/stacking interactions, primarily for Δ.
4. Attraction from binding to an already widened groove (by the first bound
complex), primarily for Λ.
The molecular models shown in Fig. 4.9 summarizes the possible nearest-neighbor 
arrangements of the Ru-phen-enantiomers. Only for the homochiral ΔΔ-pairs can the 
phenanthroline B-ring make close contact with a neighboring complex, which is 
consistent with the heterochiral y-values being more similar to ΛΛ than to ΔΔ. In addition, 
this offers an explanation for the apparent similarity in the ITC and luminescence data 
Figure 4.Ϳ Schematic illustration of the proposed nearest-neighbor interaction 
geometries for the Δ- and Λ-enantiomers of Ru(phen)2dppz2+ when intercalated to 
DNA via the minor groove. The 5,6-carbons on the phen moieties are highlighted 
(green: Δ; red: Λ). The models were constructed by manual docking and 
subsequent energy minimization in a vacuum, using the Amber 2 force field in the 
HyperChem 8.0 software package (HyperCube, Inc.).  
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for the Λ-enantiomers of Ru-phen and Ru-bpy, as the bipyridine moiety is missing the 
CH=CH part of the phenanthroline B-ring.39  
Altogether, Model B provides an excellent global fit of both ITC and photophysical data 
while still being in accordance to previous ligand-DNA interactions studies. In particular, 
Model B have two advantages compared to the simpler Model A that give a physical 
interpretation of the ligand-DNA interactions closer to reality: 
1. Model B assumes exclusive binding at either the AT/AT step or TA/TA step which
is supported by X-ray crystallography structures.31
2. The binding site coverage parameter n is no longer a freely adjustable non-
integer parameter with different values for Δ and Λ, is set to unity for all bound
ligands. Thus in Model B, all diastereomeric variation in binding affinity is limited
to the only freely adjustable binding parameters left, K and yij.
4.5 Enantioselective Antimicrobial Activity of Ru(phen)2dppz2+ 
The problem of bacterial pathogens developing multidrug-resistance toward clinically 
available antibiotic is growing larger, making is necessary to develop new types of 
antibiotics targeting alternative bacterial components. Bacterial DNA is such a potential 
target, but so far the specificity for bacterial cells has not been good enough in previous 
antibiotic candidates and they were deemed too cytotoxic to the human host. While 
ruthenium(II) polypyridyl complexes have previously been demonstrated to have a 
strong antimicrobial activity, we felt that the potential of developing Ru complexes as 
DNA-targeting antibiotics has been left mostly unexplored. To the best of our knowledge, 
no reported antibiotic studies of intercalating Ru(L)2dppz2+ complexes had tested the 
complexes in their resolved enantiopure forms. This surprised us, as it has been 
repeatedly demonstrated that chirality have a significant effect on binding affinity.  
Here, we analyzed the antimicrobial activity of enantiomeric pure Ru(phen)2dppz2+ (Ru-
phen) and μ-bidppz(phen)4Ru24+ (biRu-phen), both well-established DNA-intercalators, 
with Gram-negative Escherichia coli and Gram-positive Bacillus subtilis as the bacterial 
models. 
It is expected for DNA, being a chiral molecule itself, to interact differently with the 
dissymmetric non-intercalating peripheral pair of phen ligands on the ruthenium 
complex depending on the chirality of the complex. This is also what we observed for the 
mononuclear Ru-phen, with the Δ-form having a significantly higher inhibitory and 
bactericidal effect in comparison to the Λ-form (Fig 4.10). In contrast, the binuclear biRu-
phen complex showed very little antimicrobial activity against either bacterial strain 
with no enantiomeric difference. Only at the highest concentration level tested did the 
complex have an effect against the bacteria, with a sudden decrease in bacterial growth. 
This was more likely caused by lysis of the cellular membrane rather than DNA 
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intercalation. By quantifying the release of nucleic acids through absorption 
spectroscopy from bacterial cells after 60 min exposure of ruthenium complex, we found 
the binuclear complexes to have a similar effect as a 3% SDS solution.  
The same chiral discrimination for DNA has been previously reported with Δ-Ru-phen 
showing as much as 2-5 times stronger binding affinity than Λ-Ru-phen, indicating that 
the bactericidal mechanism of action is indeed DNA interaction. To further test this 
hypothesis, the emission of the bacterial cells was measured after exposure to an excess 
of ruthenium complex.  
Any fluorescence observed would indicate DNA-binding as Ru-phen is completely 
quenched when unbound in aqueous solution. In both bacterial strains, the intensity of 
emission from the bacterial cells were significantly higher after exposure to Δ-Ru-phen 
compared to Λ-Ru-phen. A small redshift could be seen for Λ-Ru-phen in both strains, a 
phenomena associated with DNA-complex interactions. In addition, no emission from the 
binuclear complexes was observed, further supporting that there was no DNA 
interaction.      
Figure 4.ͷͶ Surviving bacterial counts (CFU/mL) of B. subtilis (left) and E. coli 
(right) after 24 hours exposure to Ru-phen (top, a and b) and biRu-phen (bottom, 
c and d) at 37°C. Each point is the mean of 6 replicate cultures. Error bars show 
standard deviations (SD: 3σ); when not visible, these bars are as small or smaller 
than the symbols plotted.  
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Fig. 4.11 shows a confocal microscopic picture of Hoechst-stained E. coli that had been 
previously treated with either enantiomer of Ru-phen. Both enantiomers are clearly 
fluorescent, but with a much higher intensity coming from Δ-form, further indicating 
enantiomeric dependence of binding affinity and consequently, also antimicrobial 
activity.  Interestingly, the relation between the intensity of the Hoechst-stain and the 
intensity of the complex appears to be inverse; the cells with the highest intensity of 
ruthenium complex appears to have very weak, if any, fluorescence from the Hoechst-
staining, and vice versa. This relation is apparent for both enantiomers. A possible 
explanation could be that the ruthenium complexes and the DNA-stain compete for 
binding in the minor groove of DNA, and bacterial cells with a poor emission from the 
DNA-stain have their DNA binding sites already occupied by ruthenium complexes. 
Furthermore, unexposed bacterial cells used as controls showed significantly stronger 
emission from the Hoechst dye compared to bacteria exposed to ruthenium complex, 
again indicating that ruthenium complexes and the DNA-binding dye competes for the 
same binding sites.  
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Figure 4.ͷͷ Confocal microscopy images of formaldehyde fixed E. coli samples 
incubated with Δ- (top row) and Λ-Ru-phen (middle row) overnight and then 
stained with Hoechst 33342. (a) fluorescence - Hoechst 33342 (Δ-sample); (b) 
fluorescence – Δ-Ru-phen; (c) fluorescence - Hoechst 33342 (Λ-sample); (d) 
fluorescence – Λ-Ru-phen; (e) fluorescence - control sample E. coli stained with 
Hoechst 33342 (Bottom right: a black square for visual aid). Scale bar = 5 μm 
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5 CONCLUSIONS AND OUTLOOK 
As a continuance to the potential use of ruthenium complexes as antibiotics, our group 
aim to realize a binary antibiotic, with the active drug synthesized inside the bacterial 
from two prodrug reactants. These prodrugs will be bulky and substituted with 
moderately reactive groups. Once the two prodrugs have reach the bacterial DNA, they 
are able to reversibly insert themselves into the double helix. Unconnected, the prodrugs 
are harmless to the bacterial cell, but when a pair of complimentary prodrugs happens 
to be inserted next to each other, they react by forming a connecting covalent bond and 
the now active antibiotic becomes entangled to the DNA (Fig. 5.1), blocking its function 
and ultimately killing the cell. 
By controlling the rate of the biomolecular reaction, the active drug will be under kinetic 
control. The rate constant of the synthesis of the active drug is determined by the 
structure of the two prodrug and of the concentration of the prodrugs in close proximity 
of the target DNA. Effectively, the dose-response curve will be much steeper compared 
to a more conventional antibiotic (Fig. 5.2) and the significantly lower concentration of 
the binary antibiotic needed for an bactericidal effect will most likely slow down any 
resistance development.  
For the initial prodrug design and synthesis, binuclear ruthenium(II) polypyridyl 
complexes will be used as template. As demonstrated previously by our group, these 
types of bulky “dumbbell-like” complexes have a very slow dissociation rate and could 
provide a potent blockage for DNA transcription. In addition, by variating the distance 
between the ruthenium centers and the flexibility of the tether connecting the ruthenium 
groups it is possible to alter the sequence and stereo-selectivity of the complex.49, 106-107 
In addition, ruthenium complexes allow for fairly simple modular construction where 
the intercalating ligands, ancillary ligands and connecting moieties may be (almost) 
Figure 5.1 A pair of ruthenium 
complex precursor drugs: the 
intercalating ligand is colored black, 
the ruthenium(II) ion and the 
reactive groups red, the ancillary 
ligands and the chain connecting the 
reactive group orange (left); a DNA 
model showing the adjacent 
intercalation of the two precursor 
drugs after reaction, viewed from the 
minor groove (middle) and the major 
groove (right). The reacting groups 
are here aldehyde (-CHO) and 
acylhydrazine (-CONHNH2).   
50 
freely varied in order to fine-tune the reactivity of the prodrug molecules. As an added 
bonus, the long-lived excited state of many ruthenium complexes make them excellent 
environment-sensitive luminescent reporters, which will aid the imaging of the binary 
antibiotic in cell uptake and intracellular distribution studies. The reactive groups will, 
of necessity, have well-tuned bimolecular rate constants; they must be small enough to 
be virtually non-reactive in a dilute solution, while still high enough for fast ligation when 
brought together in an intercalative state. We are currently developing a system that uses 
a strained cyclooctyne-azide coupling reaction (Fig 5.3), aiming for this system to be bio-
orthogonal (i.e. not reacting with anything else in the cell). 
Figure 5.3 Schematic illustration of a cyclooctyne-azide coupling reaction 
Figure 5.2 Antibiotic binding density θ vs the concentration C of a conventional 
drug (red curve) and of a 1:1 mixture of prodrugs (black curve). Assuming that 
bacteria are killed when θ > 0.1and that θ < 0.01 is harmless, the critical drug 
concentration intervals are indicated by the colored areas. 
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Binding of Ru(terpyridine)(pyridine)-
dipyridophenazine to DNA studied with
polarized spectroscopy and calorimetry†
Anna K. F. Mårtensson and Per Lincoln*
Linear and circular dichroism (LD and CD) spectroscopy as well as isothermal titration calorimetry (ITC)
have been used to investigate the interaction of Ru(tpy)(py)dppz2+ (tpy = 2,2’:6’,2’’-terpyridyl; py = pyri-
dine; dppz = dipyrido[3,2-a:2’3’-c]phenazine) with DNA, providing detailed information about the DNA
binding thermodynamics and binding geometry of the metal complex. Flow LD, CD and isotropic absorp-
tion indicate that Ru(tpy)(py)dppz2+ bind to DNA from the minor groove with the dppz ligand intercalated
between base pairs, very similar to its chiral structural isomers Δ- and Λ-Ru(bpy)2dppz2+ (bpy = 2,2’-
bipyridine). A simple cooperative binding model with one binding geometry provide an excellent ﬁt for
calorimetric and absorption titration data. The values of the neighbor interaction thermodynamic para-
meters for Ru(tpy)(py)dppz2+ suggest that complexes bound contiguously prefer to have their tpy ligands
oriented towards the same strand.
Introduction
DNA-binding drugs are small molecules that recognize and
interact with specific DNA sites. Many of the chemotherapeutic
anticancer agents currently in use fall under this category with
cisplatin being the most prevalent example.1 DNA intercalators
that unwind DNA in order to π-stack between two base pairs
have shown cytotoxicity towards cancerous cells but are often
of limited therapeutic use due to their lack of specificity and
frequent side eﬀects. After the pioneering work by Barton and
coworkers on the selective DNA binding of substitution-inert
trisphenanthroline complexes of ruthenium, there has been
an increasing interest in octahedral transition metal com-
plexes.2 The discovery of the “light switch” complexes
Ru(phen)2dppz
2+ and Ru(bpy)2dppz
2+ (phen = 1,10-phen-
anthroline; bpy = 2,2′bipyridine; dppz = dipyrido[3,2-a:2′3′-c]-
phenazine) lead to the synthesis of many variations of dppz-
ruthenium-centered tris-bidentate structures with the potential
as biosensors and therapeutic agents.3 Interestingly, the two
ruthenium complexes that have reached clinical trials have
substitution-labile ligands and a proposed mode of action
completely diﬀerent to DNA intercalation.4
Spectroscopic and biophysical methods have established
that it is the dppz ligand in tri-bidentate complexes that is
intercalated between the base pairs of the DNA, and this has
recently been confirmed by several X-ray crystal structures.5
Compared to the intense research on the brightly luminescent
bipyridine and phenanthroline complexes, the very low
quantum yield at room temperature has led to less interest for
ruthenium dppz complexes carrying the tridentate tpy ligand
(tpy = 2,2′:6′,2″-terpyridyl), despite the fact that the absence of
a stereocentre at the metal when coordinated to a tridentate
ligand eliminates the need of separating Δ and Λ racemic mix-
tures characteristic of tris-bidentate systems. The main focus
has been on tpy-based complexes with reactive oxoruthenium(IV)
functionality that cleaves DNA by oxidation of guanine and
the 1′-deoxyribose hydrogen.6 However, not until recently has
the single free coordination site left on the metal atom been
recognized as a potential way of fine-tuning complex–DNA
interactions, either by improving the DNA cleaving ability,7 or
as a novel light-activated drug delivery system.8 Although some
spectrophotometric studies have aimed at the DNA binding
mode of tpy-based complexes to DNA,9 a definite proof of the
binding geometry has not yet been obtained.
Our group has previously determined that the tris-bidentate
complexes aﬀect each other, either cooperatively or anti-coop-
eratively, when interacting with a DNA-polymer via inter-
calation.10 A binding model that gives a satisfactory fit to the data
needs two distinct binding modes, one symmetrical (perpen-
dicular) and one unsymmetrical (polar). This model with two
modes of binding is supported by the crystallographic study by
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c4dt02642j
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Niyazi et al. (2012) where a symmetric and a non-symmetric
intercalation geometry was found for Λ-Ru(phen)2dppz2+.5f
In this study, we have carried out spectrophotometric and
calorimetric measurements in order to determine the binding
geometry and thermodynamic characteristics of Ru(tpy)(py)-
dppz2+ (Ru-tpy, see Scheme 1). To simplify the system by avoid-
ing eﬀects from DNA sequence heterogeneity, and to compare
with an earlier study,10 we chose to primarily study the inter-
action of poly(dAdT)2 (AT-DNA). However, since the AT-DNA
was too short to orient in the flow cell for the linear dichroism
study, we used calf thymus DNA (ctDNA) instead. We wanted
to characterize a tpy/dppz ruthenium complex in its simplest
form, and for the purpose of comparison, a pyridine (py)
ligand was attached to the single coordination site, making
the complex an achiral structural isomer of the original
“light-switch” complex Ru(bpy)2dppz
2+ (Ru-bpy). Once we have
gained more understanding in how this mononuclear complex
interacts with DNA, the substituents of this single coordi-
nation site could be varied to optimize properties that would
make it and its binuclear derivatives more suitable as metallo-
pharmaceuticals.
Results
Absorption
The absorption spectra of ΔRu-bpy and Ru-tpy in the absence
and presence of AT-DNA at [base pairs]/[Ru] ratio of 5 are
illustrated in Fig. 1. The broad band system centered at about
440 nm for ΔRu-bpy and 475 nm for Ru-tpy is attributed to the
metal to ligand charge transfer (MLCT) transitions, which in
the presence of AT-DNA show a slight hypochromicity and
red shift for both complexes. The characteristic 372 nm band,
assigned to the lowest π→π* transitions of the dppz chromo-
phore is almost identical for both Ru-tpy and ΔRu-bpy, and in
presence of AT-DNA there is also a very similar pronounced
hypochromicity and red-shift (see Fig. 1 and Fig. S1 in ESI†).11
For Ru-tpy, the most intense band outside the overlapping
DNA absorption is the band at about 310 nm, which is
assigned to the long-axis polarized lowest π→π* transition of
the tpy chromophore.12 This peak shows a red-shift of about
5 nm and in contrast to the 372 nm dppz band, only a slight
hypochromicity at DNA binding, indicating that of the two
large ruthenium ligands in Ru-tpy, the dppz ligand is the one
that has the closest interaction with the nucleobases. As
shown by titrating a constant concentration of Ru-tpy with
AT-DNA (see Fig. S2 in ESI†), the hypochromicity of the dppz-
band at 372 nm for Ru-tpy remains virtually constant at ratios
[base pairs]/[Ru] > 2, whereas the initial hypochromicity in the
310 nm band is somewhat reduced at higher ratios.
Circular dichroism
A pure enantiomer of a chiral ruthenium complex, such as Ru-
bpy, will show a strong intrinsic CD signal when free in
aqueous solution, but Ru-tpy, which is an achiral complex will
show zero CD signal under the same conditions. However, for
both chiral and achiral molecules, binding to DNA can lead to
a proper induced circular dichroism signal (proper ICD) by
perturbation of the chromophores of the bound molecule by
the chiral arrangement of the nucleobase chromophores. Here
the magnitude and the sign of the ICD will mainly be dictated
by the distances and angles between the interacting electronic
transition dipole moments, and similar geometries are
expected to give rise to similar ICD-patterns even for opposite
enantiomers. In addition, for chiral molecules, changes merely
in position and intensity of the intrinsic CD bands themselves,
caused by the interaction with DNA, will add an apparent ICD
contribution, but this will be characterized by a mirror-image
like pattern for opposite enantiomers with similar binding
geometries. Changes in CD were monitored upon addition of
ΔRu-bpy, ΛRu-bpy, and Ru-tpy to a [base pairs]/[Ru] ratio of
5. In order to compare the ICD spectra of the complex–DNA
interactions, the spectrum of the DNA and the spectrum of the
free complex were subtracted from the spectrum in the pres-
ence of DNA. Fig. 2 shows the ICD of all three complexes as
well as the CD spectrum of the AT-DNA. The general shape of
the ICD below 290 nm is quite similar for all three complexes:
Fig. 1 Absorption spectra of Ru-tpy (black) and ΔRu-bpy (red) (14 µM)
in 150 mM NaCl solution (dotted line) and in presence of AT-DNA (138
µM nucleotides) (solid line). The gray line shows AT-DNA only.
Scheme 1 Structures of ruthenium complexes Ru(bpy)2dppz
2+ (left)
and Ru(tpy)(py)dppz2+ (right).
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a negative band between 275 and 290 nm and a positive band
at about 260 nm, indicative of a proper ICD mechanism, while
the general mirror-image relationship of the ICD curve
>290 nm for Δ- and ΛRu-bpy suggests the predominance of an
apparent ICD mechanism in this region. Titration of a solution
with constant concentration of Ru-tpy shows an almost invar-
iant CD spectrum >300 nm for [base pairs]/[Ru] > 2, similar to
the results of the corresponding absorption titration (see
Fig. S3 in ESI†).
Linear dichroism
Fig. 3 shows the LD spectra for Ru-tpy in ctDNA solution at
[base pairs]/[Ru] ratios 8, 4 and 2. The ctDNA concentration
remained constant at 270 µM nucleotides. The reduced
LD (LDr), which is the LD divided by the isotropic absorbance,
is very similar for all [base pairs]/[Ru] ratios, indicating little or
no change in the geometric orientation at higher saturation
levels (see Fig. S4 in ESI†). Thus, the conditions were fulfilled
for determining the orientation factor S using eqn (5), (8) and
(11) (See Theory and methods section below) using the LD
spectra of free DNA (L0) and at ratios 8 (L1) and 4 (L2). The rela-
tive values S1/S0 = 1.06 and S2/S0 = 1.16 indicate that the DNA
with bound Ru-tpy becomes better oriented, as earlier found
for Δ- and ΛRu-bpy.11a Finally b, the pure (without DNA contri-
bution) Ru-tpy LD spectrum, at perfect orientation and 10 mm
optical path-length, was calculated as b = c2
−1(S2
−1L1 − S0−1L0).
The weights w1 and w2 in eqn (6) were varied manually until
the dppz band at 375 nm vanished in component e1 and the
sharp tpy absorption band at 310 nm vanished in component
envelope spectra e2, as shown in Fig. 4. The optimal weight
values were w1 = 3 ± 0.5 and w2 = −1.5 ± 0.3, the theoretical
limits for parallel and perpendicular orientation of a transition
dipole moment relative to the orientation axis. Thus, the
results show that the tpy long-axis (z) is aligned along and the
dppz long-axis (x) perpendicular to the DNA helix axis, which,
since the dppz ligand lies in the x,y plane, is consistent with
intercalation of the dppz ligand in-between the base pairs.
Binding isotherms
ITC profiles for the binding of Ru-tpy to AT-DNA at 20, 25, and
30 °C are shown in Fig. 5 and for comparison, the corres-
ponding ITC-profiles for Δ- and ΛRu-bpy from Andersson et al.
(2013).10 Ru-tpy shows a similar overall shape with a gradually
increasing exothermic enthalpy until a negative maximum is
reached at [Ru]/[base pairs] = 0.4–0.5, somewhat higher than
for the other two complexes. The initial slope of the ITC
profile is in contrast to the initial constant part of the sigmoi-
dal curve expected for the simple binding as indicated above
by absorption, circular dichroism and linear dichroism
spectroscopies, where the spectra of Ru-tpy in the presence of
DNA were found to be practically invariant with binding ratio.
This suggests that intermolecular interactions between bound
molecules must contribute to the binding enthalpy also
for Ru-tpy, as earlier concluded for Δ- and ΛRu-bpy.10 This
Fig. 2 Induced CD for Ru-tpy (blue), ΔRu-bpy (green), and ΛRu-bpy
(red) after mixing with AT-DNA. The black dashed line shows the CD
signal for AT-DNA in a 150 mM NaCl solution. The concentrations of
complex and DNA were 14 and 138 µM respectively.
Fig. 3 Linear dichroism spectra of Ru-tpy in the presence of ctDNA at
[base pairs]/[Ru] ratios 8 (blue), 4 (red) and 2 (green) in 10 mM NaCl
solution, as well ctDNA alone (dotted). The concentration of ctDNA is
270 µM nucleotides.
Fig. 4 Resolved spectra of the x and y (red) and the z (blue) polarized
absorption bands of Ru-tpy bound to ctDNA. The Y-axis units are
ε/(1000 M−1 cm−1). The arrows on the molecular structure of the
complex show the direction of the x and z transition moments.
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observation prompted us for a more thorough analysis of the
spectroscopic changes, and absorption spectra were collected
for addition of Ru-tpy to a constant concentration of AT-DNA
at 25 °C.
The data (shown in Fig. S5 in ESI†) were analyzed with
singular value decomposition (SVD) as described in Theory
and methods. The first three (normalized) singular values were
s1 = 100, s2 = 2.45 and s3 = 0.23, and the corresponding
columns of U and V are plotted in Fig. 6 and 7, respectively.
Column 4 in U and V (shown in Fig. S6 and S7 in ESI†) were
much less structured and were judged to be insignificant,
although the fourth singular value (0.18) was close to the
third.
Ru-tpy ITC and absorption data could be excellently globally
fitted with the classical McGhee–von Hippel cooperative
binding model (see Theory and methods), and the best fit to
the data are shown with solid lines in Fig. 5 and 7. Fig. 8
shows the calculated absorption spectra for free complex,
bound complex with at most one neighbor and bound
complex with at least one neighbor. For comparison, the
model was also used to fit the ITC data for ΔRu-bpy and ΛRu-
bpy, as shown in Fig. 5. A linear fit to the calculated ΔH°
values as a function of temperature is shown in Fig. 9, and
Table 1 gives the parameters and derived thermodynamic data.
Fig. 5 ITC proﬁles with ﬁtted traces for the binding of Ru-tpy (●), ΔRu-
bpy (▲), and ΛRu-bpy (Δ) to AT-DNA in 150 mM NaCl solution at 20, 25,
and 30 °C. Symbols indicate the normalized heat absorbed or evolved
upon sequential injections (2 µL) of complex into the 206 µL cell con-
taining the DNA. The data has been corrected for heat of complex
dilution. The corresponding ITC-proﬁles for Δ- and ΛRu-bpy are from
Andersson et al. (2013).10
Fig. 6 The U-vectors corresponding to the ﬁrst three singular values
(s1 blue, s2 green, s3 red) from the titration of Ru-tpy to a constant
concentration of AT-DNA in 150 mM NaCl at 25 °C.
Fig. 7 The V-vectors corresponding to the ﬁrst three singular values (s1
blue squares, s2 green circles, s3 red triangles) from the titration of Ru-
tpy to a constant concentration of AT-DNA in 150 mM NaCl at 25 °C.
The ﬁt of the model is shown as solid curves.
Fig. 8 Calculated absorption spectra for unbound complex (blue),
bound complex with at most one neighbor (green) and bound complex
with at least one neighbor (red).
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Discussion
Recently, high-resolution structures and calorimetric studies
have highlighted ligand–ligand interactions as an explanation
to the complex thermodynamical and photophysical behavior
of DNA-bound Ru(L)2dppz complexes.
5d–f,10 To further investi-
gate the role of the ancillary L ligands, we chose to study the
terpyridine/pyridine Ru-dppz complex Ru-tpy, an achiral
isomer of Ru(bpy)2dppz formally made by breaking the pyri-
dine–pyridine bond of one bpy unit and joining it to the
second (see Scheme 1).
Absorption spectroscopy shows that the spectral changes of
the dppz ligand bands are virtually identical for ΔRu-bpy and
Ru-tpy upon binding to DNA, giving a first indication that the
binding mode of the two isomers are similar. Circular dichro-
ism spectroscopy shows a negative induced CD band in the
long-axis polarized tpy band at 300 nm, similar to the negative
induced CD shown for Δ- and ΛRu-bpy in their long-axis polar-
ized bpy band at 290 nm, as could be expected for electronic
transitions positioned in the minor groove close to parallel to
the helix axis.13 Both absorption and CD are practically invar-
iant with binding ratio, although a small perturbation of the
tpy-band at 310 nm can be observed at binding ratios close to
saturation in both CD and absorption spectra. Likewise, linear
dichroism spectra were found to be invariant with binding
ratio too, allowing determination of the orientation factor S
and a quantitative analysis of the angular binding geometry.
In contrast to the Ru(L)2dppz complexes, where major tran-
sition moment directions have oblique angles to the plane of
the dppz ligand, in Ru-tpy the long-axis polarized tpy tran-
sition is perpendicular to the dppz plane. With a weight
w1 = +3 ± 0.5 we find that it is almost perfectly parallel oriented
to the DNA helix axis, and the dppz long axis polarized tran-
sition, with weight w2 = −1.5 ± 0.3, perpendicularly oriented,
the geometry expected for intercalation of the dppz ligand in-
between the base pairs of DNA. In contrast to the very minute
diﬀerences in absorption, CD and LD spectra at diﬀerent
binding ratios, the calorimetric titration show strong eﬀects on
the heat of binding. We have previously been reported such
non-classical ITC curves for Ru(L)2dppz complexes (L = bpy or
phen) and attributed them to an additional enthalpy contri-
bution from interaction between neighboring complexes on
the DNA.10 In comparison to Δ- and ΛRu-bpy, Ru-tpy showed
an ITC profile qualitatively most similar to the latter. Since a
satisfactory global fit for the ITC and absorption experimental
data of Ru-tpy could be obtained with the classical McGhee–
von Hippel model with only one type of binding geometry, for
comparison this model was also used to reanalyse our data for
Δ- and ΛRu-bpy, which were originally fitted with a symmetri-
cal and a pair of unsymmetrical intercalation geometries.10 In
this model (Model 3 in ref. 10), ligands bound with only one
nearest-neighbor are assumed to have one distinct binding
geometry (unsymmetrical), while ligands bound either isolated
or with nearest-neighbors on both sides have a second binding
geometry (symmetrical). As noted in our previous study, the fit
of the simpler model to the ITC-data alone is excellent, but
any attempt to rationalize the observed molar fractions of
the short and the long excited state life-time fails. With the
simple model, the apparent site sizes for Δ- and ΛRu-bpy
were found to be 2.2 and 2.3, consistent with the neglect of
the anti-cooperativity which is inherent in Model 3 for which
the n parameters were found to be 2.0 and 1.8, respectively.10
Interestingly, the binding site size parameter n was found to
be 2.0 for Ru-tpy, indicating that the distinction between sym-
metrical and unsymmetrical intercalation geometries might be
less pronounced for this complex. Although the low emission
quantum yield of Ru-tpy bound to DNA precluded time-
resolved luminescence measurements, the observation that
spectra (absorption, CD, LD) change very little with binding
density (see Fig. 3, S2 and S4†) support the conclusion
that diﬀerence between intercalation geometries is small for
Ru-tpy. The simple model has only one cooperativity para-
meter y, which is found to be 1 for ΔRu-bpy (i.e. non-coopera-
tive binding) and 5.5 for ΛRu-bpy (cooperative binding);
for Ru-tpy y = 2.8, in-between the values of the two Ru-bpy
enantiomers. The intrinsic binding constant K is 106 M−1 for
Ru-tpy, very similar to that of ΔRu-bpy, while K for ΛRu-bpy
is almost 50 times smaller. The latter value is about
3 times smaller than that obtained with Model 3, however,
Fig. 9 The standard binding enthalpy ΔH°b (■), standard nearest neigh-
bor interaction enthalpy ΔH°nn (●), and ΔH°baseline (▲) for binding of Ru-
tpy (blue), ΔRu-bpy (green), and ΛRu-bpy (red) to AT-DNA in 150 mM
NaCl. The slopes of the ﬁtted lines correspond to the ΔCp for the
reactions.
Table 1 Binding constants K, cooperativity parameters y, and binding
site sizes n that gave the best ﬁt to experimental data, and the derived
thermodynamic parameters for the intrinsic binding at 20 °C
Sample Ka y n ΔH°bb ΔH°nnb ΔCpbc
Ru-tpy 1 2.8 2.0 3.0 −10.2 −680
ΔRu-bpy 0.9 1 2.2 4.3 −6.9 −800
ΛRu-bpy 0.06 5.5 2.3 7.2 −17.6 −560
a K/106 M−1. bΔH°/kJ mol−1. cΔCp/J mol−1 K−1.
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since simulated binding isotherms are the most sensitive to
the value of the binding constant close to saturation, the best-
fit value will normally be quite dependent on the binding
model since the influence of the cooperativity parameters will
diﬀer.
The intrinsic binding enthalpy ΔH°b is positive for all com-
plexes at 20 °C, i.e. the binding in the absence of neighbor
interactions is endothermic. The value of ΔH°b is smaller for
Ru-tpy than for either Δ- or ΛRu-bpy, but the temperature
dependence is similar as evidenced by the negative ΔCp-values
of −680 ± 120 J K−1 M−1. The nearest-neighbor interaction
enthalpy ΔH°nn is negative (i.e. exothermic) for all complexes,
and exhibits a tendency similar to the cooperativity factor y,
namely that the value for Ru-tpy is in-between the values for
Δ- and ΛRu-bpy.
However, even if a simple, single binding geometry model
is suﬃcient to model the binding data for Ru-tpy, the lack of a
2-fold axis of symmetry, in contrast to Δ- and ΛRu-bpy, make 2
types of neighbor interaction possible: either the tpy ligands of
two consecutive complexes are oriented towards the same
strand (TSS, see Fig. 10) or they are oriented towards opposite
(alternating) strands (TAS). In comparison to Ru-bpy, neglect-
ing the influence of the single pyridine ring of Ru-tpy,
the alternating model (TAS) would have intermolecular
contacts resembling alternating Δ–Δ and Λ–Λ contacts,
while the same-side model (TSS) would everywhere have inter-
molecular contacts resembling Δ–Λ, comparable to that
found in a recent X-ray crystal structure of Δ- and Λ-Ru-
(phen)2dppz simultaneously intercalated to a DNA hexamer
duplex.5e
Since the same-side model TSS has only one type of inter-
molecular contact (Δ–Λ), it is logically consistent with the
simple one-geometry binding model, and also consistent
with the assumption that Ru-bpy interactions model those of
Ru-tpy, since 7.8, the square of the Ru-tpy y value of 2.8, is
larger than the product 5.5 of the corresponding Δ–Δ and Λ–Λ
y values for Ru-bpy. However, the values 7.8 and 5.5 are similar
enough in magnitude to suggest that both TSS and TAS arrange-
ments will be significant for Ru-tpy, even if the former arrange-
ment with tpy ligands oriented towards the same strand will
predominate. Our results indicating a relatively modest co-
operativity factor (y = 2.8) for Ru-tpy appears to be in contrast
to the case of Ru(phen)2dppz
2+, for which a rather substantial
Δ–Λ cooperativity can be inferred, since Cardin and co-
workers report that the hexamer duplex used in their crystal
structure study preferentially binds precisely one Δ- and one
Λ-Ru(phen)2dppz in solution.5e
Experimental
Materials
All experiments were performed in aqueous solution (pH =
7.0) containing 150 mM NaCl and 1 mM cacodylate (dimethyl-
arsinic acid sodium salt) except for the LD experiments where
10 mM NaCl was used (pH = 7.0). This was because a lower
salt concentration gave a higher signal intensity without
aﬀecting the overall shape of the spectra. Stock solutions of
calf thymus DNA (ctDNA) (∼5 mM nucleotides) were prepared
Fig. 10 Schematic illustration of the proposed interaction geometries
for Ru-tpy (left) and the corresponding geometries of Δ- (green) and
Λ- (red) Ru-bpy (right). Top row illustrates the “same-side” (TSS) model
while the middle and bottom row illustrate the “alternating side” (TAS)
model. Circles indicate similarities in intermolecular contacts. The
models where constructed by manual docking and subsequent energy
minimization in vacuum, using AMBER 2 force ﬁeld in the HyperChem
8.0 software package (HyperCube, Inc.).
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by dissolving highly polymerized type I sodium salt calf
thymus DNA (Sigma-Aldrich) in buﬀer. A stock solution of poly-
(dAdT)2 (AT-DNA) (∼5 mM nucleotides) was prepared by dissol-
ving the sodium salt (Sigma-Aldrich) in buﬀer. The solutions
were filtered two times through a 0.7 µm polycarbonate filter.
Stock solutions of the complexes (∼1 mM) were prepared
by dissolving the chloride salts in buﬀer. Concentrations
were determined spectrophotometric using extinction coeﬃ-
cients: ε258 = 6600 M
−1 cm−1 per nucleotide for ctDNA, ε260 =
6600 M−1 cm−1 per nucleotide for AT-DNA, ε371 = 16 900 M
−1
cm−1 for Ru-tpy and ε444 = 16 100 M
−1 cm−1 for Ru(bpy)2dppz
2+
(Ru-bpy). For ITC measurements the DNA solution was
dialyzed against pure buﬀer for at least 48 hours at 8 °C.
Ruthenium complex solutions of appropriate concentrations
were prepared by dilution of the stock solutions in the
dialysate. The dialysis membrane used had a molecular weight
cut-oﬀ of 3.5–5 kDa (Spectra-Por® Float-A-Lyzer® G2, Sigma
Aldrich).
Δ- and Λ-[Ru(bpy)2dppz]Cl2 used in this study were pre-
pared as previously reported.11a
Other chemicals were purchased from Sigma-Aldrich and
used without purification.
Synthesis of [Ru(tpy)(py)dppz]Cl2
The synthetic route for preparation of [Ru(tpy)(py)dppz]Cl2 is
shown in Scheme 2. The procedure for preparation of Ru(tpy)-
Cl3 and [Ru(tpy)(dppz)Cl]Cl are in accordance to the methods
previously reported by Zhou et al. and Leising et al., respective-
ly.7a,14 [Ru(tpy)(dppz)(py)](PF6)2 was synthesized using the
method previously described by Zhou et al. with some modifi-
cations. A portion of 0.0557 g of [Ru(tpy)(dppz)Cl]Cl and
0.0270 g of AgNO3 were refluxed in 20 mL of ethanol–water
(1 : 1) for 3 h under N2(g). The solution was filtered after
cooling and the filtrate was refluxed again under N2 (g) for
another 4 h, with 0.0101 g pyridine (py) added. The solution
was left in a fridge over night for cooling. The next day the
product was precipitated using KPF6 dissolved in MilliQ water,
left for a few hours, collected on a filter, and washed with
ethanol–ether (1 : 2). Purification of [Ru(tpy)(dppz)(py)](PF6)2
was done using column chromatography with CH3CN and
neutral Al2O3. The eluate containing the pure orange product
was collected leaving a dark purple residue layer on top of the
column.
To replace the hexafluorophosphate anion with chloride,
the CH3CN solution of [Ru(tpy)(dppz)(py)](PF6)2 was reduced
to ∼1 mL evaporating with a stream of N2 under mild heating,
where after 0.5 g of ([CH3(CH2)3]4NCl), dissolved in 1 mL of
acetone, was added in increasing portions while stirring until
the solution was only weakly yellow and the precipitation com-
plete. The product was collected by a sintered glass filter and
washed first with acetone and then with diethyl ether to yield
[Ru(tpy)(dppz)(py)]Cl2 as a brown powder (36%, calculated
from the starting material, Ru(tpy)Cl3). UV/vis (in water; λmax
in nm, ε/103 M−1 cm−1 enclosed in parenthesis): 475(12.1),
372(16.9), 310(45.4), 275(69.2). 1H NMR (as PF6 salt, 400 MHz,
acetone-d6): δ 10.03 (dd, J = 8.2, 1.3 Hz, 1H), 9.56–9.52 (m, 1H),
9.48 (dd, J = 5.4, 1.4 Hz, 1H), 8.94 (t, J = 8.0 Hz, 2H), 8.84–8.71
(m, 2H), 8.59–8.42 (m, 4H), 8.26–8.11 (m, 9H), 8.04–7.94
(m, 2H), 7.76 (ddd, J = 8.2, 5.5, 0.8 Hz, 1H), 7.49–7.42 (m, 3H).
The 1H NMR spectrum of Ru-tpy (see Fig. S8 in ESI†) was in
accordance with previous results by Zhou et al. (2009)7a and
showed no significant impurities.
Spectroscopy
Absorption spectra were measured on a Varian Cary 4000 UV/
vis spectrophotometer (path length = 1 cm). The reverse
absorption titration spectra for Ru-tpy were measured with a
constant concentration of 5 μM Ru-tpy in buﬀer. The stock
solution of AT-DNA (with 5 µM of Ru-tpy to avoid dilution)
added directly in the cuvette (path length = 1 cm) in aliquots
up to a concentration of 80 µM nucleotides.
Linear dichroism spectra (LD) were measured on a
Chirascan LD spectropolarimeter on samples oriented in an
outer-rotating Couette flow cell with a 1 mm path length at a
rate of 1000 rpm. The spectra of the same samples
were recorded without rotation for baseline contribution
and were subsequently subtracted from the LD spectra. The
concentration of ctDNA used in the measurements was
266 µM nucleotides and mixed with complex solution with
appropriate concentration to obtain desired [Ru]/[base pairs]
ratios. Circular dichroism (CD) spectra were recorded on a
Chirascan CD spectropolarimeter similarly as the absorption
spectra. Five CD spectra were averaged for each sample. To be
consistent with the absorption and ITC measurements,
AT-DNA was used for the CD measurements (∼138 µM
nucleotides).
Calorimetric data was obtained using an ITC200 isothermal
titration calorimeter (Microcal) controlled by Origin 7.0 soft-
ware. The ruthenium complexes (∼600 µM) were loaded in a
syringe (40 µL) and titrated in 2 µl aliquots into 206 µl of
AT-DNA in 150 mM NaCl aqueous solution (∼340 µM nucleo-
tides). By integrating the power required to maintain the refer-
ence and sample cells at the same temperature it is possible to
obtain a direct measurement of the heat generated or
absorbed when complex and DNA interact. The experimental
raw data consists of a series of heat flow peaks, and each peakScheme 2 Synthesis of Ru-tpy.
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corresponds to one injection of complex. These heat flow
spikes are integrated with respect to time, which gives the total
heat exchanged per mole injectant, plotted against the ratio
[Ru]/[base pairs]. The primary ITC data was corrected for the
heat of ligand dilution by subtracting the average heat per
injection of complex titrated into buﬀer. There was negligible
heat arising from DNA dilution. The experiments were
performed at 20 °C, 25 °C and 30 °C.
1H NMR spectrum of [Ru(tpy)(py)dppz](PF6)2 in acetone-d6
was recorded on an Agilent 400 MHz spectrophotometer.
Theory and methods
Analysis of LD spectra
The isotropic absorption spectrum Aiso of a sample can be con-
sidered as a simple sum of component spectral envelopes ei,
each such envelope itself being a collecting all electronic tran-
sitions with a common polarisation direction relative to the
molecular coordinate system:
Aiso ¼
X
i
ei ð1Þ
Then, the linear dichroism spectrum LD will be a weighted
sum of the same component spectral envelopes:
LD ¼
X
i
wiei ð2Þ
there for an eﬀectively uniaxial oriented system (e.g. DNA
oriented by the shear flow in a Couette cell) the weights
wi are determined by the orientation of the polarization
direction characteristic for the electronic transition dipole
moments of ei relative to the macroscopic orientation axis of
the system:
wi ¼ γ 32 Sð3 cos
2 θi  1Þ 0  S  1 ð3Þ
where γ is the ratio of the optical path-length of the LD to
the absorption measurement, θi is the angle between the
transition dipole moment direction of envelope ei and the
orientation axis of the molecular system (in our case
the DNA helix axis), and the orientation factor S
describes the degree of alignment of the molecular system
orientation axis relative to the macroscopic orientation
axis, with S = 0 for an unoriented and S = 1 for a perfectly
aligned sample.
The reduced linear dichroism LDr value at a certain wave-
length is defined as the ratio of the linear dichroism value over
the isotropic absorbance value:
LDr ¼ LD
Aiso
ð4Þ
In wavelength regions where a single component spectral
envelope ei dominates the absorption spectrum, the LD
r curve
will be essentially constant and take the value wi, e.g. as
observed around the 260 nm band of B-DNA. Since θ for the
in-plane polarized π→π* nucleobase transitions here is close to
90°, the orientation factor S0 for ligand-free DNA can readily
be calculated from the LDr value.
LDr260 ¼ w ¼ γ
3
2
S0 ð5Þ
However, in most cases, and in particular for 3D-chromo-
phores like ruthenium polypyridyl complexes, component
spectral envelopes overlap substantially over the whole
range of the spectrum, and the LDr curve will vary strongly
with wavelength. Deconvolution of the experimental Aiso and
LD spectra into component envelopes, and thereby determin-
ing the weights wi, can in favorable cases be accomplished
by the TEM-method.5a,15 For a system with two component
envelope spectra, having distinct characteristic absorption
band features and distinct weights, the TEM-method in matrix
notation can be formulated as the solution of the combined
eqn (1) and (2):
½ a b  1 w1
1 w2
 1
¼ ½ e1 e2  ð6Þ
where a, b, e1 and e2 are column vectors corresponding to the
isotropic absorption, linear dichroism and the two component
envelope spectra, respectively. The variables w1 and w2 in
eqn (6) are varied until, as determined by visual inspection,
the characteristic features of component e2 have vanished in
component e1 and vice versa.
The orientation factor S is required for the angular orien-
tation to be determined from the weights wi. For a dye that (a)
is strongly bound to DNA; (b) has significant absorption at
wavelengths >300 nm (where the DNA is transparent); and (c)
has, within a certain range of [dye]/[DNA] ratios, invariant
binding geometry and invariant absorption spectrum; S can
readily be obtained as follows:
Let two LD spectra with diﬀerent [dye]/[DNA] ratios (within
the invariant range) be column vectors L1 and L2, and L0 be
the LD spectrum of a sample with DNA only. Then, if con-
dition (c) is fulfilled, the three columns are linearly dependent,
thus scalars α and β can be found so that αL1 + βL2 = L0; in
matrix notation:
Mx ¼ L0 ð7Þ
where M = [L1 L2] and x = [α; β]. Solving eqn (7) by a least
square projection gives α and β:
ðMTMÞ1MTL0 ¼ x ð8Þ
When condition (a) is fulfilled, practically all added dye can
be considered to be bound; and with the DNA concentration
being equal in the three samples, the vectors can be
written as:
L0 ¼ γS0d L1 ¼ γS1ðdþ c1bÞ L2 ¼ γS2ðdþ c2bÞ ð9Þ
where (with γ = 1), d is the LD spectrum at perfect
orientation of DNA only, b is the LD spectrum at perfect orien-
tation of bound dye at unit concentration, and c1 and c2 are
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the two known total dye concentrations. Since condition
(b) assures that d is zero and b is non-zero for wavelengths
> 300 nm, the following two equations are obtained by insert-
ing eqn (9) in (7):
αS1 þ βS2 ¼ S0 c1αS1 þ c2βS2 ¼ 0 ð10Þ
Since γS0 can be evaluated from eqn (5), S1 and S2 can
be obtained from known quantities after solving the two
equations in (10):
S1 ¼ S0c2
αðc2  c1Þ S2 ¼
S0c1
βðc2  c1Þ ð11Þ
Analysis of binding isotherms
Although global fitting of calorimetric and excited state life-
time data for Δ- and Λ-Ru-bpy and their 1,10-phenanthroline
analogues required a fairly complicated binding model com-
prising a symmetrical and a pair of unsymmetrical intercala-
tion geometries (Model 3), fits to calorimetric data only were
found to be satisfactory with a model with a single binding
geometry.10 This model, the classical McGhee–von Hippel
single ligand cooperative binding model was used also in this
work, and involves three adjustable parameters: the thermo-
dynamic binding constant K, the binding site coverage para-
meter n and the cooperativity factor y.16 Given values of these
three parameters (assumed to be constant in the small temp-
erature range used here), and total concentrations of binding
sites [B]tot (i.e. base pairs) and DNA-ligand [L]tot (i.e. ruthe-
nium complex) for each step of the titration, the mass-balance
equations were solved iteratively with a Newton–Raphson pro-
cedure, to give consistent binding densities θ and free ligand
concentrations [L]free, as well as the conditional probabilities
pij, as previously described.
10,17
Calorimetric titration
The ITC data obtained at a certain temperature was assumed
to be composed of three components:
ITCðiÞ ¼ ðΔH°bÞΔbðiÞ þ ðΔH°nnÞΔnnðiÞ þ ΔHbaseline ð12Þ
where ΔH°b is the standard binding enthalpy change, ΔH°nn is
the standard nearest neighbor interaction enthalpy change
and ΔHbaseline is a small constant value. For titration data
point i, the change in concentration of bound ligand Δb(i)
is calculated as [B]tot(i)[θ(i) − θ(i − 1)] and the change in
concentration of nearest neighbors Δnn(i) is calculated as
[B]tot(i)[θ(i)p22(i) – θ(i − 1)p22(i − 1)], where p22 is the con-
ditional probability that a bound ligand is followed by another
bound ligand on the DNA lattice. The ΔH values were deter-
mined by projecting the matrix with the ITC data as columns,
one for each temperature, on the space spanned by the Δb,
Δnn and a constant vector. The simulated ITC curves were
then calculated with eqn (12) and the goodness-of-fit deter-
mined as the Euclidian norm of the diﬀerence between the
measured and simulated data matrices.
Spectroscopic titration
The absorption spectra were arranged in data matrix M as
columns with w elements corresponding to the wavelengths
recorded; the columns corresponding to the t titration steps.
Singular value decomposition, using the svd command in the
MATLAB software, factorized the data matrix into two matrices
of orthonormal columns U and V, and a diagonal matrix S
with the singular values s1 ≥ s2 ≥ s3⋯ ≥ 0 along the diagonal.
Keeping only the m singular values that are significantly larger
than zero make it possible to simplify the factorization:
M ¼ USVT ¼ USV T þ N ð13Þ
where S is the upper m by m submatrix of S; U and V are the
first m columns of U and V, respectively, and N is a matrix of
small elements, ideally corresponding only to the noise in the
measurements. Assuming thus that the titration involves
m diﬀerent absorbing species, with absorption spectra in w
by m matrix A and concentrations in t by m matrix C, the
factorization can now be written as
M N ¼ USV T ¼ ACT ¼ U½RR1SV T ¼ ½UR½R1SV T ð14Þ
where R is a non-singular m by m matrix. Since A = UR and C =
VS(R−1)T, any theoretical binding model, which can calculate a
matrix Cm of concentrations of m species, can be evaluated for
consistency with the data by finding the R that is the least
square projection of VS on the space spanned by Cm:
RT ¼ ðCmTCmÞ1CmTVS ð15Þ
By varying the adjustable parameters of the theoretical
model, Cm is varied to minimize the norm of the residual
VS − CmRT while keeping the specie spectra in A = UR phys-
ically reasonable (non-negative in the case of absorption
spectra). In the present case, the concentration matrix Cm was
constructed with three columns corresponding to free ligand,
bound ligand with a neighboring free binding site, calculated
as [B]totθ(1 − p22), and bound ligand adjacent to another
bound ligand, calculated as [B]totθp22.
Conclusion
The angular orientation of the dppz and tpy ligands as deter-
mined by LD and CD spectroscopies, strongly indicate that
Ru-tpy binds from the minor groove by intercalating the dppz
ligand between the base pairs, as has previously been deter-
mined for the isomeric complexes Δ- and ΛRu-bpy. The
strong hypochromicity in the dppz absorption band is almost
identical in magnitude to that of ΔRu-bpy, indicating that the
alignment in the intercalation pocket is similar, too.
A simple cooperative binding model with one symmetrical
binding geometry provide an excellent fit to data for calori-
metric and absorption titrations of Ru-tpy into AT-DNA. The
intrinsic intercalation has an equilibrium constant of 106 M−1,
close to that of Δ-Ru-bpy, and is associated with a small
endothermic enthalpy change of +3 kJ M−1. The cooperativity
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factor is 2.8, and the associated neighbor interaction enthalpy
is exothermic, −10.2 kJ M−1; these values being in-between
those of Δ- and Λ-Ru-bpy, and consistent with a slight prefer-
ence of a one-sided arrangement of tpy-ligands of complexes
consecutively bound to DNA.
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Fig. S 1  Difference spectrum (Rubound – (Rufree + DNA)) of Ru-tpy (black) and ΔRu-bpy (red) in 150 mM NaCl solution at 25°C.
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Fig. S 2  Reverse absorption spectral titration carried out for Ru-tpy (5 µM) by addition of AT-DNA in a 150 mM NaCl solution at 
25°C. The spectra follows the addition of 0-8 [base pairs] / [Ru]. The arrows indicate the course of reaction as increasing 
amounts of AT-DNA is added to the solution. To avoid dilution equal amounts of 5 μM Ru-tpy was added simultaneously. The 
increasing hypochroism at 372 nm upon addition of AT-DNA is depicted in the inset of Fig. S 2. 
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Fig. S 3  Reverse circular dichroism titration of Ru-tpy (5 μM) with AT-DNA in a 150 mM NaCl aqueous solution. The spectra 
follows the addition of 0-7 base pairs per complex. 
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Fig. S 4 Reduced Linear dichroism spectra of Ru-tpy in the presence of ctDNA in a 150 mM NaCl aqueous solution at [base 
pairs] / [Ru] ratios of 8 (blue), 4 (red) and 2 (green) in 10 mM NaCl solution. The concentration of ctDNA is 270 µM nucleotides.
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Fig. S 5  Absorption spectral titration carried out for AT-DNA (12 µM nucleotides) by addition of Ru-tpy in a 150 mM NaCl 
solution at 25°C. The spectra follows the addition of 0-2 [Ru] / [complex]. The arrow indicate the course of reaction as increasing 
amounts of Ru-tpy is added to the solution. To avoid dilution equal amounts of 12 μM AT-DNA was added simultaneously.
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Fig. S 6   The first 4 columns of V plotted against row number. Blue: v1 (s1=100); green: v2 (s2=2.45); red: v3 (s3=0.23); light 
blue: v4 (s4=0.18).
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Fig. S 7  The first 4 columns of U plotted against wavelength. Blue: u1 (s1=100); green: u2 (s2=2.45); red: u3 (s3=0.23); light 
blue: u4 (s4=0.18)
Fig. S 8 1H NMR spectrum of [Ru(tpy)(py)dppz](PF6)2 dissolved in acetone-d6.  
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Competitive DNA binding of Ru(bpy)2dppz
2+
enantiomers studied with isothermal titration
calorimetry (ITC) using a direct and general
binding isotherm algorithm†
Anna K. F. Mårtensson and Per Lincoln*
While isothermal titration calorimetry (ITC) is widely used and sometimes referred to as the ‘‘gold
standard’’ for quantitative measurements of biomolecular interactions, its usage has so far been limited
to the analysis of the binding to isolated, non-cooperative binding sites. Studies on more complicated
systems, where the binding sites interact, causing either cooperativity or anti-cooperativity between
neighboring bound ligands, are rare, probably due to the complexity of the methods currently available.
Here we have developed a simple algorithm not limited by the complexity of a binding system, meaning
that it can be implemented by anyone, from analyzing systems of simple, isolated binding sites to
complicated interactive multiple-site systems. We demonstrate here that even complicated competitive
binding calorimetric isotherms can be properly analyzed, provided that ligand–ligand interactions
are taken into account. As a practical example, the competitive binding interactions between the two
enantiomers of Ru(bpy)2dppz
2+ (Ru-bpy) and poly(dAdT)2 (AT-DNA) are analyzed using our new
algorithm, which provided an excellent global fit for the ITC experimental data.
Introduction
When studying the binding interactions between a ligand and a
macromolecule, isothermal titration calorimetry (ITC) has many
advantages. It is a powerful, high-precision tool that is often
referred to as the ‘‘gold standard’’ for quantitative measurements
of biomolecular interactions, and the only direct thermodynamic
method that enables full thermodynamic characterization
(stoichiometry, association constant, enthalpy and entropy of
binding) of the interaction after a single titration experiment.
However, the currently available analysis software is generally
limited to the analysis of multiple binding systems with isolated
(i.e. non-interactive) binding sites, and cannot adequately
take into account cooperative or anti-cooperative interactions
inherent in the binding of large ligands to DNA.1
In our previous ITC studies on ruthenium complexes inter-
calating into DNA, a generalized McGhee–von Hippel binding
isotherm algorithm was utilized to account for binding site
interactions.2,3 However, the algorithm employed4 in our earlier
work involves two nested iterations: the inner iteration for solving
the secular equations, the outer for solving the mass-balance
equations. This algorithm has never got a wide-spread use, not
unlikely due to its complexity and limited efficiency. Moreover,
it is limited to describe interactions between 1 : 1 binding
site : ligand equilibria.
Here we present a much improved and simplified algorithm,
which iterates the mass balance equations directly with just
14 lines of the MATLAB code (see the ESI†). The new method
is very general, and is no longer limited to just the nearest-
neighbor interactions between bound ligands, since higher
than 1 : 1 binding site : ligand equilibria can be treated just as
easy. While this method can be utilized for modelling ligand
binding to any type of linear biopolymers (such as actin, myosin
or tubulin), we anticipate that the most frequent usage would
be for studying the binding aﬃnity of ligands to the closely
spaced binding sites of DNA.
The intercalation ability of ligands to DNA is commonly
determined by ethidium bromide displacement assays.5–8 This
method was scrutinized in a recent study, using ITC as an
alternative non-label method.9 However, the study focused
on whether ethidium bromide displacement ability could auto-
matically be interpreted as the intercalation potential of small
molecules, not addressing the issue with ligand–ligand inter-
actions. Most often, ITC experiments included in competitive
binding studies are limited to the determination of thermo-
dynamic parameters, ignoring ligand–ligand interactions.
There are a few notable examples of ITC data analysis methods
that are capable of adequately analysing more complex
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ligand–macromolecule systems. One such example is the AFFI-
NImeter software (S4SD), which is capable of the global fitting
of non-standard binding models, such as competing ligands to
a multiple site receptor. However, while several case studies are
available exemplifying the resourcefulness of the method,10 a
binding system of a repetitive one-dimensional lattice of closely
spaced binding sites (e.g. DNA) is not included. Perhaps for
that reason, nearest-neighbor cooperativity is not addressed
either. In addition, Buurma and Haq have developed a general
software package, denoted IC-ITC, capable of analysing ITC
data with a model including two independent binding sites and
taking ligand self-aggregation into account.11
To exemplify the practical usage of our algorithm, we have
conducted a series of competitive ITC experiments titrating
enantiopure Ru(bpy)2dppz
2+ (Ru-bpy; bpy = 2,20-bipyridine;
dppz = dipyrido[3,2-a:20,30-c]phenazine) into a solution of
poly(dAdT)2 (AT-DNA). Ru-bpy is an intercalating Ru(II) poly-
pyridyl complex with a strong binding aﬃnity to DNA (and a
slight preference towards A–T base pairs). The complex has an
octahedral coordination geometry resulting in two possible
configurations, a right-handed (D) and a left-handed (L) propeller-
like structure (Fig. 1).
It is well-established that it is the dppz moiety that inter-
calates between the base pairs of the DNA helix using both
spectroscopic and biophysical methods as well as using X-ray
crystallography.12–20 However, while the intercalating proper-
ties of Ru(II) polypyridyl complexes are certainly important, it
is becoming more and more apparent that the molecular
structure of the ancillary ligands has a strong influence on the
binding characteristics of a complex,21–25 including complex–
complex interactions.2,3,26 It has often been neglected to take
into account the cooperative and anti-cooperative behaviour of
DNA-bound dppz-based Ru-centred structures when analysing
the complex-DNA interactions.
Only recently have high-resolution structures and calori-
metric studies emerged that have revealed nearest-neighbor
interactions as a possible explanation to the complicated
thermodynamic profiles of these complexes.2,3,16–19,26,27 The
non-classical ITC curves previously reported for Ru(L)2dppz
2+
complexes (L = bpy or phen (phen = 1,10-phenanthroline))
have been attributed to an additional enthalpy contribution
from neighboring complexes on the DNA as saturation of
binding sites increases.2,3 DNA, being a right-handed helical
structure, would assumingly interact differently with the D and
L-enantiomers of tri-bidentate complexes, and previous results
obtained using calorimetry do indeed indicate the D-form of
both Ru-bpy and Ru-phen to have a stronger binding affinity
towards DNA.2,14
Analysis of a single enantiomer – DNA ITC titration with a
simple neighbor interaction lattice model requires 3 binding
parameters (the intrinsic binding constant K, the cooperativity
parameter yaa and n, the number of basepairs covered by the
bound ligand) and two enthalpy parameters (the intrinsic
binding enthalpy DH

a and ligand–ligand interaction enthalpy
DH

aa), thus determining the thermodynamic characteristics of
D- and LRu-bpy binding requires (6 + 4) fitting parameters.3 By
augmenting the dataset with two continued titrations, in which
one enantiomer is titrated into DNA saturated with the opposite
enantiomer, the consistency of the model can be scrutinized by
performing a global analysis of all 4 titrations with only two
additional fitting parameters (yab and DH

ab).
Recently, Mikek et al. showed that the non-classical ITC
curves, which arise upon titration of a 25-bp DNA oligomer
duplex with ruthenium dppz complexes, can be excellently fitted
with a two independent site binding model with 4 binding
parameters (K1, K2, f1 and f2) and 2 enthalpy parameters (DH

1
and DH

2 ) per titration.
28 Since the binding site fractions f1 and f2
were found to be reasonably similar for both enantiomers,
one could envisage that a global analysis with the two indepen-
dent site model on the augmented data set could provide an
alternative interpretation to the lattice based models.
Our previous ITC studies on binding of Ru(L)2dppz
2+ com-
plexes to poly(dAdT)2 have modeled the DNA as a homo-
polymer of identical intercalation pockets.2,3 Crystallographic
studies from the Cardin group have convincingly shown that
the L-enantiomer of Ru(L)2dppz
2+ type complexes strongly
prefers 50-TA-30 to 50-AT-30.17 Thus, it is further of considerable
interest to investigate a more realistic binding model, in which
the two alternating intercalation pockets of poly(dAdT)2 are
explicitly accounted for.
Experimental
Materials and sample preparation
All experiments were performed in an aqueous buﬀer solution
(pH = 7.0) containing 150 mM NaCl and 1 mM cacodylate
(dimethylarsinic acid sodium salt). A stock solution of poly(dAdT)2
(AT-DNA) (B5 mM nucleotides) was prepared by dissolving the
sodium salt (Sigma-Aldrich) in buﬀer. Stock solutions of the
complexes (B1 mM) were prepared by dissolving the chloride
salts in buﬀer. Concentrations were determined spectrophoto-
metrically using extinction coeﬃcients: e260 = 6600 M
1 cm1
per nucleotide for AT-DNA, and e444 = 16 100 M
1 cm1 for
Ru(bpy)2dppz
2+. For ITC measurements the DNA solution was
dialyzed against pure buﬀer for at least 48 hours at 8 1C.
Ruthenium complex solutions of appropriate concentrations
were prepared by dilution of the stock solutions in the dialysate.
The dialysis membrane used had a molecular weight cut-oﬀ of
3.5–5 kDa (Spectra-Pors Float-A-Lyzers G2, Sigma-Aldrich).
Enantiopure D- and L-[Ru(bpy)2dppz]Cl2 used in this study
were prepared as previously reported.20Fig. 1 Structures of L-(left) and D-Ru(bpy)2dppz2+ (right).
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Other chemicals were purchased from Sigma-Aldrich and
used without purification.
Absorption spectra were measured on a Varian Cary 4000
UV/vis spectrophotometer (path length = 1 cm).
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) is a high-precision tool
where the heat produced or absorbed upon addition of the
complex to a DNA solution enables direct assessment of the
binding free energy by integrating the power required to main-
tain the reference and sample cells at the same temperature.
The experimental raw data consist of a series of heat flow
peaks, and each peak corresponds to one injection of complex.
These heat flow spikes are integrated with respect to time,
which gives the total heat exchanged per mole injectant plotted
against the ratio [Ru]/[base pairs].
Calorimetric data were obtained using an ITC200 isothermal
titration calorimeter (Microcal) controlled by Origin 7.0 software.
The ITC profiles of the D and L enantiomers of Ru-bpy were
obtained by a single injection of 1 ml followed by 19 sequential
titrations in 2 ml aliquot injections of complex from a syringe
stock solution (B470 mM) into the sample cell (206 ml) loaded
with AT-DNA in 150 mM NaCl aqueous solution (B300 mM
nucleotides). This was subsequently followed by an additional
20 sequential additions (single injection of 1 ml followed by
19 injections of 2 ml aliquots) of the opposite enantiomer into
the sample cell now loaded with AT-DNA saturated by the first
complex. All ITC experiments were performed at 25 1C. The
injection spacing was 180 s, the syringe rotation was 750 rpm,
and there was an initial delay of 120 s prior to the first
injection. The concentration ranges used for the complex and
DNA were set to span mixing ratios of [Ru]/[base pairs] from
0.08 to 0.6 for the first titration and from 0.7 to 1.4 for the
second titration. The primary ITC data were corrected for the
heat of complex dilution by subtracting the average heat per
injection of the complex titrated into buﬀer. There was negligible
heat arising from DNA dilution. The raw ITC data peaks were
automatically integrated using the Origin 7.0 software. For improved
accuracy of the integration, the integration range for each heat
peak was narrowed to includeB2/3 of the original range, thus
reducing the background noise from the baseline.
Results
Derivation of the general binding isotherm algorithm
The problem of modelling binding equilibria between a set of
ligands and an infinite one-dimensional lattice of identical
binding site units is advantageously treated with the statistical
thermodynamics of linear hetero-polymers, which can con-
veniently be cast into matrix equations. The binding site unit
itself can be defined to consist of one or several polymer sub-
units, and may provide one or several distinct ligand binding
sites. The mathematical equivalence between the partition
function and Markov chain formalisms have been demon-
strated earlier,4 and although we here will use a variant of the
elegant formulation by Chen of the ligand binding problem
using the former formalism,29 the derivation uses the probabil-
istic Markov chain approach, implicit in the classical paper by
McGhee and von Hippel.30
In the most general case, at equilibrium with L diﬀerent
ligands A (A = 1,. . .L), the initial homo-polymer of bare binding-
site units has been converted into a hetero-polymer with N + 1
diﬀerent types of elementary units i (i = 0, 1. . .N), where the unit 0
is the bare binding site unit, and the other N elementary units i
are composed of ni consecutive binding site units and
P
A
miA
ligands. We denote ni the length, and miA the stoichiometric
coeﬃcient with respect to the ligand A, of the elementary unit i.
At equilibrium, each elementary unit is further characterized by
its binding density yi and its binding potential xi. The probability
that a randomly chosen binding site unit is in the elementary
unit i is given by niyi, and the binding densities thus give the
total concentration of the bound ligand A:
Abound ¼ B0
X
i¼1
miAyi (1)
where B0 is the total concentration of binding site units.
The binding potential is a function of the intrinsic binding
constant Ki (the equilibrium constant for the formation of
elementary unit i from free ligands and ni consecutive bare
binding site units in the absence of interactions with neighbor
units) and the free ligand concentrations Afree:
xi ¼ K iPAAmiAfree (2)
the binding potential for unit 0 being defined as unity, x0 = 1.
The interactions between neighboring elementary units are
given by a set of non-negative cooperativity constants yij that are
elements of the cooperativity matrix Y = [yij], i, j = 0, 1,. . .N. The
product of the cooperativity constant yij and the intrinsic
binding constants Ki and Kj gives the equilibrium constant Kij
for formation of the two consecutive units i and j from free
ligands and ni + nj consecutive bare binding sites in the absence
of other neighbor interactions:
Kij =KiKjyij (3)
yij 4 1 indicates a favorable (cooperative), yij o 1 an unfavor-
able (anti-cooperative) and yij = 1 no interaction between units i
and j. The interaction between two bare binding sites is always
non-cooperative by definition, hence y00  1, and in most cases,
all cooperativity parameters involving a bare binding site unit,
y0i and yi0, are set to 1. In some binding models zero elements,
yij = 0, are used to exclude certain sequences of elementary units;
however, to provide a physically meaningful model, YZ 0 must
be a primitive nonnegative matrix, i.e. there is a power of Y
which is positive: Yp 4 0 for some p Z 1.31
Defining matrixM = [miA] and column vectors x = [xi], h = [yi],
k = [Ki], cf = [Afree] and cb = [Abound] (i = 1,. . .N; A = 1,. . .L), eqn (1)
and (2) can be expressed in matrix notation:
cb = B0M
Th (4)
x = exp[ln(k) + M ln(cf)] (5)
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where the superscript T denotes matrix transposition; and ln
and exp denote elementwise operation of the natural logarithm
and exponential functions, respectively.
Given that an N by N non-singular transformation matrix T
can be constructed such that the product TM has only 0 and 1 as
elements, with exactly one 1 in each row but no zero columns;
N mass balance equations can be set up:
TMc0 = exp(T[ln(x)  ln(k)]) + B0TMMTh (6)
where c0 = [Atotal] is a column vector with the total concentra-
tions of the L ligands as elements.
In order to solve eqn (6), the relation between x, h and Y has
to be made explicit. Given any positive N vector r, Y can be
transformed into a stochastic matrix P with the constant row
sum of 1:
P = D(s)YD([1; r]) (7)
where D(s) denotes a diagonal matrix which has the elements of
vector s along the diagonal and is zero elsewhere. The elements
si of the N + 1 vector s normalize each row sum to unity:
si = (yi0 + y
T
i r)
1, i = 0, 1,. . .N (8)
where yTi is the (i + 1)th row of Y, except for the first element
yi0. Thus
pij = siyijrj (9)
and the element pij of P gives the conditional probability that
the elementary unit i is followed by the elementary unit j.
Following the probabilistic approach of McGhee and von
Hippel, the binding potential xi can, in the absence of neighbor
interactions, be equated to the quotient between the probability
of finding the elementary unit i, preceded by the elementary
unit a and followed by the unit b, and the probability of finding
a and b enclosing ni consecutive bare binding site units:
xi ¼ paipib
pa0p00ni1p0b
(10)
McGhee and von Hippel use eqn (10) and take a and b as
the bare binding site units with y0i = yi0 = 1, in which case
xi = paipib/p00
ni+1. For the general case, inserting pij = siyijrj, in
eqn (10) and using that y00 = r0 = 1, gives
xi ¼ sayairið Þ siyibrbð Þ
saya0r0ð Þ s0y00r0ð Þni1 s0y0brbð Þ
¼ siris0ni yaiyib
ya0y0b
  (11)
The binding potential xi is defined from the equilibrium for
the formation of elementary unit i from free ligands and ni
consecutive bare binding site units in the hypothetical absence
of interactions with neighbor units. Thus, the factor involving
the cooperativity parameters on the right side of eqn (11) can be
set to 1 to give
xi = siris0
ni (12)
As long as Y is primitive, eqn (12) is valid whatever value taken
by the cooperativity parameters involving the elementary
unit i. When Y is primitive, P will be as well since r 4 0.
The theorem of Frobenius states that a primitive non-
negative square matrix has only one strictly positive right-
hand eigenvector, and that the corresponding dominant
eigenvalue is a simple root of the characteristic equation,
equal to the spectral radius of the matrix and exceeds all the
other eigenvalues in modulus.31
For any primitive stochastic matrix, the constant N + 1 vector
e = [1] is the right-hand eigenvector corresponding to the
dominant eigenvalue 1:
Pe = e (13)
Let the left-hand eigenvector corresponding to the dominant
eigenvalue 1 be the positive row vector fT, thus
fTP = fT (14)
When normalized so that fTe = 1, f gives the limiting probabilities
of the Markov chain defined by P; i.e. for an infinitely long hetero-
polymer, fi is the absolute probability that an elementary unit
picked at random is the elementary unit i. However, elementary
units may be of diﬀerent lengths ni, and it is convenient to
normalize f with respect to the length of each unit:
fT[1; n] = 1 (15)
When f is so normalized, the first element, f0 = 1  hTn, will be
the absolute probability that a lattice subunit picked at random
is a bare binding site unit, and the other N elements in f will be
the binding densities yi, thus
fT = [(1  hTn) hT] (16)
Let P be partitioned as
P ¼
p00 p
T
01
p10 P11
" #
(17)
Insertion of eqn (16) and (17) in (14) gives [(1 hTn)pT01 + hTP11 ]
= hT, which can be solved for hT:
hT = PT01V
1, V = (I + npT01  P11) (18)
where I is the identity matrix. Matrix V in eqn (18) can never
become singular, since the spectral radius of any submatrix of a
primitive, and thus irreducible, non-negative matrix is strictly
smaller than that of the full matrix, hence the eigenvalues of
P11 will all be less than 1.
Given cooperativity parameters in matrix Y and elementary
unit lengths in column vector n, the vectors of binding poten-
tials x and binding densities h are thus functions of an N-vector
r4 0 through eqn (7), (8), (12) and (18). Given intrinsic binding
constants k, stoichiometric coeﬃcients M, total ligand concen-
trations c0 and total binding site concentration B0, the mass
balance eqn (6) can be rearranged to
q = exp(T[ln(x)  ln(k)]) + TM (B0MTh  c0) (19)
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where the mass balance error in N-vector q is a function of r. The
norm of the mass balance error q is conveniently minimized by
iterating with the Newton–Raphson method:
rnþ1 ¼ rn  dqdr
 1
q (20)
where subscript n is the number of the iteration step and it
is understood that q and its derivatives are evaluated at rn. By
elementwise evaluation of the elements of (dq/dr) we find that
the derivatives of x and h can be separated:
dq
dr
 
¼ DðaÞTDðxÞ1 dx
dr
 
þ B0TMMT dhdr
 
(21)
where a = exp(T[ln(x)  ln(k)]). In the common case that T = I,
i.e. every elementary unit (except the bare binding site unit)
contains only one bound ligand, a reduces to D(k)1x and eqn (21)
simplifies to
dq
dr
 
¼ DðkÞ1 dx
dr
 
þ B0MMT dhdr
 
(22)
The derivative of si with respect to rk is readily obtained from
eqn (8):
dsi
drk
¼ si2yik ¼ sipikrk1 (23)
Thus, from eqn (12)
dxi
drk
¼ d siris0
nið Þ
drk
¼ xipikrk1 þ xirk1@ik þ xinip0krk1 (24)
where @ik is 1 only when i = k and zero otherwise. Assembling
the matrix from the elements given by eqn (24) gives:
dx
dr
 
¼ DðxÞVDðrÞ1 (25)
where V was defined in eqn (18). The derivatives of hT involve
derivatives of submatrices of P, and are thus best evaluated
row-wise from eqn (18):
dhT
drk
 
¼ dp01
T
drk
 1
V1  pT01V1
dV
drk
 
V1
¼ dp
T
01
drk
 1
 hT dV
drk
 " #
V1
(26)
where the derivatives of V follow directly from the definition of
V in eqn (18):
dV
drk
 
¼ n dp
T
01
drk
 1
þ dP11
drk
 
(27)
Insertion of eqn (27) in (26) gives:
dhT
drk
 
¼ 1 hTn  dpT01
drk
 1
þhT dP11
drk
 " #
V1
¼ fT dP1
drk
 
V1
(28)
where the left-hand eigenvector fT is given by eqn (16) and P1
is the rectangular submatrix obtained from P by omitting the
first column. The derivative of pij with respect to rk is
dpij
drk
¼ d siyijrj
 
drk
¼ siyij@jk  sipikyijrjrk1
¼ pik@jk  pikpij
 
rk
1
(29)
Insertion of eqn (29) in fT(dP1/drk) gives
fT
dP1
drk
 
¼ rk1
X
i
fipik@jk 
X
i
pikfipij
 !
¼ rk1 yk@jk  pTkD fð ÞP1
  (30)
where fi is the ith element of f (i = 0, 1,. . .N), pk is the kth column
of P1 (k = 1,. . .N) and thus
P
i
fipik ¼ fTpk ¼ yk. Assembling
the rows of eqn (30) into a matrix and transposing gives with
eqn (28):
dh
dr
 
¼ VT 1UDðrÞ1; U ¼ DðhÞ  PT1DðfÞP1  (31)
Insertion of eqn (25) and (31) in eqn (21) completes the iterative
step for solution of the mass balance in eqn (19). In the ESI,†
the code is given for the MATLAB program GeneralAlgorithm
which solves the mass-balance for a single titration point
using eqn (21). The code is also given for a series of pro-
grams ITCalgorithmModelX which show examples of how the
GeneralAlgorithm can easily be implemented for global analysis
of ITC titration data with various binding models. In addition,
the code is given for the program ITCalgorithmIndependent
which implements analysis using a model with 2 independent
binding sites.
Isothermal titration calorimetry and model fitting
Fig. 2 shows raw ITC data of titration of AT-DNA with the
enantiomers DRu-bpy and LRu-bpy. To the left, the ligand is
titrated into AT-DNA only. In accordance with our previous
results, further injections with the same enantiomer (not shown)
gave only very small, constant heat values, indicating full satura-
tion of the DNA.2,3 However, when proceeding the titration by
injecting the opposite enantiomer (Fig. 2, right) substantial
enthalpy changes are observed, indicating that both enantiomers
can displace each other on the DNA.
In the global fitting of these ITC isotherms, a data point i in
the ITC isotherm is assumed to be a sum of intrinsic and
neighbor interaction binding enthalpies:
ITCðiÞ ¼
X
a
DH

a
 
DaðiÞ þ
X
ab
DH

abDabðiÞ þ DHbaseline (32)
where DH

a is the standard enthalpy change for the formation
of elementary unit a from free ligands and binding sites in the
absence of interactions with neighbor units and DH

ab is the
standard enthalpy change of the interaction between neighbor
elementary units a and b. DHbaseline is a small constant, and
is an approximation for various enthalpy contributions not
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included in the model and not corrected for by the subtraction
of the heat of dilution. Examples of such possible contributions
could be the diﬀerent environment in the counter-ion distribu-
tion around the DNA compared to in buﬀer or weak association
of the ruthenium complex cations with the saturated, but still
negatively charged DNA.
For the titration data point i, Da(i), the change in the
concentration (per mole of the injected ligand) of the elemen-
tary unit a from the preceding point i  1, is calculated as
B0(i)ya(i)  dfB0(i  1)ya(i  1), and the change in concentration
(per mole of injected ligand) of nearest-neighbors Dab(i) is
calculated as B0(i)ya(i)pab(i)  dfB0(i  1)ya(i  1)pab(i  1),
where, at data point i, B0(i) is the total concentration of binding
site units divided with the mole amount of the injected ligand,
and pab(i) is the conditional probability that ligand a is directly
followed by ligand b on the DNA lattice. The dilution factor df
is calculated as 1  Vadd/Vcell. The DH1 values were determined
by a least-square projection of the column matrix with all the
ITC data on the space spanned by the Db and Dab columns,
and 4 constant columns corresponding to the 4 baselines.
The elements of the constant columns were 1 for the corres-
ponding titration and zero elsewhere. The simulated ITC curves
were then calculated with eqn (32) and the RMSD goodness-of-
fit determined as the Euclidian norm of the diﬀerence between
the measured and simulated data matrices, divided by the
square root of the number of data points (here 76). To facilitate
comparison with other ITC studies, we here report nRMSD
values, i.e. RMSD normalized by division with the mean
of the absolute values of the data (the mean value being
3.316 kJ per mol injectant for this data set). The MATLAB
program ITCalgorithmModelX (as shown in the ESI†) performs
this calculation, and was used with the non-linear optimization
MATLAB routine fminsearch to find the parameter values for the
best global fit to the experimental ITC data.
We have considered 5 models, which are schematically
depicted as lattice models in Fig. 3. Models 1–3 consider both
intrinsic DH

a
 
and neighbor interaction DH

ab
 
reaction
enthalpies. Model 1 is the classical model, which takes the
lattice subunit to be one base pair and thus assumes all
intercalation pockets on the DNA to be equal. The binding site
Fig. 2 ITC raw data for binding of the D and L enantiomers of Ru-bpy to AT-DNA alone (D: top left; L: bottom left) followed by a second titration of the
opposite enantiomer to already complex-saturated AT-DNA (D into L-saturated DNA: top right; L into D-saturated DNA: bottom right) in 150 mM NaCl
aqueous solution at 25 1C. Complex (B470 mM) was injected in 2 ml aliquots to the 206 ml cell containing the DNA (B300 mM nucleotides). For improved
accuracy of the integration details the integration range was narrowed to B2/3 of the original range.
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coverage vector n is allowed to vary in the fit, but is expected to
take a value close to 2, i.e. nearest-neighbor exclusion, as
observed for binding of most intercalators to DNA. Models 2
and 3 take the lattice subunit to be 2 base pairs (and n close
to 1); in model 2 the subunit is assumed to bind D or L only in
one way, modelling a strict TA (or AT) selectivity for both
enantiomers. In model 3, this selectivity is relaxed for D which
is assumed to be able to bind in either of the intercalation
pockets 1 or 2 of the lattice subunit, while L only binds in
pocket 1. Nearest-neighbor exclusion is followed since L1 or D1
cannot be directly followed by D2 (see Fig. 3). Models 4 and 5
assume two binding modes for each enantiomer, and consider
only intrinsic reaction enthalpies DH

a
 
. In model 4, the two
binding modes are modelled as two independent binding sites,
for which the fraction of the total concentration of base pairs is
a freely adjustable parameter, i.e. no lattice model is involved.
It is possible to construct a mathematically equivalent lattice
model in the case the fractions of the two binding sites have the
same value, as shown for model 4* in Fig. 3. The lattice subunit
contains here 4 base pairs, all yij = 1, and a third type
of elementary unit with two bound ligands is required, for
which the intrinsic binding constant K3 = K1K2. Model 4* gives
numerically identical results to model 4 with only one value of
the fraction parameter, but relaxing the independence of the
two binding sites (by allowing the intrinsic binding constant of
each of the 8 elementary units to vary independently) did only
marginally improve the bad global fit. Although the location
of the bound ligand(s) within the lattice subunit is arbitrary,
Fig. 3 indicates a possible physical interpretation, where the
two distinct sites of model 4* are assigned to intercalation from
minor and major groove, respectively. Thus, model 4* can be
interpreted as only permitting alternating minor and major
groove intercalation for consecutive sequences of bound ligands.
To simplify this idea, in model 5 two binding modes are defined,
which must alternate in consecutive sequences, which hence
only interact (yija 1) for different mode neighbors. The best fit
of this model was obtained when the lattice subunit was
defined to be one base pair, as depicted in Fig. 3.
For each of the models, the number of fitting parameters
(binding parameters, and for model 3 also the number
of enthalpy parameters) was also gradually reduced from the
full model by symmetry considerations or by assuming non-
cooperativity. An overview of the goodness-of-fit of the diﬀerent
models is given in Fig. 4, which plots the relative RMSD of
calculated and experimental ITC-data against the total number
of fitting parameters. If non-cooperative binding is assumed for
models 1–3 and 5 (all non-zero yij are set to 1), the RMSD
increases by a factor of 2–5 compared to the best fit, as seen to
the left in Fig. 4. While the non-interacting site model 4 makes
a descent fit (nRMSD = 3.50%) when the fractions of site 1 and
site 2 are allowed to have different values in all four different
titrations (to the right in Fig. 4), restraining the 8 fractions of
Fig. 3 Schematic illustration summarizing the 5 proposed lattice models of the DNA-ligand binding interactions.
Fig. 4 Relative RMSD plotted against the total number of fitting para-
meters comparing the goodness-of-fit for all 5 models.
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the global fit to take fewer different values makes the RMSD
increase by a factor of about 2 (see Fig. S1 in the ESI†). On
the other hand, for model 3 (total number of fitting parameters
9 + 7 = 16), which gives the lowest RMSD of all the models
investigated here (nRMSD = 2.45%), the RMSD is only slightly
increased (15%) if the binding and enthalpy parameters of D
are constrained to be the same for the two base pair steps
(total number of fitting parameters 7 + 5 = 12). Furthermore, for
(7 + 5) parameter models 1–3, the best fit value of the yDD
cooperativity parameter was found to be close to one, and
defining yDD = 1 (i.e. fitting only 6 + 5 parameters) increased
the RMSD by less than 0.5%. Fig. 5 shows the excellent fit of the
(6 + 5) parameter model 3 to the integrated peaks of the raw
data in Fig. 2. Model 5 performs almost as well as model 3, but
since it requires a larger number of binding parameters for a
comparable RMSD, the best fit values of these are not further
considered here.
An estimate for the sensitivity of the fitting parameters to
changes in the model can be obtained from Table 1, which
gives the values of the binding and enthalpy parameters,
as well as the nRMSD, for the global fit of (6 + 5) parameter
models 1–3. All three fits showed only small baseline enthalpy
values, given in Table S1 in the ESI†.
Table 2 gives standard thermodynamic values from the
(6 + 5) parameter fit of model 3. Given the 9-fold diﬀerence in
the intrinsic binding constant, the almost identical corresponding
DS1-values of D and L are striking, suggesting that the aﬃnity
diﬀerence is of purely enthalpic origin. However, the similarity
in calculated entropy changes is better regarded as coincidental
and provisional, since any small model-dependent change in the
DH1-values would partition the free energy diﬀerence diﬀerently
between enthalpy and entropy contributions.
Discussion
The general algorithm derived in this work allows quick evalua-
tion of lattice binding models of widely varying complexity, and
for the first time, mass balance equations for lattice models
which, by defining multiple-ligand units, go beyond nearest-
neighbor interactions, can be easily solved. As model complexity
increases, however, so does the number of fitting parameters,
Fig. 5 ITC profiles with fitted traces of (6 + 5) parameter model 3 for the binding of the D- and LRu-bpy to AT-DNA alone (left) followed by a second
titration of opposite enantiomer to already complex-saturated AT-DNA (right) in 150 mM NaCl aqueous solution at 25 1C. Symbols (D: green; L: red)
indicate the normalized integrated heat absorbed or evolved upon sequential 2 ml injections of the complex (B470 mM) into the 206 ml cell containing the
DNA (B300 mM nucleotides).
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and the physical meaningfulness of their best-fit values might
rapidly deteriorate if the range of experimental data in the global
fit is too narrow. As the present study is intended to show examples
of general global analysis of ITC data, we have deliberately excluded
titration data sets made by other experimental methods.
Thus, the goal of this study is to find the binding model that
gives a very good global fit to the ITC data with the smallest
number of adjustable parameters. Since neither non-cooperative
lattice-models (model 1–3 and 5) nor the restricted two indepen-
dent site model 4 produced any reasonable global fit (see Fig. 4),
we conclude that ligand–ligand interactions, whether direct or
mediated by the DNA, are an absolute requirement to under-
stand the behavior of the present system. Furthermore, since
models 4 and 5, in which no neighbor interaction enthalpy is
considered, require a considerably larger number of fitting
parameters for acceptable fits, we conclude that for a minimal
parameter model, the enthalpic contribution from ligand–ligand
interactions has to be included.
Using model 1, the present dataset with extended competi-
tive titrations gave only minor diﬀerences in intrinsic and
homochiral interaction parameters compared to our earlier
analysis of single titration D- and LRu-bpy ITC data.3 However,
the X-ray structure evidence for the LRu-bpy 50-TA-30 selectivity
suggests that the assumption in model 1 of identical inter-
calation pockets in poly(dAdT)2 is erroneous. Assuming that
DRu-bpy shares the same selectivity, model 2 models poly(dAdT)2
as consisting of repeating units of 2 base pairs, to which 50-TA-30
selective ligands can bind with essentially no overlap, but the fit
is slightly worse (nRMSD = 4.48%) than with model 1 (4.04%). It
should be noted that assuming DRu-bpy to be homo-chiral non-
cooperative (i.e. reducing the binding parameters from 7 to 6
by setting yDD = 1) had a negligible influence on the fit for
models 1 and 2.
Relaxing this assumption in model 3, and allowing the
50-TA-30 and 50-AT-30 intercalation sites for DRu-bpy to have
diﬀerent values for the intrinsic binding constant and homo-
chiral cooperativity parameter (9 + 7 fitting parameters, nRMSD
2.45%), gave the best fit of all models tried, although at the
drawback of having 2 additional binding and 2 additional
enthalpy parameters. Restricting the 50-TA-30 and 50-AT-30 inter-
calation sites for DRu-bpy to have the same fitting parameter
values and setting yDD = 1 gave only a slightly inferior fit (6 + 5
fitting parameters, nRMSD 2.83%). The better fit of the (6 + 5)
parameter model 3 compared to the (6 + 5) parameter model 2
suggests that DRu-bpy can intercalate 50-AT-30 as well as
50-TA-30 steps, but in view of the good overall fit of both models,
conclusive evidence will require independent experimental
data for the sequence preferentiality of DRu-bpy.
Although binding parameters variate due to the fact that the
stoichiometry of binding sites is diﬀerently defined, models 1–3
show the same overall pattern: D itself binds non-cooperatively
and has a larger (3 to 9-fold) intrinsic binding constant than L;
the latter, on the other hand, has a stronger (3 to 6-fold)
cooperative binding, both with itself and with D. Notably, for
all models 1–3, the hetero-chiral cooperativity parameter value
is close to the homo-chiral value for L.
Also the enthalpy parameters show a similar overall
pattern for models 1–3: the intrinsic binding is endothermic
Table 1 Binding and enthalpy parameter values from global fitting of (6 + 5) parameter models to ITC data
Model D L DDa LL DL nD nL nRMSDb (%) rRMSDc
1 Kd 0.604 0.075 y 1 6.75 5.62 2.28 2.53 4.04 1.65
DH

a
e 3.43 5.05 DH

ab
e 6.83 17.68 15.23 (10.3) (4.18) f
2 K 0.919 0.256 y 1 2.67 2.88 1.18g 1.25 4.48 1.83
DH

a
4.77 3.89 DH

ab
5.87 15.17 14.14 (7.72) (3.14)
3 K 0.700 0.081 y 1 5.23 6.17 1.13 1.30 2.83 1.15
DH

a
3.29 8.33 DH

ab
6.59 19.61 15.37 (10.0) (4.11)
a RMSD decreases less than 0.5% if yDD is allowed to vary: best fit values 1.22 (1), 1.28 (2), 1.09 (3). b nRMSD: RMSD normalized by division with
the mean of the absolute values of the ITC data. c rRMSD (relative RMSD): RMSD divided by the RMSD of the (9 + 7) parameter fit of model 3
(nRMSD 2.45%). d K/106 M1. e DH1/kJ mol1. f Enclosed in parentheses; nRMSD and rRMSD of the non-cooperative (4 + 5) parameter fit. g Models
2 and 3 define the lattice subunit to be 2 base pairs, hence for comparison with model 1 the n values should be multiplied by 2.
Table 2 Standard thermodynamic values (25 1C) from the fit of (6 + 5) parameter model 3
Equilibrium constant DG1/kJ mol1 DH1/kJ mol1 DS1/J K1 mol1
KD 7.00  105 M1 33.36 +3.29 +122.9
KL 8.10  104 M1 28.02 +8.86 +121.9
yDD 1 0 6.53 22.9
yLL 5.23 4.10 19.16 52.0
yDL 6.17 4.51 15.37 36.4
KDyDD 7.00  105 M1 33.36 3.30 +100.8
KLyLL 4.82  105 M1 32.12 11.28 +69.9
KDyDDa 9.19  105 M1 34.04 1.10 +110.5
KLyLLa 6.84  105 M1 33.30 11.28 +73.9
a (6 + 5) parameter model 2.
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(although the relative magnitude for the two enantiomers is
clearly model sensitive), while the interaction enthalpies are
exothermic, with LL about 2.7 and DL about 2.3 times that
of DD for all three models. Comparing the enthalpy values
with the associated standard free energy changes (see Table 2)
clearly shows the endothermic intrinsic binding to be massively
entropy driven, while the exothermic ligand–ligand interaction
is nearly compensated for by a large entropy decrease.
The stronger homo-chiral cooperativity largely compensates
for the smaller intrinsic binding constant for L, which
for models 3 and 2 leads to a very similar ratio KDyDD/KLyLL =
1.4  0.05. The value of the product of the intrinsic binding
constant and the homo-chiral cooperativity parameter Ky is
essentially the eﬀective binding constant in the vicinity of
saturation of the intercalation sites, where the curvature of
the ITC curve changes rapidly. Hence, the value of Ky, and the
value of the corresponding enthalpy change, can both be
expected to be the best determined quantity form the fit to
the data. Indeed, as seen in the last rows of Table 2, where
models 2 and 3 are compared, these values show relatively
small variations between the models Thus, we can draw the
conclusion, independent of whether DRu-bpy discriminates
between the two base pair steps or not, that the binding of
DRu-bpy next to a bound DRu-bpy is almost entirely driven by
entropy, and that the binding of LRu-bpy next to a bound
LRu-bpy is to about one third driven by enthalpy.
A simple allosteric explanation of the lower intrinsic binding
constant and higher cooperativity for the L enantiomer would
be that, due to the seemingly less good steric fit compared to the D
enantiomer,32 L pays a free energy penalty by widening the groove
upon intercalation, which pays back for the second L enantiomer
intercalating from the already widened groove. However, this
simple allosteric model does not explain the hetero-chiral coop-
erativity, since by hypothesis the better fitting, non-cooperative D
enantiomer does not need to widen the groove upon intercalation.
Although allosteric interactions undoubtedly play an important
role, we suggest that ligand–ligand interactions also make a
significant contribution. Fig. 6 shows models of the different
combinations of Ru-bpy enantiomers intercalating (from the
minor groove, as suggested by X-ray structures) two base pairs
apart on DNA. We can distinguish three essentially different types
of arrangements of the close-by bipyridine moieties: DD: face to
face; LL: edge to edge; DL: face to edge. These three types of
arrangements can be expected to be significantly different with
regard to direct, mainly enthalpic interactions such as pi-stacking
and electrostatic repulsion, but also with respect to entropy-
contributing effects of water solvation and the counter-ion
distribution. We believe that it presently would be premature
to attempt to do a more detailed correlation between structural
differences and changes in the thermodynamic quantities.
Conclusions
By developing a new simple algorithm, no longer restricted by the
complexity of the binding system and general enough to be
implemented to any biopolymers, we have been able to demon-
strate a method that can capture the most essential eﬀects of the
nearest-neighbor interactions between ligands. This has allowed
us to critically examine diﬀerent bindingmodels for the analysis of
competitive calorimetric binding isotherms for the enantiomers of
Ru(bpy)2dppz
2+, for which we find a significant hetero-chiral
binding cooperativity. It is our hope that this method will con-
tribute in the future search for better pharmacological therapeutics
and biotechnological applications.
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Fig. 6 Schematic illustration of the proposed nearest-neighbor inter-
action geometries for the D (green) and L (red) enantiomers of Ru-bpy
when intercalated to DNA via the minor groove. The models were con-
structed by manual docking and subsequent energy minimization in a
vacuum, using the AMBER 2 force field in the HyperChem 8.0 software
package (HyperCube, Inc.).
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2Note that in the following programs, the total concentration of binding sites, denoted B0 in the 
main text, is now denoted D0.
GeneralAlgorithm.m
function [conc,x,f,P,r]=GeneralAlgorithm(C0,M,T,Y,K,n,r)
%General algortihm for solving the mass balance for
%ligands interacting with a linear polymer of identical binding site units
%D with explicit nearest neighbor interaction.
 
%INPUT:
%CO=[D0 A0 B0...] 1x(1+L) vector with total concentration of 
%binding site units D and L ligands A, B...
%M = mxL matrix of the stoichiometric coefficients for the m ligand-
containg elementary
%units.
%T = mxm non-singular matrix transforming M such that in the product T*M no 
column is
%zero, and each row only contains one 1, the rest being zeros.
%Y =(m+1)x(m+1)matrix containg the cooperativity parameters for nearest 
%neighbor interactions between the elementary units, the first row and
%column being the interactions with the ligand-free elementary unit.
%K = Intrinsic binding constants of the elementary units.
%n = Number of binding site units made inaccesible by formation of the 
elementary unit.
%r = Guess for vector r
 
%OUTPUT
%conc = [[Afree; Bfree ...][ Abound; Bbound ...]]
%x = binding potentials of elementary units
%f = binding densities of elementary units
%P = matrix of conditional probabilities
%r = vector r that solves the mass balance equations
 
[m,l]=size(M);
lnK=log(K);
TMM=T*M*M';
L0=T*M*C0(2:end,1); %free ligand concentrations
D0=C0(1);
q=1;
    while norm(q)>1e-9;
       s=1./(Y*[1;r]);
       P=diag(s)*Y*diag([1;r]);
       v=eye(m)-P(2:end,2:end)+n'*P(1,2:end);
       f=inv(v')*P(1,2:end)';
       x=s(2:end).*r./(s(1).^n');
       etl=exp(T*(log(x)-lnK));
       q=etl+D0*TMM*f-L0;
       u=inv(v')*(diag(f)-P(:,2:end)'*diag([1-n*f;f])*P(:,2:end));
       dqdr=(D0*TMM*u+diag(etl)*T*v);
        dr=diag(r)*(dqdr\q);
       while min(r-dr)<=0    %ensures that r remains positive
           dr=dr/3;
       end
       r=r-dr;
    end
       conc=[etl D0*TMM*f];
       
3ITCalgorithmModel3.m
function [err,sim,heat,conc]=ITCalgorithmModel3(par,totdata,inj)
%Calculates ITC curve for binding of two ligands La and Lb 
%with a lattice binding model in which  
%A forms symmetrical subunits A1 and A2 (here with identical properties), 
when binding
%to an infinite chain of alternating binding sites 1 and 2, and B only 
%binds to site 1.
%This code is (7+5) parameter Model 3; can easily be converted to Model 1 
%or Model 2, see comments on line 32-33 and 40.
%INPUT:
%par=[1) Ka 2) Kb 3) yAA  4) yBB 5) yAB 6) na 7) nb] 
%For (9+7) parameter Model 3, Ka2 and yA2A2 are included in par
%and inserted into the appropriate matrices below.
%totdata=[ITC-data D0 La0 Lb0] (4*20) X 4 matrix with data and total
%concentrations of basepairs and ligands, preferably with total 
concentrations of Ln in increasing order
%inj=[inj1 inj2 inj3 inj4] injN = mol injectant/Vcell for titration N
%OUTPUT:
%err is the least square error
%sim = [ITC-data   simulated data]
%heat=[bl1 bl2 bl3 bl4 bl5 dHa dHb dHaa dHbb dHab]; bln is baseline value 
%for titration n, dHa etc. enthalpy changes per mol
data=totdata([2:20 22:40 42:60 62:80],1);
o=ones([19,1]);
e4=eye([4,4]);
bl=[o*e4(1,:);o*e4(2,:);o*e4(3,:);o*e4(4,:)];
dc=[];    
K=par([1 1 2])';
%K(2)=1e-9;  %Effectively removes A binding to site 2, converting Model 3 
to Model 2 (when ff=0.5) or
%to Model 1 (when ff=1).
Y=[1 1 1 1  ;1 par(3) 0 par(5);1 1 par(3) 1 ;1 par(5) 0 par(4)];
n=par([6 6 7]);
C0=totdata(:,2:4);
conc=[];
M=[1 0;1 0;0 1];
T=eye(3);
ff=.5;  %Fraction of binding site unit per basepair, set to 1 for Model 1
if min(par(1:7))<=0 %Ensures the variables stay positive
    err=1e6;
else
dc=[];    
C0=totdata(:,2:4);
conc=[];
    r=[.1 .1]'; % For titrations 1 and 2, the appropriate submatrices are 
defined; here La only
    Kt=K(1:2);
    Mt=M(1:2,1);
    Tt=T(1:2,1:2);
    nt=n(1:2);
    Yt=Y(1:3,1:3);
 for t=C0(1:20,:)';
    t(1)=t(1)*ff; 
4    t=t(1:2);
    [C,x,f,P,r]=GeneralAlgorithm(t,Mt,Tt,Yt,Kt,nt,r);
    PP=t(1)*diag(f)*P(2:3,2:3);
    conc=[conc;(t(1)*[1 1]*f)' 0 PP(1,1)+PP(2,2) 0 0];
    %Note that the assumed identical La contributions are summed together
 end
    r=[.1 ]';   %Lb only
    Kt=K(3);
    Mt=M(3,2);
    Tt=T(3,3);
    nt=n(3);
    Yt=Y([1 4],[1 4]);
for t=C0(21:40,:)';
    t(1)=t(1)*ff; 
    t=t([1 3]);
    [C,x,f,P,r]=GeneralAlgorithm(t,Mt,Tt,Yt,Kt,nt,r);
    PP=t(1)*diag(f)*P(2,2);
    conc=[conc;0  (t(1)*f)' 0  PP(1,1) 0 ];
end
r=[.1 .1 .1 ]';
for t=C0(41:60,:)'; %La into Lb + DNA
    t(1)=t(1)*ff; 
    [C,x,f,P,r]=GeneralAlgorithm(t,M,T,Y,K,n,r);
    PP=t(1)*diag(f)*P(2:4,2:4);
    conc=[conc;(t(1)*[1 1 0;0 0 1]*f)' PP(1,1)+PP(2,2) PP(3,3) PP(1,3)*2 ];
end
r=[.1 .1 .1 ]';   %Lb into La + DNA
for t=C0(61:80,:)';
    t(1)=t(1)*ff; 
    [C,x,f,P,r]=GeneralAlgorithm(t,M,T,Y,K,n,r);
    PP=t(1)*diag(f)*P(2:4,2:4);
    conc=[conc;(t(1)*[1 1 0;0 0 1]*f)' PP(1,1)+PP(2,2) PP(3,3) PP(1,3)*2 ];
end
%Calculated concentration changes per mol injectant
%corrected for dilution:
    dc=[dc;[conc(2:20,:)-conc(1:19,:)*204/206]/inj(1)];
    dc=[dc;[conc(22:40,:)-conc(21:39,:)*204/206]/inj(2)]; 
    dc=[dc;[conc(42:60,:)-conc(41:59,:)*204/206]/inj(3)];
    dc=[dc;[conc(62:80,:)-conc(61:79,:)*204/206]/inj(4)];
    dc=[bl dc];
    heat=pinv(dc)*data;
    sim=dc*heat;
    err=norm(data-sim,'fro');
    sim=[data sim];
end
5ITCalgorithmIndependent.m
function [err,sim,heat]=ITCalgorithmIndependent(par,totdata,inj)
%Calculates ITC curve for competitive binding of two ligands La
%and Lb to two types of independent, non-overlapping binding sites X and Y.
%The fractions fX and fY can take independent values for each of the four
%titrations, or at wish be restricted to fewer independent values.
%
%INPUT:
%par=[1) Kax 2) Kay  3) Kbx 4) Kby 5) fraction; 
%fraction can be one variable, as in the present case, or up to 8 variables 
in the unrestricted case. 
%totdata=[ITC-data D0 La0 Lb0] (4*20) X 4 matrix with data and total
%concentrations of basepairs and ligands, preferably with total
%concentrations of Ln in increasing order.
%The data are assumed to be ordered as only La, only Lb, La into Lb, Lb
%into La
%inj=[inj1 inj2 inj3 inj4] injN = mol injectant/Vcell for titration N
 
%OUTPUT:
%err is the least square error
%sim = [ITC-data   simulated data]
%heat=[bl1 bl2 bl3 bl4 dHax dHay dHbx dHby]; bli is baseline value for
%titration i, dHax etc. enthalpy changes per mol, same units as in ITC-data 
 
data=totdata([2:20 22:40 42:60 62:80],1);   %The column of ITC-data
o=ones([19,1]);
C0=totdata(:,2:4);  %The 3 columns of total concentrations
e4=eye([4,4]);
bl=[o*e4(1,:);o*e4(2,:);o*e4(3,:);o*e4(4,:)];
 
fraction=par(5)*[[1 1 1 1];[1 1 1 1]];
%fraction=[par([5 7 9 11]);par([6 8 10 12])]; %Unrestricted case, first row
%X-fractions, second row Y-fractions
conc=[];
Kx=par([1 2]);
Ky=par([3 4]);
dc=[];
if min(par(1:5))<=0  %All variable values should be positive, here 5 
variables are varied.
    err=1e6;
else
 f=fraction(:,1);
 L=[.1]; %Guess for free ligand concentration
 for t=C0(1:20,:)'; % La only titration
    D0=t(1);  %basepair concentration.
    L0=t(2)'; %Ligand total concentration
    q=1;
    kx=Kx(1);
    ky=Ky(1);
    while norm(q)>1e-9;
       q=(kx*L/(1+kx*L)*f(1)+ky*L/(1+ky*L)*f(2))*D0+L-L0;
       dqdL=(kx/(1+kx*L)*f(1)+ky/(1+ky*L)*f(2)-
(f(1)*L*kx^2/((1+kx*L)^2))+f(2)*L*ky^2/((1+ky*L)^2))*D0+1;
       dL=q*inv(dqdL);
       L=L-dL;
    end
    conc=[conc;[f(1)*kx*L/(1+kx*L) 0 f(2)*ky*L/(1+ky*L) 0]*D0];
    
6 end
    f=fraction(:,2);
 L=[.1]; 
 for t=C0(21:40,:)';    %Only Lb titration
    D0=t(1); 
    L0=t(3)'; 
    q=1;
    kx=Kx(2);
    ky=Ky(2);
    while norm(q)>1e-9;
q=(kx*L/(1+kx*L)*f(1)+ky*L/(1+ky*L)*f(2))*D0+L-L0;
dqdL=(kx/(1+kx*L)*f(1)+ky/(1+ky*L)*f(2)-
(f(1)*L*kx^2/((1+kx*L)^2))+f(2)*L*ky^2/((1+ky*L)^2))*D0+1;
dL=q*inv(dqdL);
L=L-dL;
    end
    conc=[conc;[0 f(1)*kx*L/(1+kx*L) 0 f(2)*ky*L/(1+ky*L)]*D0];
 end
 f=fraction(:,3);
 L=[.1 .1];
 for t=C0(41:60,:)';%lLa into Lb
    D0=t(1); 
    L0=t(2:3)'; 
    q=1;
    while norm(q)>1e-9;
q=(Kx.*L/(1+Kx*L')*f(1)+Ky.*L/(1+Ky*L')*f(2))*D0+L-L0;
dqdL=(diag(Kx)/(1+Kx*L')*f(1)+diag(Ky)/(1+Ky*L')*f(2)-
(f(1)*(diag(L)*Kx'*Kx/((1+Kx*L')^2))+f(2)*(diag(L)*Ky'*Ky/((1+Ky*L')^2))))*
D0+eye(2);
dL=q*inv(dqdL');
L=L-dL;
    end
    conc=[conc;[f(1)*Kx.*L/(1+Kx*L') f(2)*Ky.*L/(1+Ky*L')]*D0];
 end
 f=fraction(:,4);
 L=[.1 .1];
for t=C0(61:80,:)'; %Lb into La
    D0=t(1); 
    L0=t(2:3)'; 
    q=1;
    while norm(q)>1e-9;
q=(Kx.*L/(1+Kx*L')*f(1)+Ky.*L/(1+Ky*L')*f(2))*D0+L-L0;
dqdL=(diag(Kx)/(1+Kx*L')*f(1)+diag(Ky)/(1+Ky*L')*f(2)-
(f(1)*(diag(L)*Kx'*Kx/((1+Kx*L')^2))+f(2)*(diag(L)*Ky'*Ky/((1+Ky*L')^2))))*
D0+eye(2);
dL=q*inv(dqdL');
L=L-dL;
    end
    conc=[conc;[f(1)*Kx.*L/(1+Kx*L') f(2)*Ky.*L/(1+Ky*L')]*D0];
end
   dc=[dc;[conc(2:20,:)-conc(1:19,:)*204/206]/inj(1)]; %Calculated 
concentration changes per mol injectant
    dc=[dc;[conc(22:40,:)-conc(21:39,:)*204/206]/inj(2)]; %corrected for 
dilution
    dc=[dc;[conc(42:60,:)-conc(41:59,:)*204/206]/inj(3)];
7    dc=[dc;[conc(62:80,:)-conc(61:79,:)*204/206]/inj(4)];
    dc=[bl dc];
    
    heat=pinv(dc)*data;
    sim=dc*heat;
    
   err=norm(data-sim,'fro');
  
    sim=[data sim];
end
8ITCalgorithmModel4:
function [err,sim,heat]=ITCalgorithmModel4(par,totdata,inj)
%Uses the lattice model to calculates the ITC curve for binding of two 
ligands La
%and Lb to two independent binding sites X and Y, which fractions are equal 
 
%INPUT:
%par=[1) Ka1 2) Kb1 3) Ka2 4) Kb2 5) fraction ] 
 
%totdata=[ITC-data D0 La0 Lb0] (4*20) X 4 matrix with data and total
%concentrations of basepairs and ligands, preferably with total 
concentrations of Ln in increasing order
 
%inj=[inj1 inj2 inj3 inj4] injN = mol injectant/Vcell for titration N
 
%OUTPUT:
%err is the least square error
 
%sim = [ITC-data   simulated data]
 
%heat=[bl1 bl2 bl3 bl4 dHaX dHbX dHaY dHbY]; bln is baseline value for
%titration n, dHaX etc. enthalpy changes per mol, same units as in ITC-data 
 
data=totdata([2:20 22:40 42:60 62:80],1);
o=ones([19,1]);
e4=eye([4,4]);
bl=[o*e4(1,:);o*e4(2,:);o*e4(3,:);o*e4(4,:)];
dc=[];    
C0=totdata(:,2:4);
conc=[];
 
ff=par(5); %Fraction of binding site per base-pair.
 
 
Y=ones([9,9]); %No cooperativity in this case
K=[par(1:4) par(1)*par(3) par(2)*par(4) par(1)*par(4) par(2)*par(3)]'; %To 
comply with the 2 independent site model
 
n=ones([1,8]);  %Binding site coverage is unity
mm=[eye(4);[1 0 1 0;0 1 0 1;1 0 0 1;0 1 1 0] ];     %Matrix of elementary 
unit composition in terms of LaX, LbX, LaY and LbY                                                   
M=mm*[1 0 1 0;0 1 0 1]';                             
T=eye(8);  
T(5,5)=.5;
T(6,6)=.5;
T(7,2)=-1;
T(8,1)=-1;
 
if min(par(1:5))<=0  %Ensures that the variables stays positive
    err=1e6;
else
 
    r=[.1 .1 .1]';  %For each of the 4 titrations, appropriate submatrices 
are constructed. Here La only titration.
    Kt=K([1 3 5]);
    Mt=M([1 3 5],1);
    Tt=T([1 3 5],[1 3 5]);
9    nt=n([1 3 5]);
    Yt=Y([1 2 4 6],[1 2 4 6]);
    mmt=mm([1 3 5],:);
 for t=C0(1:20,:)';
    t(1)=t(1)*ff; 
    t=t(1:2);
    [C,x,f,P,r]=GeneralAlgorithm(t,Mt,Tt,Yt,Kt,nt,r);
    conc=[conc;t(1)*f'*mmt ];
 end
 
    r=[.1 .1 .1]';  %Lb only titration
    Kt=K([2 4 6]);
    Mt=M([2 4 6],2);
    Tt=T([2 4 6],[2 4 6]);
    nt=n([2 4 6]);
    Yt=Y([1 3 5 7],[1 3 5 7]);
    mmt=mm([2 4 6],:);
 for t=C0(21:40,:)';
    t(1)=t(1)*ff; 
    t=t([1 3]);
    [C,x,f,P,r]=GeneralAlgorithm(t,Mt,Tt,Yt,Kt,nt,r);
    conc=[conc;t(1)*f'*mmt ];
 end
 
r=[.1 .1 .1 .1 .1 .1 .1 .1]';   %La into Lb, the full matrices are used.
for t=C0(41:60,:)';
    t(1)=t(1)*ff; 
    [C,x,f,P,r]=GeneralAlgorithm(t,M,T,Y,K,n,r);
     conc=[conc;t(1)*f'*mm ];
end
 
r=[.1 .1 .1 .1 .1 .1 .1 .1]';   %Lb into La
for t=C0(61:80,:)';
    t(1)=t(1)*ff; 
    [C,x,f,P,r]=GeneralAlgorithm(t,M,T,Y,K,n,r);
     conc=[conc;t(1)*f'*mm ];
end
    %Calculated concentration changes per mol injectant
    %corrected for dilution
    dc=[dc;[conc(2:20,:)-conc(1:19,:)*204/206]/inj(1)]; 
    dc=[dc;[conc(22:40,:)-conc(21:39,:)*204/206]/inj(2)]; 
    dc=[dc;[conc(42:60,:)-conc(41:59,:)*204/206]/inj(3)];
    dc=[dc;[conc(62:80,:)-conc(61:79,:)*204/206]/inj(4)];
    dc=[bl dc];
    
    heat=pinv(dc)*data;
    sim=dc*heat;
    
    err=norm(data-sim,'fro');
    
    sim=[data sim];
end
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Analysis of the ITC data:
The total concentrations in TotData are calculated from the concentration of injectant stock solution, 
volume added (2 μL) and the initial content of the cell and its volume (206 μL). For each injection, the 
injectant is assumed to displace 2 μL of the content in the cell before mixing. Inj is the concentration 
resulting from one 2 μL addition of injectant into a cell filled with buffer, and used to normalize the 
species concentrations calculated to the ITC-data in the first column. All concentrations are given in 
μM. See further comments in the program ‘ITCalgorithm’ above.
Indata:
TotData =
    3.5673  148.8010    6.9029    0.0000
    2.8297  147.3563   11.4378    0.0000
    2.2158  145.9257   15.9287    0.0000
    1.5232  144.5089   20.3760    0.0000
    0.8603  143.1059   24.7801    0.0000
    0.2285  141.7165   29.1415    0.0000
-0.6821  140.3406   33.4605    0.0000
-1.6861  138.9781   37.7376    0.0000
-2.6287  137.6288   41.9732    0.0000
-3.0987  136.2926   46.1676    0.0000
-3.3115  134.9694   50.3213    0.0000
-3.1798  133.6590   54.4347    0.0000
-2.5041  132.3613   58.5081    0.0000
-2.0208  131.0763   62.5420    0.0000
-1.5544  129.8037   66.5368    0.0000
-1.0936  128.5435   70.4927    0.0000
-0.7567  127.2955   74.4103    0.0000
-0.5287  126.0596   78.2898    0.0000
-0.4940  124.8357   82.1316    0.0000
-0.4883  123.6237   85.9362    0.0000
0.3559  148.8010    0.0000    6.8738
-2.1600  147.3563    0.0000   11.3896
-4.5524  145.9257    0.0000   15.8615
-6.7236  144.5089    0.0000   20.2900
-8.1363  143.1059    0.0000   24.6756
-9.3413  141.7165    0.0000   29.0185
-10.7015  140.3406    0.0000   33.3193
-11.6217  138.9781    0.0000   37.5784
-12.7751  137.6288    0.0000   41.7961
-13.4433  136.2926    0.0000   45.9728
-13.2426  134.9694    0.0000   50.1090
-11.4619  133.6590    0.0000   54.2050
-8.2448  132.3613    0.0000   58.2613
-5.8635  131.0763    0.0000   62.2781
-3.6970  129.8037    0.0000   66.2560
-2.4371  128.5435    0.0000   70.1953
11
   -1.7974  127.2955    0.0000   74.0963
   -1.2967  126.0596    0.0000   77.9595
   -1.1205  124.8357    0.0000   81.7851
   -1.1004  123.6237    0.0000   85.5736
    0.9546  121.8234    6.9029   84.3274
    1.5000  120.6406   11.4378   83.5087
    1.5933  119.4693   15.9287   82.6979
    1.6437  118.3094   20.3760   81.8950
    1.6524  117.1608   24.7801   81.0999
    1.6227  116.0233   29.1415   80.3125
    1.5730  114.8969   33.4605   79.5328
    1.5407  113.7814   37.7376   78.7606
    1.4867  112.6767   41.9732   77.9960
    1.4239  111.5828   46.1676   77.2387
    1.3592  110.4994   50.3213   76.4888
    1.2688  109.4266   54.4347   75.7462
    1.1883  108.3642   58.5081   75.0108
    1.0863  107.3121   62.5420   74.2826
    1.0232  106.2703   66.5368   73.5614
    0.9363  105.2385   70.4927   72.8472
    0.8703  104.2168   74.4103   72.1399
    0.7674  103.2050   78.2898   71.4395
    0.6834  102.2030   82.1316   70.7459
    0.6225  101.2107   85.9362   70.0591
   -9.5212  121.8234   84.6847    6.8738
   -9.2077  120.6406   83.8625   11.3896
   -8.0398  119.4693   83.0483   15.8615
   -7.0590  118.3094   82.2420   20.2900
   -6.0224  117.1608   81.4435   24.6756
   -4.9818  116.0233   80.6528   29.0185
   -4.2492  114.8969   79.8698   33.3193
   -3.7254  113.7814   79.0944   37.5784
   -3.2104  112.6767   78.3265   41.7961
   -2.8004  111.5828   77.5660   45.9728
   -2.4630  110.4994   76.8129   50.1090
   -2.1631  109.4266   76.0672   54.2050
   -1.9390  108.3642   75.3287   58.2613
   -1.7970  107.3121   74.5973   62.2781
   -1.7187  106.2703   73.8731   66.2560
   -1.6006  105.2385   73.1559   70.1953
   -1.5198  104.2168   72.4456   74.0963
   -1.4685  103.2050   71.7422   77.9595
   -1.4097  102.2030   71.0457   81.7851
   -1.3651  101.2107   70.3560   85.5736
Inj =
    4.6019    4.5825    4.6019    4.5825
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MATLAB Command Window:
>> options=optimset('Display','Iter','MaxIter',4000,'MaxFunEvals',8000,'TolX',1e-6,'TolFun',1e-6);
(7+5) parameter Model 3
>> [Err,Sim,Heat]=ITCalgorithmModel3(Par,TotData,Inj)
>> Par=fminsearch('ITCalgorithmModel3',[ 1  0.1  1  5  5  1.1  1.3],options,TotData,Inj)
After 35 seconds (722 iterations / 1127 evaluations of ’ITCalgortithmModel3’), 
convergence criteria are satisfied and
Par =
     0.6478    0.0871    1.0918    5.0097    5.9443    1.1374    1.2942
>> [Err,Sim,Heat]=ITCalgorithm(Par,TotData,Inj)
Err =
     0.8155
Sim =
     2.8297    2.8322
    2.2158    2.2557
    1.5232    1.6102
    0.8603    0.8886
    0.2285    0.0881
   -0.6821   -0.7817
   -1.6861   -1.6821
   -2.6287   -2.5191
   -3.0987   -3.1242
   -3.3115   -3.3150
   -3.1798   -3.0614
   -2.5041   -2.5475
   -2.0208   -1.9960
   -1.5544   -1.5225
   -1.0936   -1.1504
   -0.7567   -0.8660
   -0.5287   -0.6487
   -0.4940   -0.4809
   -0.4883   -0.3495
   -2.1600   -2.2965
   -4.5524   -4.6329
   -6.7236   -6.4670
   -8.1363   -8.0184
   -9.3413   -9.3977
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  -10.7015  -10.6599
  -11.6217  -11.8149
  -12.7751  -12.8037
  -13.4433  -13.4215
  -13.2426  -13.1845
  -11.4619  -11.4535
   -8.2448   -8.4612
   -5.8635   -5.6108
   -3.6970   -3.6860
   -2.4371   -2.5319
   -1.7974   -1.8380
   -1.2967   -1.4028
   -1.1205   -1.1164
   -1.1004   -0.9195
    1.5000    1.3515
    1.5933    1.5931
    1.6437    1.7416
    1.6524    1.7752
    1.6227    1.7211
    1.5730    1.6243
    1.5407    1.5166
    1.4867    1.4130
    1.4239    1.3188
    1.3592    1.2348
    1.2688    1.1603
    1.1883    1.0942
    1.0863    1.0353
    1.0232    0.9825
    0.9363    0.9350
    0.8703    0.8919
    0.7674    0.8526
    0.6834    0.8167
    0.6225    0.7836
   -9.2077   -9.1190
   -8.0398   -8.1612
   -7.0590   -7.0409
   -6.0224   -5.9605
   -4.9818   -5.0206
   -4.2492   -4.2490
   -3.7254   -3.6341
   -3.2104   -3.1495
   -2.8004   -2.7678
   -2.4630   -2.4652
   -2.1631   -2.2231
   -1.9390   -2.0273
   -1.7970   -1.8673
   -1.7187   -1.7351
   -1.6006   -1.6247
   -1.5198   -1.5317
   -1.4685   -1.4526
   -1.4097   -1.3848
   -1.3651   -1.3262
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Heat =
     0.4159
   -0.2019
    0.0503
   -0.7214
    3.4328
    8.0063
   -6.5616
  -19.2850
  -15.3134
(5+4) Parameter Model 4
>> ParInd=fminsearch('ITCalgorithmIndependent',[2 2 1 1 .2],options,TotData,inj) 
After 13 seconds (428 iterations / 712 evaluations of ’ITCalgortithmIndependent’), 
convergence criteria are satisfied, the error is 2.1216 and
ParInd =
     0.9017    1.4730    0.7276    1.3105    0.2079
(5+4) Parameter Model 4*
>> ParModel4=fminsearch('ITCalgorithmModel4',[2 2 1 1 .2],options,TotData,inj) 
After 30 seconds (420 iterations / 703 evaluations of ’ITCalgortithmModel4’), 
convergence criteria are satisfied, the error is 2.1216 and
ParModel4 =
     0.9017    1.4730    0.7276    1.3105    0.2079
[Err4,Sim4,Heat4]=ITCalgorithmModel4(ParModel4,TotData,Inj)
Err4 =
    2.1216
Sim4 =
    2.8297    3.2909
    2.2158    2.4080
    1.5232    1.5269
    0.8603    0.6543
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    0.2285   -0.1992
   -0.6821   -1.0166
   -1.6861   -1.7699
   -2.6287   -2.4126
   -3.0987   -2.8717
   -3.3115   -3.0540
   -3.1798   -2.8981
   -2.5041   -2.4675
   -2.0208   -1.9469
   -1.5544   -1.4952
   -1.0936   -1.1621
   -0.7567   -0.9317
   -0.5287   -0.7739
   -0.4940   -0.6644
   -0.4883   -0.5867
   -2.1600   -2.9630
   -4.5524   -4.5572
   -6.7236   -6.1438
   -8.1363   -7.7100
   -9.3413   -9.2349
  -10.7015  -10.6822
  -11.6217  -11.9861
  -12.7751  -13.0214
  -13.4433  -13.5500
  -13.2426  -13.1635
  -11.4619  -11.4283
   -8.2448   -8.5654
   -5.8635   -5.7166
   -3.6970   -3.6968
   -2.4371   -2.4671
   -1.7974   -1.7358
   -1.2967   -1.2875
   -1.1205   -1.0000
   -1.1004   -0.8075
    1.5000    1.3615
    1.5933    1.4045
    1.6437    1.4241
    1.6524    1.4272
    1.6227    1.4185
    1.5730    1.4014
    1.5407    1.3782
    1.4867    1.3508
    1.4239    1.3205
    1.3592    1.2881
    1.2688    1.2546
    1.1883    1.2204
    1.0863    1.1859
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    1.0232    1.1514
    0.9363    1.1172
    0.8703    1.0835
    0.7674    1.0503
    0.6834    1.0178
    0.6225    0.9861
   -9.2077   -8.8329
   -8.0398   -7.7102
   -7.0590   -6.7332
   -6.0224   -5.8861
   -4.9818   -5.1535
   -4.2492   -4.5206
   -3.7254   -3.9739
   -3.2104   -3.5016
   -2.8004   -3.0929
   -2.4630   -2.7389
   -2.1631   -2.4315
   -1.9390   -2.1641
   -1.7970   -1.9309
   -1.7187   -1.7269
   -1.6006   -1.5482
   -1.5198   -1.3910
   -1.4685   -1.2525
   -1.4097   -1.1301
   -1.3651   -1.0217
Heat4 =
   -0.3016
   -0.1824
   -0.0516
    0.0726
   56.3874
  179.2164
  -57.6632
 -200.5562
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Figure S1: Fit of (7+5) parameter Model 3 (red) and (5+4) parameter model 4* (blue) to the 
ITC data. Note that in addition to an inferior fit, the enthalpy values obtained from Model 4 
are of an unrealistically high magnitude.
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Eﬀects of methyl substitution on DNA
binding enthalpies of enantiopure
Ru(phenanthroline)2dipyridophenazine
2+
complexes†
Anna K. F. Mårtensson and Per Lincoln*
Isothermal titration calorimetry (ITC) has been utilized to investigate the eﬀect of methyl substituents on
the intercalating dppz ligand of the enantiomers of the parent complex Ru(phen)2dppz
2+ (phen = 1,10-
phenanthroline; dppz = dipyrido[3,2-a:20,30-c]phenazine) on DNA binding thermodynamics. The methylated
complexes (10-methyl-dppz and 11,12-dimethyl-dppz) have large, concentration-dependent, positive heats
of dilution, and a strong endothermic background is also apparent in the ITC-profiles from titration of
methylated complexes into poly(dAdT)2, which make direct comparison between complexes diﬃcult.
By augmenting a simple cooperative binding model with one equilibrium for complex self-aggregation
in solution and one equilibrium for complex aggregation on saturated DNA, it was possible to find an
excellent global fit to the experimental data with DNA aﬃnity parameters restricted to be equal for all
D-enantiomers as well as for all L-enantiomers. In general, enthalpic diﬀerences, compared to the
unsubstituted complex, were small and less than 4 kJ mol1, except for the heat of intercalation of
D-10-methyl-dppz (11,6 kJ mol1) and L-11,12-dimethyl-dppz (+4.3 kJ mol1).
Introduction
Since the mid-1980s, there have been extensive studies on
ruthenium(II) polypyridyl complexes.1–5 Along with their inter-
esting photophysical properties, ruthenium complexes have
been shown to have various useful interacting properties, such
as acting as DNA probes6 or inducing DNA cleavage.7 Extending
one of the planar ligands of the complex will facilitate inter-
calation between the base pairs, the most studied examples
being ruthenium complexes possessing a dppz moiety (dppz =
dipyrido[3,2-a:20,30-c]phenazine). Originally denoted ‘‘light-switch
complexes’’, tris-bidentate complexes of the general structure
Ru(L)2dppz
2+ (L = phen(1,10-phenanthroline) or bpy (2,20-
bipyridine)) will display a massive increase in the quantum
yield when intercalated to DNA,6,8–10 owing to the hydrophobic
environment between the base pairs protecting the dppz moiety
from hydrogen bonding with the solvent water molecules.11,12
By introducing small changes into the molecular structure
of the complex, it is possible to modify the photophysical
properties and also the DNA binding aﬃnity and specificity.
Consequently, there have been numerous reports on ruthenium
complexes with substituents on both the ancillary and the
intercalating ligands.13–18 By adding methyl groups on the
outermost benzene ring of the dppz ligand in Ru(phen)2dppz
2+
the steric consequences might alter the binding motifs of the
complex. Previous studies observed a significant lengthening of
the excited state lifetimes of dppz-based ruthenium complexes
with methyl substitutions in the 10-position and in the 11,12-
positions of the dppz moiety, which was attributed to a steric
interference of the hydration cage around the complex.6,19 The
structurally similar complex Ru(TAP)2dppz
2+ (TAP = 1,4,5,8-
tetraazaphenanthrene) has been reported to bind more strongly
to DNA when methyl-substituted in the 11,12-position of the
dppz moiety.20 Methyl substituents in the 11,12-positions of the
dppz moiety of Cr(phen)2dppz
3+ also increased the binding
affinity of the parent complex.21 In contrast, methyl substituted
dpq (dpq = dipyrido[3,2-f:20,30-h]-quinoxaline), a close analogue
of dppz, has shown a decrease in DNA binding strength com-
pared to its parent complex Ru(phen)2dpq
2+, which was attributed
to steric hindrance of the bulky methyl groups.22 Clearly, methyl
substituents may alter the binding properties of intercalative
complexes, but there are still many questions on the underlying
binding mechanism that have been left unanswered. Also, many
of the previous studies have limited themselves to unresolved
ruthenium complexes. This is unfortunate as it has been demon-
strated on numerous occasions by various experimental methods
that DNA binding is highly influenced by the chirality of
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tris-bidentate ruthenium complexes with the right-handed
D-form generally having a stronger affinity to DNA than the
L-form.1,18,23–27
Isothermal titration calorimetry (ITC) is a high-precision tool
used for the thermodynamic characterization of ligand binding
to a macromolecule (e.g. DNA) and is the only thermodynamic
method that directly measures all energetics associated with
the ligand–macromolecule interaction process.28–30 Aliquots of
the ligand are added to a solution of the macromolecule and the
resulting heat effects observed can then be analysed for quanti-
tative characterization of the energetic processes associated with
the binding reaction. As the titration progresses, the binding
sites on the macromolecule become increasingly occupied and at
the end of the titration, only a small heat change caused by
ligand dilution and other non-specific effects will be registered.
In most cases this is corrected for by simply subtracting the
average heat of dilution from a blank titration of ligand into
buffer. However, if the blank titration shows a large non-
constant heat of dilution it cannot simply be dismissed by
subtraction. As an effect of the highly concentrated titrant
solution, the ligands may self-aggregate to form oligomers, which
partly dissociate when added to the macromolecule solution.31,32
Being another equilibrium process involving the free ligand in
solution, the self-aggregation needs to be included in the analysis
of the ligand–DNA interaction.
Intercalating dppz-based ruthenium complexes have pre-
viously been demonstrated to either facilitate or hinder the
adjacent binding of neighboring complexes along the DNA
polymer.27,33 In addition, the binding sites on a DNA polymer
are in such close proximity of each other that each intercalated
ruthenium complex covers more than one binding site. Based
on the classical McGhee and von Hippel model, where DNA is
treated as a one-dimensional lattice of binding sites,34 we have
recently developed a general algorithm that can be utilized for
the model fitting of binding interactions between ligands and
linear biopolymers.35
In this study, we seek to thermodynamically characterize the
DNA binding of Ru(phen)2dppz
2+ with methyl groups substi-
tuted in the 10-position or the 11,12-positions of the dppz
moiety (Fig. 1). In order to avoid the eﬀects of DNA sequence
heterogeneity, we chose to use poly(dAdT)2 (AT-DNA) for the
ligand–DNA interaction. Since the methylated complexes show
a pronounced non-constant heat of dilution, this has been
included in the analysis.
Experimental
Materials and sample preparation
All experiments were performed in aqueous solution (pH = 7.0)
containing 150 mM NaCl and 1 mM cacodylate (dimethylarsi-
nic acid sodium salt). A stock solution of poly(dAdT)2 (AT-DNA)
(B5 mM nucleotides) was prepared by dissolving the sodium
salt (Sigma-Aldrich) in buﬀer. Stock solutions of the complexes
(B1 mM) were prepared by dissolving the chloride salts in
buﬀer. Concentrations were determined spectrophotometrically
using extinction coeﬃcients: e260 = 6600 M
1 cm1 per nucleo-
tide for AT-DNA and e440 = 20000 M
1 cm1 for the ruthenium
complexes. For ITC measurements the DNA solution was dialyzed
against pure buﬀer for at least 48 hours at 8 1C. Ruthenium
complex solutions of appropriate concentrations were prepared by
dilution of the stock solutions in the dialysate. The dialysis
membrane used had a molecular weight cut-oﬀ of 3.5–5 kDa
(Spectra-Pors Float-A-Lyzers G2, Sigma-Aldrich).
The enantiopure D- and L-[Ru(phen)2dppz]Cl2, [Ru(phen)2-
dppzCH3]Cl2 and [Ru(phen)2dppz(CH3)2]Cl2 (here denoted 1,
2 and 3, respectively) used in this study were synthesized and
resolved as previously reported.23,36
Other chemicals were purchased from Sigma-Aldrich and
used without purification.
Absorption spectra were measured on a Varian Cary 4000 UV/vis
(Agilent Technologies) spectrophotometer (path length = 1 cm).
Isothermal titration calorimetry
During an isothermal titration calorimetry (ITC) experiment,
the heat produced or absorbed upon addition of the complex to
a DNA solution enables direct assessment of the binding free
energy by integrating the power required to maintain the refer-
ence and sample cells at the same temperature. The experimental
raw data consist of a series of heat flow peaks and each peak
corresponds to one injection of the ruthenium complex. These
heat flow peaks are then integrated with respect to time, to give
the total heat exchanged per mole injectant plotted against the
ratio [Ru complex]/[base pairs].
Calorimetric data were obtained using a MicroCal iTC200
isothermal titration calorimeter (Malvern) controlled by Origin
7.0 software. The ITC profiles of the resolved ruthenium com-
plexes were obtained by a single injection of 1 ml followed by
19 sequential injections of 2 ml aliquots of stock solution
(B590 mM) of the complex from a syringe into the sample cell
Fig. 1 Structures of ruthenium complexes Ru(phen)2dppz
2+ (1), Ru(phen)2dppzCH3
2+ (2) and Ru(phen)2dppz(CH3)2
2+ (3).
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(206 ml) loaded with AT-DNA in 150 mM NaCl aqueous buﬀer
solution (B312 mM nucleotides) or with buﬀer alone. All ITC
experiments were performed at 25 1C. The injection spacing
was 180 s, the syringe rotation was 750 rpm and there was an
initial delay of 120 s prior to the first injection. The raw ITC data
peaks were automatically integrated using the Origin 7.0 software.
For improved accuracy of the integration, the integration range for
the spacing between each heat peak was narrowed, thus reducing
the background noise from the baseline.
Analysis of binding isotherms
For the analysis of the ITC-data we have used the classical
McGhee–von Hippel DNA binding model, which assumes iden-
tical intercalation pockets in-between each base pair. In this
model, the DNA ligand is characterized by an intrinsic binding
constant K (for binding without neighbor interactions), a
cooperativity parameter y (for cooperative binding interactions
with neighbors, y 4 1, for anti-cooperative neighbor inter-
actions 0 o y o 1) and the number n of binding sites made
inaccessible by the binding of one ligand. We have previously
described an efficient algorithm for solving the mass balance
for a general McGhee–von Hippel system,35 and here we have
also incorporated a ligand solution oligomerization equilibrium
m L- Lm into the mass balance (for details of the implementa-
tion, see the program code in ESI†). The thermodynamic con-
stant for this equilibrium is
Km ¼ Lm½ 
L½ m  C
ðm1Þ (1)
(where, as described elsewhere in this paper, equilibrium
constants are unit-less and refer to the standard state concen-
tration C1 = 1 mol per liter). To be able to compare oligomerization
constants with different m, the value of the effective dimerization
constant K1/(m1)m was calculated.
Two diﬀerent intercalation pockets, TA/TA and AT/AT, alter-
nate in the AT-DNA used for this study. However, for simplicity,
the present model considers them to be equal, and thus n is
expected to be close to 2 as for classical intercalation.
Furthermore, each intercalated ligand is also assumed to be
able to become an external binding site for an additional ligand,
characterized by an external binding constant Kext, which we
have arbitrarily set as 104 for all ligands. The eﬀect of external
binding on the mass balance has been neglected, since Kext used
will be at least 100 times less than the eﬀective ligand inter-
calation binding constant, which is in the range between Ky
and Ky2 when the free ligand concentration starts to rise as a
consequence of increasing intercalation site saturation.
Results
Isothermal titration calorimetry and model fitting
The raw ITC data of the enantiomers of complexes 1, 2 and 3
are shown in Fig. S1(D) and S2(L) of ESI.† To the left side of the
figures, the ligand is titrated into AT-DNA, and to the right, the
ligand is titrated into pure buﬀer. The ITC profiles obtained
deviate strongly from the standard sigmoidal shape typically
expected from a ligand–macromolecule binding system with a
single type of non-overlapping binding sites. This is consistently
observed for both enantiomers of complexes 1–3. As previously
suggested by us, this indicates a more complicated ligand–
macromolecule binding system with at least two different types
of binding interactions present.27,33,35 The L-enantiomers share
the common feature of showing a more exothermic ITC profile
than their D counterpart. All complexes show a non-constant
heat of dilution, which is small for the unsubstituted complex 1,
but very prominent for methylated complexes 2 and 3. Moreover,
upon saturation at the end of the titration, when almost all
binding sites on the DNA strand are occupied by ligands, the
methyl substituted complexes 2 and 3 both show much more
intense endothermal heat peaks, compared to the parent
complex 1, which cannot be explained by heat of dilution only.
To account for the phenomena in a physically meaningful way,
here we have explicitly considered the heat of aggregation
in solution as well as of external ligand binding to saturated
DNA, rather than to introduce constant base-line terms in
the model.
Linear dichroism studies in solution do not indicate signi-
ficant binding geometry diﬀerences between 1, 2 and 3 for either
enantiomer,19 and high resolution X-ray crystal structures of the
L-enantiomers show virtually identical intercalation geometries
irrespective of methyl substituents.20 Thus, it seemed reasonable
to attempt a global fit to the ITC data assuming identical
intercalation equilibrium constants K and neighbor interaction
parameters y for each set of enantiomers, while allowing the
binding site coverage parameter n to vary freely.
Aside from the intrinsic (DHK ) and neighbor interaction
(DHy ) reaction enthalpies, this model also considers the
oligomer dissociation (DH

m) as well as the external DNA
association (DH

ext) enthalpy. As can be seen in Fig. 2, it is
possible to find a very good global fit to the integrated peaks of
the raw data in Fig. S1 and S2 (ESI†) which gave nRMSD = 7.3%
(nRMSD: normalized root-mean-square-deviation, the Eucli-
dian norm of the residual divided by the Euclidian norm of
the data). In fact, allowing K and y to vary freely gave only a
slightly lower nRMSD (6.4%), indicating that the assumption of
similar binding aﬃnity parameters for each set of enantiomers
was consistent with the data.
Table 1 gives the best global fit binding parameter values,
showing that the D-enantiomer is anti-cooperative in its nearest-
neighbor interactions while the L-enantiomer is cooperative.
It is worth noting that although the intrinsic binding constant
K diﬀers by more than two orders of magnitude between the
enantiomers, the eﬀective binding constant close to saturation,
Ky2, is rather similar: Ky2 = 5.9  106 for D and 3.2  106 for L.
Interestingly, the L-enantiomers all have larger binding site
coverage parameters n compared to D. While the diﬀerence is
small for complexes 1 and 3, it is prominent for complex 2.
The self-aggregation (expressed as the eﬀective dimerization
constant K1/(m1)m in Table 1) increases with the number of methyl
groups, but the eﬀective dimerization enthalpy DH

m
ðm 1Þ
remains relatively constant as shown in Table 2. The external
binding contribution to the ITC-signal DH

ext becomes more
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prominent uponmethylation, in particular for the L-enantiomers,
but the weak binding makes it impossible to partition this trend
into external binding aﬃnity and external binding enthalpy.
However, the distinct diastereomeric diﬀerences for 2 and, in
particular, for 3 suggest that the distal benzene ring of the dppz of
one complex and the phenanthroline of another are important for
the external binding mode. By electrostatic arguments, it appears
most likely that this interaction occurs in the groove opposite to
where the Ru(phen)2-moieties of the intercalated complexes
reside, i.e. that it is the phenanthrolines of the externally bound
complexes that interacts with the methyl groups of the inter-
calated ones.
The diﬀerences in the intercalation enthalpy (DH

K ) between
the enantiomers of the same complex show no clear trend,
but the neighbor interaction enthalpy (DH

y) for L is about
2–3 times more exothermic than that of D. (As an example, the
different enthalpy contributions are illustrated for complex 2 in
Fig. S3 of ESI.†)
Table 3 highlights the diﬀerences in the enthalpy values due
to methyl substitution. The much more exothermic intercalation
for the D-enantiomer of 2 compared to 1 stands out as the most
significant eﬀect, followed by the less exothermic intercalation of
the L-enantiomer of 3 and the less exothermic neighbor inter-
action enthalpies of the D-enantiomers of 2 and 3.
Table 4 gives the free energy changes and entropy contribu-
tions calculated from the data in Tables 1 and 2. Since the free
energy changes were assumed to depend on chirality only,
diﬀerences in TDS1 between diﬀerent complexes directly reflect
the enthalpy changes in Table 3. However, these are small enough
not to change the overall pattern: intercalation is in all cases
predominantly entropy driven, and most so for D-enantiomers;
Fig. 2 ITC profiles with fitted traces for the titrations of the D-enantiomers (top left) and the L-enantiomers (top right) into poly(dAdT)2. The symbols
(circle: 1; triangle: 2; square: 3) indicate the normalized heat absorbed or evolved upon 2 ml injections of the complex (B590 mM) into the 206 ml cell
containing DNA (B320 mM nucleotides). The bottom right graph shows the averaged titration of both enantiomers into pure buﬀer. All titrations were
performed in 150 mM NaCl aqueous solution at 25 1C.
Table 1 Binding parameter values from global fit to ITC-data (enantiomer-
common fit values in italics)
KD/10
6 yDD nD KL/10
6 yLL nL K
1/(m1)
m m
1 41 0.38 2.17 0.28 3.4 2.29 400 2.0
2 41 0.38 2.25 0.28 3.4 2.99 3300 3.0
3 41 0.38 2.24 0.28 3.4 2.25 8900 2.7
Table 2 Enthalpy values from fit to ITC-data (in kJ mol1)
D L
1 2 3 1 2 3
DH

mðm 1Þ 19.5 26.8 21.8 19.5 26.8 21.8
DH

K
+1.2 10.4 +0.4 4.5 6.1 0.2
DH

y
7.7 4.3 4.4 13.7 14.8 16.3
DH

ext
1.0 +2.1 +2.4 0.5 +5.1 +9.2
Table 3 Changes in enthalpy values due to methyl substitution (in kJ mol1)
Complex D DH

KD
 
D DH

yD
 
D DH

KL
 
D DH

yL
 
2 11.6 +3.4 1.6 1.1
3 0.8 +3.3 +4.3 2.6
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the neighbor interaction on the other hand, in all cases, has a
large unfavorable entropy.
Discussion
Adding methyl substituents on the distant benzene ring of the
intercalating dppz ligand in the parent complex Ru(phen)2dppz
2+
increases the hydrophobicity of the complex causing an increased
self-aggregation of dimer/trimer structures. This in turn results in
a high non-constant heat of dilution when the ligand is added to
the macromolecule solution. This additional enthalpy change is
in the majority of ITC-studies simply subtracted from the experi-
mental data, but here the magnitude of the heat change is too
large not to be included in the analysis.
For any bindingmodel to be of practical use, a large number of
fitting parameters is not acceptable. Here, we demonstrate an
algorithm making it possible to fit experimental data of compli-
cated ligand–macromolecule systems using only a minimum of
additional parameters. In order not to over-interpret the data, we
have limited the binding model to be the simplest possible. Thus
effects due to AT/AT and TA/TA-differences, possible different
groove-locations and different intercalation geometries are all
neglected. Furthermore, we test the hypothesis that methyl sub-
stitution does significantly alter K and y for a given enantiomer.
When the self-aggregation and external binding eﬀects had
been accounted for, the seemingly disparate ITC-curves of 1, 2
and 3 (Fig. 2) were indeed found to be consistent with the same
binding aﬃnity for all D and all L enantiomers, i.e. all diﬀer-
ences due to methylation could satisfactorily be accounted for
as diﬀerences in the binding site coverage (n) and the binding
and the interacting enthalpy values. This suggests that methyl-
ation on the distant benzene ring does not dramatically alter
the binding aﬃnity characteristics typical for the enantiomers.
The graphs of concentration changes in the total bound
ligand and the neighboring bound ligand, respectively, for D
and L are depicted for 1 in Fig. 3. The more cooperative binding
of L becomes apparent in the initial part of the interaction
curve; the convex shape is due to the facilitated binding of
additional ligands. D-enantiomers, in contrast, have a concave
initial shape due to the anti-cooperative behavior of the ligands.
Since the fitting model needs to produce a close coincidence of
the D and L-curves at the end of the titrations, the intrinsic
binding constant K has to be correspondingly higher for the
anti-cooperative D-enantiomer than for L.
X-ray structures by Hall et al. have demonstrated the
Ru(TAP)2dppz analogues of L-1, -2 or -3 to intercalate with
the same depth and the same angular orientation.20 The X-ray
structure further showed that the 10-methyl group on dppz
eﬃciently protects the exposed dppz aza-nitrogen from inter-
action with water, consistent with the observation by Olofsson
et al. that methyl substitution in the 10-position gave longer
luminescence lifetimes for both enantiomers, in polyol solution
as well as when intercalated to DNA.19 Fig. 4 (left) shows a
model of three D-2 complexes consecutively intercalated (from
the minor groove, as per the suggestion from X-ray structures)
two base pairs apart from each other. A more hydrophobic
environment around the 10-methyl group, as suggested by the
model, than for the methyl groups of the 11,12-disubstituted
derivative D-3 (Fig. 4 (right)) might account for the significantly
more exothermic intercalation enthalpy of D-2. If this is the case,
Table 4 Derived thermodynamic parameters from global fit (in kJ mol1
at 25 1C)
DG

KD ¼ 43:5 DG

yD ¼ þ2:4 DG

KL ¼ 31:1 DG

yL ¼ 3:0
TDS

KD TDS

KL TDS

yD TDS

yL
1 +44.7 +26.6 10.1 10.7
2 +33.1 +25.0 6.7 11.8
3 +43.9 +30.9 6.8 13.3
Fig. 3 ITC titrations with complex 1 into poly(dAdT)2 with the changes in
the concentration of the total bound ligand (solid line) and the neighboring
bound ligand (dotted line) (black: D; red: L).
Fig. 4 Schematic illustration of the proposed interaction geometries for
D-2 (left) and D-3 (right) intercalated into DNA. The model was constructed
by manual docking and subsequent energy minimization in vacuum, using
the Amber 2 force field in the HyperChem 8.0 software package (HyperCube,
Inc.). The ruthenium(II) ions together with the ancillary and intercalating
ligands are colored orange, while the methyl substituents are colored red
for easier identification.
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the environment around the methyl group of the corresponding
enantiomer L-2 is expected to be diﬀerent, perhaps due to a
diﬀerent intercalation depth or diﬀerent angular orientation in
the intercalation pocket.
Conclusions
The addition of methyl substituents on the intercalating dppz
moiety of ruthenium(II) polypyridyl complexes results in non-
constant heat of dilution when titrated into a DNA solution.
These heat peaks are too strong to simply be subtracted from
the intrinsic binding enthalpy and must be included in the
analysis. By incorporating the oligomer dissociation as well as the
external DNA association enthalpy changes into our general mass
balance solving algorithm, we have here demonstrated how
complicated binding systems with a large background enthalpy
change can still be properly fitted into a binding model, without
the need to add unnecessary many parameters. A satisfactory
global fit was found when assuming the binding aﬃnities
for each enantiomer of both non-methylated and methylated
dppz-Ru to be equal, while only allowing the binding site size to
vary freely.
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2Figures
Figure S1 ITC raw data for the titration of the Δ-enantiomer of (a) 1 to AT-DNA; (b) 1 to buffer; (c) 2 to AT-DNA; (d) 2 to buffer; 
(e) 3 to AT-DNA; (f) 3 to buffer. All titrations were performed in 150 mM NaCl aqueous solution at 25°C. Complex (~590 μM)
was injected in 2 μl aliquots to the 206 μl cell containing the DNA (~320 μM nucleotides).
3Figure S2 ITC raw data for the titration of the Λ-enantiomer of (a) 1 to AT-DNA; (b) 1 to buffer; (c) 2 to AT-DNA; (d) 2 to buffer; 
(e) 3 to AT-DNA; (f) 3 to buffer. All titrations were performed in 150 mM NaCl aqueous solution at 25°C. Complex (~590 μM)
was injected in 2 μl aliquots to the 206 μl cell containing the DNA (~320 μM nucleotides).
4Figure S3 ITC profiles with fitted traces for the titrations of Δ-2 (left) and Λ-2 (right) to poly(dAdT)2. Each trace show the 
different contributions of enthalpy change for the ligand-DNA binding interaction; Green: dilution of free ligand; Red: 
intercalation; Blue: neighbor interactions; Magenta: external binding; Orange: background (dilution + external); Black: ITC 
signal with background enthalpy removed.  
5Programs
ITCalgorithmDeltaLambda
function [err,err0,sim,heat]=ITCalgorithmDeltaLambda(tpar,totdata1,totdata2,A0)
%Calculates the ITC curves for binding of enantiomer ligands La and Lb
%that form single symmetrical subunits when binding
%to an infinite chain of identical binding sites D using 
%the combined SGF-McGhee von Hippel approach. The oligomerization of L in solution
%and the further binding of L to the saturated lattice are both taken into account.  
%INPUT:
%tpar=[1) Ka  2) yAA 3) na 4) Kb 5) yBB 6) nb 7) Km 8) m-2] 
%there Km is the equilibrium constant for oligomerization: m L <-> Lm
%totdata1=[ITC-dilution ITC-data D0 La] Delta enantiomer data
%totdata1=[ITC-dilution ITC-data D0 Lb] Lambda enantiomer data
%(4*19) X 4 matrix with data and total
%concentrations, preferably with total concentrations of L in increasing order
%A0 = concentration in injectant stock solution
%OUTPUT:
%err = least square error of fit to data including penalty for very high
%entalpy and parameter values
%err0 = least square error of fit to data 
%sim = [ITC-data  simulated data]
%heat = calculated heat of reaction
if min(tpar)<=0
    err=1e6;
else
Km=tpar(7)/1000; 
m=tpar(8)+2;
data=[(totdata1(2:end,1)+totdata2(2:end,1))/2;totdata1(2:end,2);totdata2(2:end,2)]; 
%The dilution data for La and Lb are averaged.
L=1;
q=1;
while norm(q)>1e-10
    q=L+m*Km*L^m-A0;
    dqdL=1+m^2*Km*L^(m-1);
    dL=q/dqdL;
    while norm(L-dL)<=0
dL=dL/3;
    end
    L=L-dL;
end
    M0=Km*L^m; 
%Dilution
tot=totdata1(:,4);
C=[];
for t=tot'
    L=1;
q=1;
while norm(q)>1e-10
    q=L+m*Km*L^m-t;
    dqdL=1+m^2*Km*L^(m-1);
    dL=q/dqdL;
    while norm(L-dL)<=0
dL=dL/3;
    end
    L=L-dL;
end
    C=[C;Km*L^m];
end
dc0=C(2:end,1)-(204*C(1:end-1,1)+2*M0)/206;
dc1=dc0/(2*A0/206);
%Delta:
par=tpar(1:3);
K=par(1);
Y=[1 1 ;1 par(2)];
6n=par(3);
C0=totdata1(:,3:4);
r=0.01;
conc=[];
for t=C0';
    D0=t(1);
    L0=t(2);
    q=1;
    while norm(q)>1e-9;
s=1./(Y*[1;r]);
P=diag(s)*Y*diag([1;r]);
v=1-P(2,2)+n*P(1,2);
f=inv(v)*P(1,2);
x=s(2)*r/(s(1)^n);
q=x/K+f*D0+m*Km*(x/K)^m-L0;
u=inv(v)*(f-P(:,2)'*diag([1-n*f;f])*P(:,2));
dqdr=(D0*u+(x/K)*(1+m^2*Km*(x/K)^(m-1))*v)/r;
dr=q/dqdr;
while min(r-dr)<=0
dr=dr/3;
end
r=r-dr;
    end
    conc=[conc;[(Km*(x/K)^m)-M0 D0*f*[1 P(2,2) 0.001*x/K] ]];
end
dc2=[conc(2:end,:)-conc(1:end-1,:)*204/206]/(2*A0/206);
%Lambda:
par=tpar(4:6);
K=par(1);
Y=[1 1 ;1 par(2)];
n=par(3);
C0=totdata2(:,3:4);
r=0.01;
conc=[];
for t=C0';
    D0=t(1);
    L0=t(2);
    q=1;
    while norm(q)>1e-9;
s=1./(Y*[1;r]);
P=diag(s)*Y*diag([1;r]);
v=1-P(2,2)+n*P(1,2);
f=inv(v)*P(1,2);
x=s(2)*r/(s(1)^n);
q=x/K+f*D0+m*Km*(x/K)^m-L0;
u=inv(v)*(f-P(:,2)'*diag([1-n*f;f])*P(:,2));
dqdr=(D0*u+(x/K)*(1+m^2*Km*(x/K)^(m-1))*v)/r;
dr=q/dqdr;
while min(r-dr)<=0
dr=dr/3;
end
r=r-dr;
    end
    conc=[conc;[(Km*(x/K)^m)-M0 D0*f*[1 P(2,2) 0.001*x/K] ]];
end
dc3=[conc(2:end,:)-conc(1:end-1,:)*204/206]/(2*A0/206);
ze1=zeros(size(dc1(:,1)));
dc=[ dc1 ze1 ze1 ze1 ze1 ze1 ze1;dc2 ze1 ze1 ze1 ;dc3(:,1) ze1 ze1 ze1 dc3(:,2:4)];
heat=pinv(dc)*data;
    sim=dc*heat;
    err0=norm(data-sim,'fro');
    err=err0;
    err=err+norm(tpar)/220;        %Penalty for guess with very high parameter values
    err=err+norm(heat,'fro')/75;  %Penalty for guess that result in very high enthalpy values
    sim=[data sim];
end
7GlobalITC
function [err,err0,sim,heat,terr,terr0,tvar]=GlobalITC(var,d1,d2,d3,d4,d5,d6,A0)
%Global fit of 3 ITC titrations of Delta and Lambda enantiomers of 3
%different compounds, sharing the same KD, KL, yDD and yLL binding parameters. n-values
%are allowed to vary between the 3 pairs of enantiomers, while heat of dilution is
%the same for Delta and Lambda.
%No:   1  2  3   4  5   6  7  8  9 10  11  12   13   14   15   16
%var=[KD KL yDD yLL n1 n2 n3 n4 n5 n6 Km12 Km34 Km56 m12  m34  m56  ]
%A0=stock solution conc för 1-6
if min(var)<=0
    err=1e6;
else
[err1,err01,sim1,heat1]=ITCalgorithmDeltaLambda(var([1 3 5 2 4 6 11 14]),d1,d2,A0);
[err2,err02,sim2,heat2]=ITCalgorithmDeltaLambda(var([1 3 7 2 4 8 12 15]),d3,d4,A0);
[err3,err03,sim3,heat3]=ITCalgorithmDeltaLambda(var([1 3 9 2 4 10 13 16]),d5,d6,A0);
terr=[err1 err2 err3];
terr0=[err01 err02 err03];
err=norm(terr);
err0=norm(terr0);
sim=[sim1;sim2;sim3];
heat=[heat1 heat2 heat3];
tvar=[var([1 3 5 2 4 6 11 14]);var([1 3 7 2 4 8 12 15]);var([1 3 9 2 4 10 13 16])];
end
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The initial guess for this global fit is based on fits of individual datasets using 
ITCalgorithmDeltaLambda. The search is restarted until no further reduction of the error is noted. 
For information on what the numerical values etc. represent, see comments in the programs above 
or MATLAB documentation.   
>> options=optimset('Display','Iter','MaxIter',24000,'MaxFunEvals',48000,'TolX',1e-6,'TolFun',1e-6);
>> Initguess=[10 1 1 3 2 2 2 2.5 2 2 .5 .01 .4 .01 1 .5];
>> tic;Bestfit=fminsearch('GlobalITC',Initguess,options,D1,L1,D2,L2,D3,L3,595);toc
…
13692        17930          8.26786         shrink
Optimization terminated:
 the current x satisfies the termination criteria using OPTIONS.TolX of 1.000000e-06 
 and F(X) satisfies the convergence criteria using OPTIONS.TolFun of 1.000000e-06 
Elapsed time is 332.361541 seconds.
>> tic;Bestfit=fminsearch('GlobalITC', Bestfit,options,D1,L1,D2,L2,D3,L3,595);toc
…
8463        11179          8.21745         shrink
Optimization terminated:
 the current x satisfies the termination criteria using OPTIONS.TolX of 1.000000e-06 
 and F(X) satisfies the convergence criteria using OPTIONS.TolFun of 1.000000e-06 
Elapsed time is 204.539907 seconds.
>> tic;Bestfit=fminsearch('GlobalITC',Bestfit,options,D1,L1,D2,L2,D3,L3,595);toc
…
8167        10802          8.19854         shrink
Optimization terminated:
 the current x satisfies the termination criteria using OPTIONS.TolX of 1.000000e-06 
 and F(X) satisfies the convergence criteria using OPTIONS.TolFun of 1.000000e-06 
Elapsed time is 196.558224 seconds.
>> tic;Bestfit=fminsearch('GlobalITC',Bestfit,options,D1,L1,D2,L2,D3,L3,595);toc
…
2745         3756          8.19836         shrink
Optimization terminated:
 the current x satisfies the termination criteria using OPTIONS.TolX of 1.000000e-06 
 and F(X) satisfies the convergence criteria using OPTIONS.TolFun of 1.000000e-06 
Elapsed time is 72.861021 seconds.
>> tic;Bestfit=fminsearch('GlobalITC',Bestfit,options,D1,L1,D2,L2,D3,L3,595);toc
9…
482          856          8.19836         reflect
Optimization terminated:
 the current x satisfies the termination criteria using OPTIONS.TolX of 1.000000e-06 
 and F(X) satisfies the convergence criteria using OPTIONS.TolFun of 1.000000e-06 
Elapsed time is 16.680446 seconds.
>> [err,err0,sim,heat,terr,terr0,tvar]=GlobalITC(Bestfit,D1,L1,D2,L2,D3,L3,595);
>> err0
err0 =
       6.1998
>> Bestfit
Bestfit =
  Columns 1 through 8
       41.389      0.27884      0.38022       3.4107        2.166       2.2949       2.2537       2.9887
  Columns 9 through 16
        2.235       2.2463      0.40589    0.0098819      0.36508   1.7433e-22       1.0198      0.67749
>> heat
heat =
-19.497       -53.73      -37.039
       1.1894      -10.448      0.41634
-7.7106      -4.2695      -4.3563
-9.9474       20.846       23.757
-4.5145      -6.1307     -0.22318
-13.682      -14.811      -16.324
-4.7473       50.509       92.476
Indata matrices:
Column order:     Titration into buffer     Titration into AT        [Base pair]/μM        [Complex]/μM
Δ-Ru(phen)2dppz2+
D1 = 
       3.7566       1.7417       153.74         8.67
       2.2114       2.3686       152.26        14.39
       2.1588       1.9945       150.79        20.04
       2.1218       1.9235       149.33        25.64
       2.0451       1.5358       147.89        31.18
       2.0713      0.25638       146.46        36.67
       2.0021       -2.139       145.04         42.1
10
       1.9833      -5.6969       143.64        47.47
       1.9416      -9.7722       142.25        52.79
       1.9244      -8.8324       140.87        58.05
       1.7454      -5.2572        139.5        63.25
         1.61      -1.7669       138.15         68.4
       1.6451      -1.3845       136.81        73.49
       1.6068     -0.35549       135.48        78.52
       1.5799       0.3018       134.17         83.5
       1.5607      0.64449       132.86        88.42
       1.5472       1.0198       131.57        93.28
       1.5006       1.0894       130.29        98.09
       1.4047       1.0863       129.02       102.84
Λ-Ru(phen)2dppz2+
L1 = 
       3.6679      -4.4849       153.74         8.67
       2.4308      -6.9631       152.26        14.39
       1.2044      -8.4961       150.79        20.04
       1.2727      -10.139       149.33        25.64
       1.9543      -11.975       147.89        31.18
       2.9779      -14.014       146.46        36.67
       2.0697      -16.678       145.04         42.1
       2.0657      -15.619       143.64        47.47
       1.8531      -15.893       142.25        52.79
       1.9834      -14.655       140.87        58.05
       2.2098      -10.472        139.5        63.25
        1.791      -6.2251       138.15         68.4
       1.8303      -2.6333       136.81        73.49
       1.8249     -0.37025       135.48        78.52
       1.7614      0.11584       134.17         83.5
       1.7011      0.22984       132.86        88.42
       1.7606       0.6107       131.57        93.28
       1.5178      0.55798       130.29        98.09
       1.7619      0.62827       129.02       102.84
Δ-Ru(phen)2(10-methyl-dppz)2+
D2 = 
       12.416      0.31566       153.74         8.67
11
       10.517      0.24837       152.26        14.39
       10.162      0.30629       150.79        20.04
       9.8768     -0.40978       149.33        25.64
       9.7437     -0.75786       147.89        31.18
       9.4239      -2.6523       146.46        36.67
       8.9994      -2.9636       145.04         42.1
       8.4868      -4.3023       143.64        47.47
       8.1519      -4.6395       142.25        52.79
       7.9208      0.15112       140.87        58.05
       7.3004       5.2111        139.5        63.25
       7.2236       8.1081       138.15         68.4
       6.7909       9.2696       136.81        73.49
       6.3102       9.7464       135.48        78.52
       6.1268       10.187       134.17         83.5
       5.8662       9.8917       132.86        88.42
       5.6248       9.6414       131.57        93.28
        5.268       9.5963       130.29        98.09
       5.0021       8.7626       129.02       102.84
Λ-Ru(phen)2(10-methyl-dppz)2+
L2 = 
       12.855      0.60192       153.74         8.67
       10.758     -0.96573       152.26        14.39
       10.553       -3.284       150.79        20.04
       10.035      -3.8993       149.33        25.64
       9.8803       -7.235       147.89        31.18
       9.5248      -9.0557       146.46        36.67
       9.2223      -8.2744       145.04         42.1
       8.6871      -3.9809       143.64        47.47
       8.5194        1.559       142.25        52.79
       8.0096       6.6224       140.87        58.05
       7.5553       9.3006        139.5        63.25
       7.0243       10.702       138.15         68.4
       6.5891       10.453       136.81        73.49
       6.1541       10.094       135.48        78.52
       5.6981       9.5558       134.17         83.5
       5.3517       9.3407       132.86        88.42
       4.9173       8.9005       131.57        93.28
12
       4.8942       8.5054       130.29        98.09
       4.6641       8.0139       129.02       102.84
Δ-Ru(phen)2(11,12-dimethyl-dppz)2+
D3 = 
         10.58       10.371       153.74         8.67
       7.1918       10.341       152.26        14.39
       7.8112       10.743       150.79        20.04
       7.6949        10.25       149.33        25.64
       5.5588       8.6108       147.89        31.18
       4.9684       9.3071       146.46        36.67
       4.5578       8.0644       145.04         42.1
       4.1777       5.9082       143.64        47.47
       3.8389       3.4691       142.25        52.79
       3.4636       4.1023       140.87        58.05
       3.3941       9.7325        139.5        63.25
       3.0645       8.8561       138.15         68.4
       2.9066       8.3933       136.81        73.49
       2.8998        7.409       135.48        78.52
       2.6279       6.9091       134.17         83.5
       2.4923       6.1043       132.86        88.42
       2.3662       5.5711       131.57        93.28
       2.3631       5.1123       130.29        98.09
        2.239       4.6724       129.02       102.84
Λ-Ru(phen)2(11,12-dimethyl-dppz)2+
L3 = 
        17.21       6.8366       153.74         8.67
       10.192       4.4014       152.26        14.39
       7.5429       3.0983       150.79        20.04
       6.9045      0.57154       149.33        25.64
       5.8226       -1.795       147.89        31.18
       5.4285      -2.8647       146.46        36.67
       4.7281      -5.7139       145.04         42.1
       4.3836      -7.6943       143.64        47.47
       4.1021      -6.5846       142.25        52.79
       3.9974      -3.3864       140.87        58.05
       3.4657       -1.755        139.5        63.25
13
       3.4623       3.4692       138.15         68.4
       3.2753       7.7886       136.81        73.49
       2.9811       8.8617       135.48        78.52
       2.8622       8.5585       134.17         83.5
       2.6108       8.1266       132.86        88.42
       2.2241       7.2354       131.57        93.28
       2.2353       6.3073       130.29        98.09
       1.9823       5.5744       129.02       102.84
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Abstract 
The biexponential excited-state emission decay characteristic of DNA intercalating tris-
bidentate dppz-based ruthenium complexes of the general form Ru(L)2dppz2+ has previously 
been explained by a binding model with two distinct geometry orientations of the bound 
ligands. However, it has been found that upon DNA binding of Ru(phen)2dppz2+ the fractions 
of short and long lifetimes are strongly dependent of environmental factors such as salt 
concentration and, in particular, temperature. Using competitive isothermal titration 
calorimetry (ITC) to evaluate the current binding model of Ru(phen)2dppz2+ enantiomers 
interacting with poly(dAdT)2, we found that rather than assigning each excited-state lifetime 
to a specific geometric orientation, each intercalated complex should be seen as being in 
equilibrium with a short and long lifetime state, which may be altered by neighboring bound 
ligands affecting each other. In addition, as the titration progresses and the binding sites on the 
DNA polymer become increasingly occupied, a general resistance for the saturation of the 
binding sites is observed suggesting diastereomeric crowding of the neighboring bound 
ligands.    
Introduction 
The discovery of the “light-switch” complex, Ru(bpy)2dppz2+ (Ru-bpy; bpy = 2,2’-bipyridine; 
dppz = dipyrido[3,2-a:2’,3’-c]phenazine) by Barton and Sauvage almost 30 years ago was 
soon followed by Ru(phen)2dppz2+ (Ru-phen; phen = 1,10-phenanthroline) (Fig. 1) and 
initiated the synthesis of many variations of dppz-based ruthenium-centered tris-bidentate 
structures.1-3 Having interesting photophysical properties together with strong binding affinity 
to DNA and a slight selectivity towards A-T base pairs have made these DNA intercalative 
complexes attractive candidates for new pharmacological therapeutics and biosensors.4-5 The 
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luminescence of these complexes, attributed to a dppz-localized 3MLCT excited state6-10, is 
effectively quenched in hydroxylic solvents, and to be completely extinguished, both of the 
9,14-nitrogens on the extended (phenazine) part of the dppz ring are required to be H-bonded 
in the excited state.11 However, when the phenazine nitrogens are shielded from forming H-
bonds with the water molecules in a hydrophobic environment, such as in-between the DNA 
base pairs, their luminescence is turned on. Even more interesting, when bound to DNA, 
complexes of the general form Ru(L)2dppz2+ (L = ancillary polypyridyl ligand) exhibit almost 
invariably biexponential excited-state emission decays.1, 12-14  
Figure 1 Structures of Λ- (left) and Δ-Ru(phen)2dppz2+ (right). 
Octahedral tris-bidentate ruthenium complexes of the general form Ru(L)2dppz2+ are chiral 
and will adopt a structure much like a three-winged propeller, which can either have a right-
handed (Δ) or a left-handed (Λ) configuration (Fig. 1). Being a right-handed helical structure 
in its common form, DNA is itself a chiral molecule. Not surprisingly, diastereomeric effects 
are observed when enantiopure Ru-bpy or Ru-phen are intercalated to DNA, where both 
Figure 2 Schematic illustration of the proposed binding geometries of the a (left),
the symmetric c (middle) and b (right) elementary units of Δ-Ru-phen viewed from
above of the DNA helix axis. The 9,14-nitrogens on the extended part of the dppz 
moiety are colored red. 
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spectroscopic and calorimetric studies report a generally stronger binding affinity for the Δ-
enantiomer than for the Λ-enantiomer.14-20 The two emission lifetimes observed for both Ru-
bpy and Ru-phen have previously been assigned to two distinct binding geometries, where the 
shorter life time is attributed to complexes centered in the intercalation pocket and the longer 
lifetime is from a more canted intercalation geometry (Fig. 2).17, 21-22 This has further been 
supported by recent X-ray crystallography studies, reporting differently angled intercalation 
geometries for intercalation from the minor groove for Λ-Ru-phen.23-24  
Both photophysical data and calorimetric data have previously revealed the DNA binding 
characteristics of the Λ-enantiomers of Ru-bpy and Ru-phen to be very similar to each other, 
with both the relative contributions from the two emitting species, their excited state lifetimes 
as well as very similar calorimetric titration isotherms.17, 21 In contrast, the binding 
characteristics of the Δ-enantiomers are much more different in appearance, indicating a strong 
influence from the 1,10-phenanthroline B-ring, which is missing in 2,2’-bipyridine. The DNA 
molecule consists of long polymers of identical binding sites which overlap each other when 
occupied by bulky structures such as Ru-bpy and Ru-phen. Therefore, for any binding model 
to give a satisfactory global fit, cooperativity effects must be included, meaning that bound 
neighboring ligands may affect the binding geometry orientation of each other.17, 20, 25 In our 
first global analysis of ITC and luminescence data for Ru-dppz complexes, the differences 
between the Δ-enantiomers was suggested to origin from a preference of forming doublets, 
canted away from each other, already at low binding densities of Δ-Ru-phen, whereas Δ-Ru-
bpy was suggested to prefer a centered intercalation of single complexes at the same, low 
binding densities.17 
In this study, we modeled the DNA strand as a homo-polymer of identical intercalation pockets 
using a generalized McGhee-von Hippel26 binding isotherm algorithm.17, 25 While this 
method27 accounted for binding site interactions, it was still a complicated algorithm with 
limited efficiency that never gained any general popularity. Recently, we have developed a 
much simplified algorithm that is general enough to be utilized for modeling ligand binding to 
any type of linear biopolymer.20 We demonstrated the practical usage of this algorithm by a 
series of competitive isothermal titration calorimetry (ITC) experiments using enantiopure Ru-
bpy titrated to poly(dAdT)2 (AT-DNA) already saturated by the opposite enantiomer. 
[4] 
 
While for Ru-bpy it is possible to fit calorimetric data to a simpler binding model with only 
one assumed binding geometry, the enthalpic changes for Ru-phen interacting with DNA are 
more prominent and might require a complicated binding model. While the earlier model with 
two distinct binding geometries accounts for the two emission lifetimes, it does not satisfactory 
explain why the fractions of short and long lifetimes appear to be temperature and salt 
concentration dependent in more recent results.22 In this study, we seek to evaluate the earlier 
binding model for Ru-phen in a competitive setting as we did previously for Ru-bpy. If needed, 
our aim is to find an improved binding model that also accounts for the more recent extensive 
photophysical research performed on the ligand-DNA characterization of Ru-phen, using our 
newly developed simplified general algorithm.  
Experimental 
Materials and sample preparation 
All experiments were performed in an aqueous buffer solution (pH = 7.0) containing 150 mM 
NaCl and 1 mM cacodylate (dimethylarsinic acid sodium salt). A stock solution of 
poly(dAdT)2 (AT-DNA) (~5 mM nucleotides) was prepared by dissolving the sodium salt 
(Sigma-Aldrich) in buffer. Stock solutions of the complexes (~1 mM) were prepared by 
dissolving the chloride salts in buffer. Concentrations were determined spectrophotometrically 
using extinction coefficients: ε260 = 6600 M-1cm-1 per nucleotide for AT-DNA, and ε440 = 
20000 M-1cm-1 for Ru(phen)2dppz2+. For ITC measurements the DNA solution was dialyzed 
against pure buffer for at least 48 hours at 8°C. Ruthenium complex solutions of appropriate 
concentrations were prepared by dilution of the stock solutions in the dialysate. The dialysis 
membrane used had a molecular weight cut-off of 3.5-5 kDa (Spectra-Por® Float-A-Lyzer® 
G2, Sigma-Aldrich).  
Enantiopure Δ- and Λ-[Ru(phen)2dppz]Cl2 used in this study were prepared as previously 
reported.14  
Other chemicals were purchased from Sigma-Aldrich and used without purification. 
Absorption spectra were measured on a Varian Cary 4000 UV/vis spectrophotometer (Agilent 
Technologies) (path length = 1 cm).  
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Isothermal titration calorimetry 
Isothermal titration calorimetry has many advantages when studying the binding interactions 
between biomolecules, and is often referred to as the “gold standard” for quantitative 
measurements of ligand-macromolecule associations. It is also the only method capable of 
direct thermodynamic measurement of all the energetics associated with the binding 
interaction process, enabling a full thermodynamic characterization (stoichiometry, 
association constant, enthalpy and entropy of binding).28-30 It is a high-precision tool where the 
heat produced or absorbed upon addition of the complex to a DNA solution enables direct 
assessment of the binding free energy by integrating the power required to maintain the 
reference and sample cells at the same temperature. The experimental raw data consists of a 
series of heat flow peaks, and each peak corresponds to one injection of complex. These heat 
flow spikes are integrated with respect to time, which gives the total heat exchanged per mole 
injectant plotted against the ratio [Ru] / [base pairs]. 
Calorimetric data was obtained using a MicroCal iTC200 isothermal titration calorimeter 
(Malvern Instruments) controlled by Origin 7.0 software. The ITC profiles of the Δ and Λ 
enantiomers of Ru-phen were obtained by a single injection of 1 μL followed by 19 sequential 
titrations in 2 μL aliquots injections of complex from a syringe stock solution (~550 μM) into 
the sample cell (206 μL) loaded with AT-DNA in 150 mM NaCl aqueous solution (~408 μM 
nucleotides). We chose to use AT-DNA for the ligand-DNA interaction in order to avoid any 
effects from DNA heterogeneity. 
 This was subsequently followed by an additional 20 sequential injections (single injection of 
1 μL followed by 19 injections of 2 μL aliquots) of the opposite enantiomer into the sample 
cell now loaded with AT-DNA saturated by the first complex. The injection spacing was 180 
s, the syringe rotation was 1000 rpm, and there was an initial delay of 120 s prior the first 
injection. The primary ITC data was corrected the heat of complex dilution by subtracting the 
average heat per injection of complex titrated into buffer. There was negligible heat arising 
from DNA dilution. The raw ITC data peaks were automatically integrated using the Origin 
7.0 software. For improved accuracy of the integration, the integration range for the spacing 
between each heat peak was narrowed, thus reducing the background noise from the baseline. 
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Binding models 
A ligand bound to a homogenous one-dimensional lattice of binding sites can be in three 
distinct environments: either isolated, i.e. without any ligand neighbors, or with one ligand 
neighbor on one side and one empty binding site on the other (end binding), or with neighbors 
on both sides (interior binding). In the present study we have used two models: Model A, in 
which the ligand-ligand interaction energy is assumed to be additive and independent of the 
environment, and Model B, in which the ligand-ligand interaction energies may be taken to be 
different for ligands at ends and in the interior of a sequence of consecutively bound ligands.  
In Model B, this is modelled by 4 different elementary units (two unsymmetrical units a and 
b, occurring only to the left and to the right, respectively, of a ligand neighbor; and two 
symmetrical units: c, occurring only in the interior of ligand sequences, and d, which only 
occur isolated. In the earlier model (denoted Model C) proposed by Andersson et al. there is 
only one symmetrical elementary unit c which can occur both isolated and in the interior of 
ligand sequences.17 In addition, c may also be an end unit when bound next to either a or b. In 
Model B, this arrangement is not allowed but the end unit must be an unsymmetrical unit. 
Model C and Model B are illustrated in Fig. 3. For the simultaneous binding to a lattice of two 
different ligands 1 and 2, the cooperative factor matrix Y then becomes: 
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The lattice with bound ligands is symmetrical, thus Ya1c1 = Yc1b1, Ya2c2 = Yc2b2, 
Ya1b2=Ya2b1, Ya1c2=Yc2b1, Ya2c1=Yc1b2 and Yc1c2=Yc2c1, but in general, Ya1c2 ≠ Ya2c1. 
If all cooperativity factors involving a particular pair of ligands 1 and 2 are equal (Ya1b1 = 
Ya1c1 = Yc1c1 = Y11; Ya2b2= Ya2c2= Yc2c2 = Y22; and Ya1b2 = Ya1c2= Ya2c1 = Yc1c2 = 
Y12= Y21) Model B is reduced to Model A, with Y: 
[7] 
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For both models, at a given total concentration of binding sites and ligands, the bound ligands 
are partitioned into the 3 categories (isolated, end or interior) by calculating the probability 
that a bound ligand has a certain neighbors using the conditional probabilities in the Markov 
chain transition matrix P. When two different ligands are present, the concentrations of all end 
ligands with a different type of ligand as neighbor are summed up, as are the concentrations of 
all interior ligands with at least one neighbor of a different type.  
Fitting models to data 
Photophysical data. The experimental pre-exponential factors (α-values), from the data of 
titrations of AT-DNA with Δ- and Λ-Ru-phen in 5 mM phosphate buffer given by McKinley 
et al.21, were projected on the space spanned by the calculated probabilities P that a bound 
ligand belongs to one of the 3 categories (calculated as in Table 1) to obtain the least square 
fit.  
ߙୱ୦୭୰୲ǡୡୟ୪ୡ୳୪ୟ୲ୣୢ ൌ ܿ୧ୱ୭୪ ୧ܲୱ୭୪ ൅ ܿୣ୬ୢܲୣ ୬ୢ ൅ ܿ୧୬୲ ୧ܲ୬୲ሺ͵ሻ 
Figure 3 Schematic illustration comparing the old lattice Model C (left) with the
proposed lattice Model B (right) showing the 4 different element units and their 
possible ligand-DNA interactions.
[8] 
 
Table 1 Calculation of category probability 
Probability for isolated end interior 
Model A P012 2P01P11 P112 
Model B θd(θd + 2θa + θc)-1 2θa(θd + 2θa + θc)-1 θc(θd + 2θa + θc)-1 
 
ITC data. The change in concentration upon addition of ligand was calculated for the 
categories (3 for Δ, 3 for Λ and 2 for Δ-Λ pairs), as well as the change in concentration of 
ligand dimers and of externally bound ligand.20, 31 Ligand dimerization in solution was 
assumed not to be dependent on stereochemistry, whereas the external binding was assumed 
to be dependent on the chirality of the externally bound ligand, but not on the chirality of the 
intercalated ligand. The entire ITC-data set of one blank (buffer) and 5 ligand titrations (114 
data points) was projected on the space of these concentration changes as 11 columns.  
Global fit. The sum of the residual norm of the ITC fit and of the fit to the α-values was 
minimized by varying the binding constants K, the binding site coverage number n, the 
cooperativity factors y and the dimerization constant Km using the fminsearch function of 
MATLAB. 
Results 
Isothermal titration calorimetry and model fitting 
The raw ITC data with the enantiomers of Ru-phen and also racemic Ru-phen titrated into AT-
DNA is shown in Fig. 4. The ITC profiles in the left column show the ligand titrated into AT-
DNA only. At the end of the titration, further injections with the same enantiomer (not shown) 
only gave very small constant heat values, indicating full saturation of the DNA. This is 
attributed to heat of dilution of the free ligands and is in accordance to our previous results.17, 
20, 31 Proceeding the titration by switching to the opposite enantiomer, significant enthalpy 
changes are observed (Fig. 4, right), strongly indicating that both enantiomers are capable of 
displace each other on the DNA also in the Ru-phen series.17, 31 
We recently showed that the 2 categories intrinsic binding and neighbor interaction, as 
calculated by Model A, could give a good fit to the ITC curves for the pure enantiomers of Ru-
phen.31 In the Ru-bpy series, augmenting these categories with a single Δ-Λ neighbor 
[9] 
 
interaction was found to produce a very good fit of Model A to the competition ITC curves.20  
For the present ITC data set, the fit of Model A with 2 intrinsic binding (Δ and Λ) and 3 
neighbor interaction (ΔΔ, ΛΛ and ΔΛ) categories was not as good. A better fit to the ITC data 
was obtained when the neighbor interaction category was differentiated into an end and an 
interior contribution, as described above under Methods. Nether the less, when calculating α-
values by assigning the long lifetime exclusively to the end category, Model A failed 
Figure 4 ITC raw data for binding of the Δ and
Λ enantiomers of Ru-phen to AT-DNA alone
(Δ: a; Λ: c) followed by a second titration of 
the opposite enantiomer to already ligand-
saturated AT-DNA (Δ into Λ-saturated DNA:
b; Λ into Δ-saturated DNA: d). Bottom panel 
(e) shows racemic Ru-phen titrated to AT-
DNA alone. All titrations were performed in 
an aqueous 150 mM NaCl buffer solution at 
25°C. Complex (~550 μM) was injected in 2 
μL aliquots to the 206 μL cell containing the 
DNA (~408 μM nucleotides).     
[10] 
completely to simultaneously fit the ITC and the photophysical data. Similarly, Model C, used 
in our previous global analysis of ITC and photophysical data for Ru-phen enantiomers, which 
assigned the long lifetime exclusively to the end category,17 failed to produce an acceptable 
global fit.  
The strict assignment of excited state lifetimes to specific species defined by a binding model 
could be relaxed if it is assumed that every intercalated Ru complex could be in equilibrium 
with a long-lived and a short-lived species, and that it is the corresponding equilibrium 
constant that is affected by the neighbors. Thus assuming that the α-values could be calculated 
according to Eq. 3 gave much better global fits. 
For Model A, the best fit was obtained by assuming equal binding to the alternating AT/AT 
and TA/TA steps. By contrast, for Model B, the best fit was obtained when binding was 
assumed to occur exclusively at one of these steps, moreover, the binding site coverage 
parameter n could be set to be exactly 1 for both enantiomers without significantly increasing 
the residual norm. Fig. 5 shows the best global fit to the integrated peaks of the raw data (Fig. 
4)using Model B, which gave nRMSD = 11.1% (Table 2) (nRMSD: normalized root-mean-
square-deviation, the Euclidian norm of the residual divided by the Euclidian norm of the data). 
The best global fit obtained for Model A is shown in Supplementary Information Fig. S1 which 
gave nRMSD = 14.3% (Table 2). 
Table 2 nRMSD values for the best global fit of ITC and photophysical data with Model A or Model B͘ 
ITC alpha 
Model A 14.3% 4.4% 
Model B 11.1% 2.5% 
[11] 
Table 3 compares the best global fit parameter values for Model A and Model B. Model A, 
with only one type of elementary unit has only one cooperativity factor y, which showed a 
slight cooperativity in the nearest-neighbor interactions of both Δ-Δ and Λ-Λ while Δ-Λ 
interactions were anti-cooperative. In Model B, Δ showed a modest cooperative interactions 
when bound to the DNA lattice as a-b (i.e. as an isolated dimer) but is essentially non-
cooperative as the isolated trimer a-c-b, the latter which very reluctantly expands to tetramers 
a-c-c-b etc. due to the strong anti-cooperativity of the c-c-interaction. In contrast, while the
isolated trimer a-c-b is also non-cooperative for Λ, the isolated dimer a-b is modestly anti-
cooperative as is the c-c-interaction. Interestingly, the values for the heterochiral interactions
are closer to Λ than to Δ.
Figure 5 ITC profiles with fitted traces of Model B for the titrations of Δ and ΛRu-
phen to AT-DNA alone (left) followed by a second titration of opposite enantiomer 
to already ligand-saturated AT-DNA (right). Also shown is the ITC profile for rac-Ru-
phen titrated to AT-DNA alone. Symbols (Δ: green; Λ: red; rac: blue) indicate the 
normalized integrated heat absorbed or evolved upon 19 sequential 2 μL injections 
of the complex (~550 μM) into the 206 μL cell containing the DNA (~408 μM
nucleotides). All titrations were performed in 150 mM NaCl aqueous solution at 
25°C.   
[12] 
 
Table 3 Binding parameter values from global fitting of Model A and Model B to ITC data. Included is 
also the parameters from the old Model C (data taken from Andersson et al.17). 
 K/106 n y yab yac ycc 
Model A       
Δ 7.06 2.57 1.46    
Λ 2.09 2.31 1.08    
Δ-Λ   0.78    
dimer 2.0E-4      
Model B       
Δ 13.7   2.70 1.12 0.07 
Λ 3.71   0.45 0.93 0.25 
Δ-Λ    0.70 1.26 0.19 
dimer 2.9E-4      
Model C  na/nc     
Δ 1.1 2/1.8  56 6 0.01 
Λ 0.2 2/1.8  9 9 0.05 
 
The enthalpy ΔH° parameter values for the binding of the different categories from the global 
fitting of Model A and Model B are presented in Table 4, together with the enthalpy values for 
the outer binding mode to saturated DNA and the formation of dimer in solution. Derived 
standard thermodynamic values for the equilibrium parameters K and yij from the fit of model  
B are given in Table 5, in which the cooperativity factor enthalpies were calculated by linear 
combination of the categories enthalpies.  
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Table 4 Enthalpy parameter valuesa from global fitting of Model A and Model B to ITC data.   
 outerb isolated end interior end, mix interior, mix dimer 
Model A        
Δ -1.0 -1.2 +1.4 -7.9 -11.0 -16.1 -14.2 
Λ +1.5 -5.0 -18.3 -14.9    
Model B        
Δ +0.4 -0.7 -0.6 -24.5 -7.4 -21.3 -24.1 
Λ +0.8 -4.4 -17.3 -14.3    
a(ΔH°/kJ mol-1)    bAssuming Kouter = 100 
Table 5 Standard thermodynamic quantities at 25°C derived from the fit of Model B. 
 Δ     Λ    
 K yab yac ycc  K yab yac ycc 
Value 13.7·106 2.70 1.12 0.07  3.7·106 0.45 0.93 0.25 
ΔG°/kJ mol-1 -40.7 -2.5 -0.3 +6.6  -37.5 +2.0 +0.2 +3.4 
ΔH°/kJ mol-1 -0.7 +0.2 -11.8 -23.8  -4.4 -25.8 -17.8 -9.9 
ΔS°/J mol-1 K-1 +134 +8.9 -39 -102  +111 -93 -60 -45 
 
Fig. 6 shows the best global fit for the experimental pre-exponential factors for the shorter 
lifetime αs of Δ- and Λ-Ru-phen titrated to AT-DNA (data obtained from McKinley et al.21) 
using Model B, which gave nRMSD = 2.5% (Table 2). The best global fit obtained for Model 
A is shown in Supplementary Information Fig. S3 which gave nRMSD = 4.4% (Table 2). As 
the titration progresses, more and more binding sites on the DNA polymer become occupied 
by ligands, i.e. the DNA becomes saturated. Hence the fraction short excited state lifetime, 
which is more associated with the isolated elementary unit d decreases. For the Δ-enantiomer, 
the ratio αs is subsequently lower than for the Λ-enantiomer, most likely caused by a higher 
number of a-b dimer conformations preferred by Δ. In addition, the slightly increased ratio αs 
observed at the highest [Ru]/[base pairs] ratio for Δ is predicted to be caused by the reluctant 
formation of longer consecutive sequences like a-c-c-b units in the sterically crowded DNA 
lattice. 
[14] 
Model A and B gave qualitatively similar results when fitted to the photophysical data, as 
shown in Table 6. It should be noted, however, that these data were obtained at a much lower 
salt concentration (5 mM sodium phosphate buffer) than used in the ITC experiments, and that 
it has been shown that the proportion of the long lifetime increases with ionic strength,22 thus 
the results have to be interpreted with some caution.  For Δ, the fit of Model B assigns the 
short lifetime almost exclusively to isolated and interior and the long lifetime to end ligands 
(see Table 5), in close parallel to our previous analysis, that used a smaller set of α-values 
obtained at the same high salt concentration as in the ITC.17 In contrast, for Λ, the interior 
ligand is the dominating contributor to the long lifetime, with some end ligand contribution as 
well.   
Figure 6 Fitted traces of Model B to the α-values for the short lifetime, data taken 
from the titrations of AT-DNA with enantiopure Ru-phen (Δ: green; Λ: red) by 
McKinley et al.21 All titrations were performed in 5 mM phosphate buffer at 25°C.   
[15] 
Table 6 Coefficients c for the best fit to experimental αshort data. 
Model A Model B 
isolated end interior isolated end interior 
Δ 0.82 0 0.45 0.89 0.07 1.00
Λ 0.92 0.51 0.30 0.91 0.65 0.11
Discussion 
Our previous global analysis of ITC and excited state populations suggested that the two 
distinct lifetimes observed for each of the Ru-phen enantiomers bound to AT-DNA were 
directly corresponding to two distinct binding geometries, which were assigned to those 
observed by X-ray crystallography for the Λ-enantiomer.17 The present results shows that this 
immediate correspondence needs to be modified, if a binding model of the type here 
investigated should be able to make a satisfactory global fit to competitive ITC titration and 
excited state population data. We suggest that instead of identifying each excited state lifetime 
with a specific geometric arrangement in the intercalation pocket, each intercalated complex 
could be regarded as being in equilibrium with a short and a long lifetime state, and that it is 
this equilibrium that might be altered by the neighbor ligands. This suggestion further provides 
a plausible explanation for the observation that the short lifetime α-value is found to decrease 
dramatically with temperature.22  Since this value also decreases upon saturation of the DNA 
(see Fig. 6), i.e. as the number of complex interactions increases, a large decrease of αshort at a 
fixed Ru/base pair ratio upon an small increase in temperature must in the previous model then 
be due to a corresponding increase in a cooperativity factor, and hence such an equilibrium 
must be endothermic. But complex interaction equilibria appear exothermic when monitored 
by ITC. We propose that a more likely endothermic process that could explain the endothermic 
decrease in the short lifetime population is the release of a slowly exchangeable water molecule 
in the vicinity of a phenazine nitrogen of the intercalated dppz chelate. 
Even if we ignore the not-so-good fit of Model A to the competitive ITC titrations (see Fig. 
S1 in Supplementary Information), Model B presents two advantages to Model A in the 
physical interpreting the model parameters:   
[16] 
 
1) The TA-step specificity, inferred for the Λ enantiomer from X-ray crystal structures, 
is inherent in the model.23 
2) The binding site coverage number n can be set to unity for all bound ligands 
regardless of their environment, instead of being a freely adjustable non-integer 
parameter with different values for Δ and Λ. Thus, in Model B, all diastereomeric 
variation in binding affinity parameters is contained in the values of K and the yij. 
Although Model C, employed in our previous global analysis, gave the same n values for Δ- 
and Λ-Ru-phen (2.0 for elementary units a and b, and 1.8 for c), it gave a large span (0.01 – 
56) in the value of the cooperativity parameter y, and it was not able to fit the completion ITC 
data. With Model B, the span is much smaller (0.07 – 2.7), which facilitates a rationalization 
of the diastereomeric differences in structural terms. Our data supports the conjecture, 
originally made by Barton et al. for Ru(phen)32+ more than 30 years ago18, that a higher 
intrinsic binding constant K for Δ-enantiomers of trigonal metallo-intercalators is to be 
expected due to their better fit to the groove(s) of a right-handed double helix. Furthermore, 
the values of the cooperativity parameters suggest that a general steric crowding resists full 
lattice saturation (ycc < 1 for all combinations), but that this crowding is modulated by 
diastereomeric differences in the attractive and repulsive intermolecular contacts.  
As seen from the molecular models in Fig. 7, the phenanthroline B-ring can make a close 
contact with a neighboring complex only for the homochiral ΔΔ-pairs, which is consistent with 
the heterochiral y-values being more similar to ΛΛ than to ΔΔ. As suggested earlier, this 
arrangement further offers an explanation for the similarity in the ITC and luminescence data 
for the Λ-enantiomers of Ru-phen and Ru-bpy (in 2,2’-bipyridine, the CH=CH part of the 
phenanthroline B-ring is missing) and the dissimilarity in the data for the Δ-enantiomers.17 
The values of the y-parameters can be expected to be a product of both attractive and repulsive 
factors, of which we expect the 4 most important to be:  
1) A repulsive factor from the electrostatic repulsion of neighboring positive cations. 
2) A repulsive factor due to inter-complex steric clashes. 
3) An attractive factor due to hydrophobic/stacking interactions, primarily for Δ. 
4) An attractive factor from binding to a groove already widened by the first bound 
complex, primarily for Λ.   
[17] 
 
 
Since the yac parameter is close to unity for both homo- and heterochiral combinations, it 
appears that in all triplets a-c-b, the repulsive and the attractive contributions seem to balance. 
The Δ-enantiomer forms slightly cooperative a-b pairs, but very un-cooperative a-c-c-b 
quartets, suggesting that a weak hydrophobic attractive factor type 3 is gradually overcome by 
a steric repulsive factor type 2. By contrast, for the Λ-enantiomer, the steric repulsive factor 2 
seem less prominent, and is balanced by an attractive factor type 4, slightly favoring isolated 
complexes d over a-c-b triplets. The pronounced diastereomeric differences in the binding 
enthalpy and entropy values in Table 5 for the binding equilibria are very likely to reflect the 
differences in the contributing factors discussed above, however, we believe that it would be 
too speculative to here attempt to resolve the contribution of each factor.     
Conclusion 
Even though our previous model for the ligand-DNA interactions of Ru(phen)2dppz2+ gave a 
satisfactory global fit for both calorimetric and photophysical experimental data by directly 
connecting the two distinct excited-state emission decays characteristic of this complex with 
Figure 7 Schematic illustration of the proposed nearest-neighbor interaction
geometries for the Δ- and Λ-enantiomers of Ru(phen)2dppz2+ when intercalated to
DNA via the minor groove. The 5,6-carbons on the phen moieties are highlighted 
(green: Δ; red: Λ). The models were constructed by manual docking and subsequent 
energy minimization in a vacuum, using the Amber 2 force field in the HyperChem 
8.0 software package (HyperCube, Inc.).  
 
[18] 
two distinct binding geometries, it could not fit the competitive calorimetric titrations, and 
would not properly explain the observed salt concentration and temperature dependence of the 
lifetime fractions without an extreme salt or temperature dependence of the equilibrium 
parameters. Here we propose a different interpretation, where all intercalated complexes are 
instead regarded to be in equilibrium with a short and a long lifetime state; and that this 
equilibrium is affected by interactions from neighboring bound ligands. The decrease in the 
cooperativity parameter value for complexes interior to consecutive sequences suggest steric 
crowding of the bulky ancillary ligands causing a general resistance of forming longer 
sequential chains of bound complexes upon DNA saturation, which is further consistent with 
the diastereomeric differences in intermolecular contacts suggested by molecular models.         
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Figure S1 ITC profiles with fitted traces of Model A for the titrations of Δ and ΛRu-
phen to AT-DNA alone (left) followed by a second titration of opposite enantiomer 
to already ligand-saturated AT-DNA (right). Also shown is the ITC profile for rac-Ru-
phen titrated to AT-DNA alone. Symbols (Δ: green; Λ: red; rac: blue) indicate the
normalized integrated heat absorbed or evolved upon 19 sequential 2 μL injections 
of the complex (~550 μM) into the 206 μL cell containing the DNA (~408 μM
nucleotides). All titrations were performed in 150 mM NaCl aqueous solution at 
25°C.    
[22] 
 
 
 
 
 
 
Figure S1 ITC profiles with fitted traces of Model A (left) and Model B (right) for the 
averaged titrations of Δ and ΛRu-phen to pure buffer. Black squares indicate the 
averaged normalized integrated heat absorbed or evolved upon 19 sequential 2 μL 
injections of the complex (~550 μM) into the 206 μL cell containing 150 mM NaCl 
aqueous solution. The titrations were performed at 25°C.    
Figure S3 Fitted traces of Model A to the α-values for the short lifetime, data taken 
from the titrations of AT-DNA with enantiopure Ru-phen (Δ: green; Λ: red) by 
McKinley et al.21 All titrations were performed in 5 mM phosphate buffer at 25°C.     
Paper V 
View this journal online at wileyonlinelibrary.com
 
Chirality
ISSN 0899-0042
Volume 28
Issue 11
2016
Included in this
online edition:
Number 11 (November)
Received: 10 March 2016 Revised: 5 June 2016 Accepted: 21 September 2016DOI 10.1002/chir.22656S HORT COMMUN I CAT I ONDiastereomeric bactericidal effect of Ru(phenanthroline)2
dipyridophenazine
Anna K. F. Mårtensson1 | Mattias Bergentall2 | Valentina Tremaroli2 | Per Lincoln11Department of Chemistry and Chemical
Engineering, Chalmers University of Technology,
Gothenburg, Sweden
2Wallenberg Laboratory and Sahlgrenska Center
for Cardiovascular and Metabolic Research,
Department of Molecular and Clinical Medicine,
Institute of Medicine, University of Gothenburg,
Gothenburg, Sweden
Correspondence
Anna K. F. Mårtensson, Department of Chemistry
and Chemical Engineering, Chalmers University
of Technology, SE‐41296 Gothenburg, Sweden.
Email: marann@chalmers.se
Funding Information
Vetenskapsrådet, VR 2012–1661.This is an open access article under the terms of the Cre
the original work is properly cited, the use is non‐comm
[The copyright line for this article was changed on 10
© 2016 The Authors. Chirality Published by Wiley Pe
Chirality 2016; 28: 713–720ABSTRACT
Metal susceptibility assays and spot plating were used to investigate the antimicro-
bial activity of enantiopure [Ru(phen)2dppz]
2+ (phen =1,10‐phenanthroline and
dppz = dipyrido[3,2‐a:2´,3´‐c]phenazine) and [μ‐bidppz(phen)4Ru2]4+ (bidppz
=11,11´‐bis(dipyrido[3,2‐a:2´,3´‐c]phenazinyl)), on Gram‐negative Escherichia
coli and Gram‐positive Bacillus subtilis as bacterial models. The minimum inhib-
itory concentrations (MIC) and minimum bactericidal concentrations (MBC) were
determined for both complexes: while [μ‐bidppz(phen)4Ru2]4+ only showed a bac-
tericidal effect at the highest concentrations tested, the antimicrobial activity of [Ru
(phen)2dppz]
2+ against B. subtilis was comparable to that of tetracyline. In addition,
the Δ‐enantiomer of [Ru(phen)2dppz]2+ showed a 2‐fold higher bacteriostatic and
bactericidal effect compared to the Λ‐enantiomer. This was in accordance with the
enantiomers relative binding affinity for DNA, thus strongly indicating DNA bind-
ing as the mode of action.
KEYWORDS
antimicrobial activity, chirality, confocal microscopy, emission, metal susceptibility
assay, minimum bactericidal concentration, minimum inhibitory concentration,
ruthenium complex1 | INTRODUCTION
The treatment of bacterial infections has become more and
more problematic due to the emergence of multidrug‐resis-
tant pathogens.1,2 With few exceptions, the antibiotics that
are currently available for clinical use all target the same lim-
ited set of bacterial components (the cell wall, the cell mem-
brane, and a few enzymes essential for bacterial growth), thus
increasing the risk for multiresistance.3 Another problem is
that new antibiotics that are coming onto the market are
mostly variants of existing drugs, with the risk that resistance
mechanisms have already developed.4 A noteworthy excep-
tion is the recent discovery of teixobactin, the first member
of a novel class of antibiotics that targets lipid II and lipidative Commons Attribution‐NonCom
ercial and no modifications or adap
January 2017 after original online pu
riodicals, Inc.
wileyonlineIII, both membrane‐anchored cell wall precursors essential
for bacterial cell wall synthesis.5
There are several components in bacteria that have not
been fully explored as potential antimicrobial targets. Bacte-
rial DNA is an attractive antimicrobial target, provided that
specificity to bacterial cells can be established, as DNA
targeting compounds have the potential risk of also damaging
eukaryotic cells. Actinomycin D, doxorubicin, and daunoru-
bicin are a few examples of DNA binding antimicrobials that
were deemed too cytotoxic for the host6 and were therefore
developed as anticancer treatments.7–9
While a number of reports have analyzed the combina-
tion of transition metals with antibiotics as a way to
increase compounds’ potency against infectionsmercial‐NoDerivs License, which permits use and distribution in any medium, provided
tations are made.
blication.]
library.com/journal/chir 713
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the antimicrobial activity of metal complexes alone. Plati-
num‐containing complexes such as cisplatin were shown to
have antimicrobial activity, but were too damaging to
eukaryotic cells, thus only suitable for anticancer treat-
ment.13,14 Ruthenium complexes show less general toxicity
than platinum compounds,15,16 and in particular
ruthenium(II) polypyridyl complexes have several properties
that would make them suitable for antimicrobial treatments
(e.g., water soluble, coordinately saturated, and inert to substi-
tution). While the DNA intercalating ability of chiral ruthe-
nium(II) polypyridyl complexes have been extensively
studied and debated for more than 30 years,17–21 there has
been comparably little interest in testing their antimicrobial
activity despite the pioneering work of Dwyer et al. more than
60 years ago.22,23 This is somewhat surprising, as they are very
stable, readily synthesized, and have strong DNAbinding abil-
ity.24 In addition, their properties are readily modulated by the
peripheral ligands, making it possible to influence DNA bind-
ing and enantioselectivity.20 While the antimicrobial activity
of mononuclear ruthenium(II) polypyridyl complexes has pre-
viously been demonstrated,25,26 to the best of our knowledge
no reported study resolved the complexes in their pure enan-
tiomeric forms. Even fewer studies have been published on
antimicrobial activity in binuclear ruthenium(II) polypyridyl
complexes, with the exception of the work by Li and Keene
et al. 27–33 By coordinating bidentate ligands to the ruthenium
ion two conformations are possible: either a right‐ (Δ) or left‐
handed (Λ) helical structure. The resulting diastereomeric
interactions when bound to a chiral macromolecule, such asSCHEME 1 Structures of (a) Λ‐ (left) and ΔRu‐phen (right), (b) ΛΛbiRu‐
phen, and (c) tetracyclineDNA, would assumingly not be identical for both
enantiomers.
In this study we analyzed the antimicrobial activity
of enantiomeric pure [Ru(phen)2dppz]
2+ (Ru‐phen) (phen
=1,10‐phenanthroline and dppz = dipyrido[3,2‐a:2´,3´‐
c]phenazine) and [μ‐bidppz(phen)4Ru2]4+ (biRu‐phen)
(bidppz =11,11´‐bis(dipyrido[3,2‐a:2´,3´‐c]phenazinyl))
(see Scheme 1). Both complexes are well‐established
DNA intercalators and Ru‐phen has already been shown
to not be cytotoxic against HeLa cells.34 As bacterial
models, we used Gram‐negative E. coli and Gram‐positive
B. subtilis. As a reference for antimicrobial activity, we
used tetracycline, a broad‐spectrum antibiotic that is active
against both Gram‐positive and Gram‐negative bacteria.
2 | MATERIALS AND METHODS
2.1 | Materials
Enantiopure [Ru(phen)2dppz]Cl2 and [μ‐bidppz(phen)4Ru2]
Cl4 used in this study were synthesized as described
elsewhere.35,36 Concentrations were determined
spectrophotometrically using extinction coefficients:
ε440 = 20 000 M−1 cm−1 for Ru‐phen and ε262 = 200
000 M−1 cm−1 for biRu‐phen. Tetracycline hydrochloride
(Sigma‐Aldrich, St Louis, MO), the DNA stain Hoechst
33342 (bis‐benzimidine, Thermofisher, Waltham, MA),
PFA (para‐formaldehyde, Sarstedt, Sweden), SDS (sodium
dodecyl sulfate, Sigma‐Aldrich) and other chemicals were
used without purification. Luria‐Bertani (LB) medium
(10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl), 0.9% saline
solution, 10 mM NaPO4 + 1% LB medium (pH 7), LB agar
plates and phosphate‐buffered saline (PBS) were prepared
at the department of Clinical Microbiology at the
Sahlgrenska University Hospital.
2.2 | Bacterial Strains and Culture Conditions
The bacterial strains used in this study were Escherichia coli
DSM 1103 and Bacillus subtilis 168. The strains were pur-
chased from the American Type Culture Collection (ATCC,
Manassas, VA) (ATCC 25922, ATCC 23857) and activated
from freeze‐dried conditions in accordance with the protocol
provided upon delivery. Strains were grown on LB medium
aerobically at 37°C. Stock solutions of the bacterial strains
were prepared from freshly grown bacterial cultures and
stored in 20% glycerol at −70°C.
2.3 | Stock Solutions of Tetracycline and Metals
A stock solution of 5 mg/ml tetracycline was prepared in 70%
ethanol and stored protected from light at 8°C. Stock solu-
tions of the complexes were prepared at 5 times the highest
concentration used in the challenge plate (~2000 μM) by
dissolving the chloride salts in autoclaved MilliQ water
(Billerica, MA).
MÅRTENSSON ET AL. 7152.4 | Metal Susceptibility Assays
Metal susceptibility assays were performed using a method
similar to the MBEC high‐throughput assay as previously
described.37 Frozen stocks of the bacterial strains were
streaked out on agar LB plates to obtain subcultures. After
24 h incubation, a single colony from each strain was col-
lected from the subcultures and suspended in LB medium.
After 24 h incubation, this suspension was diluted 100‐fold
in LB medium and left to grow an additional 4 h. To ensure
that the bacterial growth was in the exponential phase, optical
density (OD) at 650 nm was measured and the bacterial solu-
tions were spot plated for colony count (OD = 0.3, CFU/
ml = 108, diluted 1:3, used 20 μl so that CFU/well =
2 × 106). Serial dilutions of the ruthenium complexes were
made in LB medium along the length of a sterile 96‐well
microtiter plate (the challenge plate), allowing the first col-
umn to serve as a sterility control and the last column to serve
as a growth control. Each ruthenium complex and tetracy-
cline were tested in triplicate and repeated once to ensure
reproducibility. The challenge plates where incubated for
24 h. To ensure aerobic conditions, a shaking table was used
for incubation of the plates and cultures. A schematic illustra-
tion summarizing the assay protocol can be found in the
Supporting Information (Figure S1).
2.5 | Minimum Inhibitory Concentration and
Minimum Bactericidal Concentration
The MIC is defined as the lowest concentration of a com-
pound that inhibits the visual growth of an organism. We
determined the MIC values by reading the optical density
of the challenge plate at 650 nm (OD650) on a SpektraMax
Plus 384 Microplate Reader (Molecular Devices, MSD Ana-
lytical Technologies, UK). The cellular suspensions in each
row of the challenge plate were then transferred to new sterile
96‐well microtiter plates and diluted 101–108‐fold with
10 mM NaPO4 + 1% LB medium. Twenty‐μl aliquots of each
dilution of each bacterial culture were spot plated in duplicate
onto LB agar plates and incubated for 24 and 48 h. The MBC
is defined as the lowest concentration of an antibiotic
required to kill a particular bacterial strain. The MBC values
were determined by qualitatively scoring the spot plates for
bacterial growth (this was done after 24 and 48 h to ensure
complete eradication of the bacterial cells). The number of
viable bacteria was expressed in CFU (colony‐forming units)
per ml:
CFU
ml
¼ Average colony count
Volume
×dilution (1)
2.6 | DNA Binding Emission
Emission spectra were recorded on a Varian Cary Eclipse
Fluorescence spectrophotometer (Agilent Technologies,
Santa Clara, CA). Inoculums of B. subtilis and E. coli inthe exponential phase were incubated overnight (37°C,
120 rpm), either with the enantiomers of Ru‐phen and
biRu‐phen (40 μM) in LB medium or in the medium alone.
After incubation, 1 ml of each bacterial suspension was
centrifuged at 6000 g at room temperature. The pellet was
washed twice in 1× PBS and then resuspended in 1 ml of
1× PBS solution. The samples were excited at 440 nm and
emissions were recorded at 500–800 nm.
2.7 | Confocal Microscopy
Confocal microscopy images were obtained with a Leica
TCS SP5 confocal scanning laser microscope (Leica
Microsystems, Germany) controlled by Leica Application
Suite Advanced Fluorescence (LAS AF) 2.6.0.7266 software.
Inoculums of B. subtilis and E. coli in the exponential phase
were incubated with Δ‐ and ΛRu‐phen (40 μM) in LB
medium overnight (37°C, 120 rpm) together with
nonexposed bacterial suspensions as controls. After incuba-
tion, 1 ml of each bacterial suspension was centrifuged at
6000 g at room temperature. The pellet was washed twice
in 1× PBS and then resuspended in 1 ml of 1× PBS solution.
Droplets (40 μl) of each suspension were placed on micros-
copy glass slides (Superfrost, VWR), allowed to adhere for
10 min, and then fixed with 2% PFA in PBS for 10 min.
The slides were washed using PBS solution and the bacteria
were stained with Hoechst 33342 (1:10,000 dilution) for
15 min. The slides were washed one final time with PBS
before mounting using fluorescence mounting medium
(Invitrogen, La Jolla, CA). Samples were viewed using a
63× objective (total magnification 630×) and Ru‐phen
(λex ~ 440 nm, λem ~ 610 nm) was excited using a 458 nm
blue argon laser at 40% intensity. Emission fluorescence of
Ru‐phen was collected at 600–670 nm. Hoechst 33342
(λex ~ 354 nm, λem ~ 486 nm) was excited with an ultraviolet
diode laser and detected using a blue/cyan filter.
2.8 | Nucleotide Leakage
Measurements were performed in accordance with a previous
method described by Henie et al., with minor modifica-
tions.38 Solutions containing bacterial inoculum in the expo-
nential phase treated with biRu‐phen (~300 μM) were filtered
through a 0.22‐μm pore size Millipore Express Millex GP
sterile syringe filter with PES membrane (Merck Millipore,
Germany) at 0, 10, 20, 30, 40, 50, and 60 min; 3% SDS solu-
tion was used as a comparison. Absorption at 260 nm for bac-
terial nucleic acids were measured using a Varian Cary 4000
UV/vis spectrophotometer (Agilient Technologies). All mea-
surements were performed in triplicate and repeated once to
ensure reproducibility.3 | RESULTS AND DISCUSSION
In this study we investigated whether there was an enantio-
meric difference in antimicrobial activity of both
716 MÅRTENSSON ET AL.mononuclear and binuclear dppz‐ruthenium(II)‐centered
complexes with phen as the peripheral ligands, and the
plausible mode of action for their antimicrobial effect.
Neither ΔΔ‐ nor ΛΛbiRu‐phen showed any significant
antimicrobial activity against either bacterial strain, and no
enantiomeric difference could be observed. The sudden drop
in bacterial growth at the highest complex concentrations
could be caused by lysis of the cellular membrane, and not
by interaction with DNA. To verify this hypothesis, we
exposed microbial cells to the highest concentration of
binuclear complexes and quantified the release of nucleic
acids. During 60 min of biRu‐phen exposure the optical
density at 260 nm of cell‐free filtrates increased for both
B. subtilis and E. coli, indicating nucleotide leakage (seeTABLE 1 MIC and MBC valuesa
Compound B. subtilis E. coli
MIC MBC MIC MBC
Δ 8 16 32 > 400
Λ 16 32 128 > 400
Δ Δ NDb 150 NDb 300
Λ Λ NDb 150 NDb 300
Tetracycline 8 16 < 1 < 1
aMIC and MBC values indicated as μM. (Ru‐phen: 1 μM = 0.82 μg/ml; biRu‐
phen: 1 μM = 1.63 μg/ml; Tetracycline hydrochloride: 1 μM = 0.48 μg/ml).
bNot determined due to the ruthenium complex precipitating in the LB medium.
(A)
(C)
FIGURE 1 Surviving bacterial counts (CFU/mL) of B. subtilis (left column) and
phen (bottom row, c,d) at 37°C. Each point is the mean of six replicate cultures. Er
small as or smaller than the symbols plottedFig. S2 in the Supporting Information). Notably, the leakage
of nucleic acid material was similar for the binuclear com-
plexes and a 3% SDS solution, indicating a similar effect of
the metal complexes and the detergent. The more gradual
OD260 increase in E. coli compared to B. subtilis was most
likely caused by the less‐permeable outer membrane charac-
teristic of Gram‐negative bacteria.39 No enantiomeric differ-
ence was observed. As bacterial membranes have a higher
proportion of negatively charged phospholipids compared
with eukaryotic cells, as well as negatively charged teichoic
acid and lipopolysaccharides,40–42 it is not surprising that
the large binuclear ruthenium complex with a 4+ cationic
charge would preferentially bind to the outer membrane of
the bacterial cell.
Table 1 shows a summary of determined MIC and MBC
values. The lowest MIC value was observed with ΔRu‐phen
against B. subtilis, with an inhibitory effect comparable to
that of tetracycline against the same bacteria. In contrast,
ΛRu‐phen was less effective, with a 2‐fold increase in its
MIC value. The enantiomeric difference in Ru‐phen was even
higher when tested against E. coli, with Λ requiring an 4‐fold
higher concentration for the same bacteriostatic effect as Δ,
but with an overall weaker inhibitory effect compared with
B. subtilis.
In order to determine the MBC values for both ruthenium
complexes a series of spot plating was performed (Figure 1(B)
(D)
E. coli (right column) after 24‐h exposure to Ru‐phen (top row, a,b) and biRu‐
ror bars show standard deviations (SD: 3σ); when not visible, these bars are as
(A)
(B)
FIGURE 2 Normalized emission spectra of bacterial cells. (a) B. subtilis;
(b) E. coli after overnight exposure to ruthenium complex (40 μM) at 37°C.
The cells were washed twice and resuspended in 1× PBS solution. Emission
from bacterial cells without exposure has been deducted. Black: ΔRu‐phen;
red: ΛRu‐phen; black dot: ΔΔbiRu‐phen; gray dash: ΛΛbiRu‐phen
MÅRTENSSON ET AL. 717[SD: 3σ] and Table 1). E. coli was never fully eradicated even
with the highest concentrations tested. However, both Δ‐ and
ΛRu‐phen showed a high bactericidal effect in B. subtilis,
with a 2‐fold higher efficiency in Δ compared to Λ. We also
observed a plateau for the viability of E. coli at increasing
concentrations of the mononuclear complexes (Figure 1b)
before a sudden drop to almost zero bacterial growth. A
similar yet much less pronounced effect can be seen for
the binuclear complexes (Figure 1d). This response is
likely the effect the emergence of a small subpopulation
bacteria (so called “persisters”) that is able to survive
antimicrobial exposure, and is part of a survival strategy
already well established in E. coli.43–45 The slow‐growing
persister cells emerge as a response to environmental
triggers such as antibiotics and acts as an insurance for
the general bacterial population to survive in a stressful
environment.
It is conceivable that DNA, being chiral due to its right‐
handed helical structure, would interact differently with the
disymmeric nonintercalating peripheral pair of phen ligands
on the ruthenium complex depending on chirality. Being
either right‐ or left‐handed, the Δ‐ and Λ‐forms should fit dif-
ferently into the grooves of the DNA. This could be observed
in the early experiments with [Ru(phen)3]
2+ where the Δ‐ and
Λ‐forms differed in their individual binding modes with
DNA17,46,47 and was further supported in studies with the
intercalating analog Ru‐phen, where ΔRu‐phen was deter-
mined to have a stronger binding affinity (2–5 times) for
DNA compared to the Λ‐form.48,49 The same chiral discrim-
ination was observed in this study, with ΔRu‐phen showing
both stronger bacteriostatic effect against both B. subtilis
and E. coli compared to the Λ‐form, indicating DNA binding
as the primary antimicrobial mode of action. To test this
hypothesis, emission of the bacterial cells was recorded after
an overnight incubation with the ruthenium complexes. The
bacterial cells were exposed to an excess of ruthenium com-
plex, as indicated by the yellow color of the supernatants after
washing. No emission of the supernatants was observed, thus
suggesting that the cellular membranes of the bacteria had
remained intact. Both Ru‐phen and biRu‐phen are known as
“light‐switch complexes,” meaning that they are completely
quenched when unbound in aqueous solution, but show
intense fluorescence when intercalated to DNA. Therefore,
any fluorescence observed would suggest DNA binding. In
both strains, the intensity of emission from the bacterial cells
after incubation with ΔRu‐phen was significantly higher than
that of the Λ‐form (Figure 2). A slight redshift was observed
for ΛRu‐phen in both strains, a phenomenon associated with
DNA‐complex interactions.35,50 The largest difference was
observed in E. coli, consistent with the results from the metal
susceptibility assays. The smaller difference in emission for
cells of B. subtilis exposed to ΔRu‐phen or ΛRu‐phen could
depend on the base composition of the genome. The genome
of B. subtilis has a higher content of the A and T nucleic acids
(56.5%)51 compared to the genome of E. coli (49.2%),52 andtherefore could explain the less profound difference in inten-
sities, in accordance with the early work by Hiort et al., where
the same relative intensities were observed to differ less
between Δ‐ and Λ‐[Ru(phen)2dppz]2+ when bound to AT‐
sequences compared to calf thymus DNA.35 No emission in
the binuclear complex was observed, indicating no interac-
tion with DNA.
Figure 3 shows a confocal microscopic picture of
Hoechst‐stained E. coli that had been previously treated with
either enantiomer of Ru‐phen. The figure clearly shows emis-
sion from both enantiomers, but with much higher intensity
from the Δ‐form. In addition, the relation between the inten-
sity of the Hoechst stain and the intensity of the complex
appears to be inverse; the cells with the highest intensity of
ruthenium complex appears to have very weak if any fluores-
cence from the Hoechst staining, and vice versa. This relation
is apparent for both enantiomers. The ruthenium complex and
the DNA‐stain compete for binding in the minor groove of
DNA, thus explaining why bacterial cells with high signal
FIGURE 3 Confocal microscopy images of
formaldehyde fixed E. coli samples incubated
with Δ‐ (top row) and ΛRu‐phen (middle row)
overnight and then stained with Hoechst 33342.
(a) fluorescence, Hoechst 33342 (Δ‐sample); (b)
fluorescence, ΔRu‐phen; (c) fluorescence,
Hoechst 33342 (Λ‐sample); (d) fluorescence,
ΛRu‐phen; (e) fluorescence, control sample E. coli
stained with Hoechst 33342 (Bottom right: a black
square for visual aid). Scale bar =5 μm
718 MÅRTENSSON ET AL.for Ru‐phen have poor emission from the DNA‐stain due to
saturation on binding sites on the DNA. The same effect
could be observed in B. subtilis, while the enantiomeric dif-
ference in emission was not as distinct (shown in Figure S3
in the Supporting Information). Furthermore, unexposed bac-
terial cells used as controls showed significantly stronger
emission from the Hoechst dye compared to bacteria exposed
to ruthenium complex, again indicating that ruthenium com-
plex and the DNA binding dye competes for the same binding
sites.
In conclusion, this is the first reported work of the poten-
tial usage of enantiopure [Ru(phen)2dppz]
2+ and [μ‐
bidppz(phen)4Ru2]
4+ as antimicrobial compounds. While
the binuclear complex had no major toxic effect on bacterial
cells, the mononuclear complex showed a high antimicrobial
activity, especially in B. subtilis, where the effect was compa-
rable to that of tetracycline (as given in Table 1). Importantly,we observed the Δ‐enantiomer of [Ru(phen)2dppz]2+ to be 2‐
fold more effective in both inhibiting and killing B. subtilis in
comparison to the Λ‐enantiomer. Our initial results suggest
diastereomeric DNA interactions as the antimicrobial mode
of action, which was further supported by stronger emission
from Δ compared with Λ in bacterial cells exposed to the
compounds. This study clearly demonstrates the potential of
enantioselectivity in the bactericidal action of substitution
inert transition metal complexes, and emphasizes the impor-
tance of studying enantiopure compounds.4 | CONCLUSION
Two ruthenium(II) polypyridyl complexes were tested
for their antimicrobial activity: [Ru(phen)2dppz]
2+ and
[μ‐bidppz(phen)4Ru2]4+, both resolved into their pure
MÅRTENSSON ET AL. 719enantiomeric forms (Δ andΛ). Both enantiomers of [Ru(phen)
2dppz]
2+ displayed high bactericidal effect against Gram‐pos-
itive B. subtilis, comparable to the antimicrobial activity of
tetracycline, while having a more bacteriostatic effect on
Gram‐negative E. coli. In contrast, [μ‐bidppz(phen)4Ru2]4+
showed significantly lower antimicrobial activity against both
bacterial strains with a bactericidal effect only at the highest
concentrations tested.
ACKNOWLEDGMENTS
The authors thank Fredrik Bäckhed at the Wallenberg Labo-
ratory (Sahlgrenska Academy) for funding the materials and
equipment used in this study. Also, we thank Vetenskapsrådet
(grant VR 2012–1661) and Chalmers Area of Advance Nano
for funding and COST action CM1105 for providing a forum
for stimulating discussions.
LITERATURE CITED
1. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem.
2009;119–146.
2. Gootz TD. The global problem of antibiotic resistance. Crit Rev Immunol.
2010;30(1):79–93.
3. Projan SJ. New (and not so new) antibacterial targets— from where and when
will the novel drugs come? Curr Opin Pharmacol. 2002;2(5):513–522.
4. Projan SJ. Why is big Pharma getting out of antibacterial drug discovery?
Curr Opin Microbiol. 2003;6(5):427–430.
5. Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens
without detectable resistance. Nature. 2015;517(7535):455–459.
6. Demain AL, Sanchez S. Microbial drug discovery: 80 years of progress. J
Antibiot. 2009;62(1):5–16.
7. Marchal JA, Prados J, Melguizo C, et al. Actinomycin D treatment leads to
differentiation and inhibits proliferation in rhabdomyosarcoma cells. J Lab
Clin Med. 1997;130(1):42–50.
8. Frei Iii E. The clinical use of actinomycin. Cancer ChemotherRep.
1974;58(1):49–54.
9. Braña MF, Cacho M, Gradillas A, De Pascual‐Teresa B, Ramos A.
Intercalators as anticancer drugs. Curr Pharm Des. 2001;7(17):1745–1780.
10. Ming LJ. Structure and function of "metalloantibiotics.". Med Res Rev.
2003;23(6):697–762.
11. Sabale PM, Kaur P, Patel Y, Patel J, Patel R. Metalloantibiotics in therapy: An
overview. J Chem Pharm Res. 2012;4(11):4921–4936.
12. Uivarosi V. Metal complexes of quinolone antibiotics and their applications:
An update. Molecules. 2013;18(9):11153–11197.
13. Cohen SM, Lippard SJ. Cisplatin: From DNA damage to cancer chemother-
apy. 2001;93–130.
14. Kelland L. The resurgence of platinum‐based cancer chemotherapy. Nat Rev
Cancer. 2007;7(8):573–584.
15. Wee HA, Dyson PJ. Classical and non‐classical ruthenium‐based antican-
cer drugs: Towards targeted chemotherapy. Eur J Inorgan Chem.
2006;20:4003–4018.
16. Brabec V, Novakova O. DNA binding mode of ruthenium complexes and
relationship to tumor cell toxicity. Drug Resist Updates. 2006;9(3):111–122.
17. Barton JK, Goldberg JM, Kumar CV, Turro NJ. Binding modes and base
specificity of tris(phenanthroline)ruthenium(II) enantiomers with nucleic
acids: Tuning the stereoselectivity. J Am Chem Soc. 1986;108(8):2081–2088.
18. Barton JK, Danishefsky AT, Goldberg JM. Tris(phenanthroline)ruthenium(II):
stereoselectivity in binding to DNA. J Am Chem Soc. 1984;106(7):
2172–2176.
19. Lincoln P, Nordén B. DNA binding geometries of ruthenium(II) complexes
with 1,10‐phenanthroline and 2,2 ‘‐bipyridine ligands studied with lineardichroism spectroscopy. Borderline cases of intercalation. J Phys Chem B.
1998;102(47):9583–9594.
20. Erkkila KE, Odom DT, Barton JK. Recognition and reaction of
metallointercalators with DNA. Chem. Rev. 1999;99(9):2777–2795.
21. Pages BJ, Ang DL, Wright EP, Aldrich‐Wright JR. Metal complex interac-
tions with DNA. Dalton Trans. 2015;44(8):3505–3526.
22. Dwyer FP, Reid IK, Shulman A, Laycock GM, Dixson S. The biological
actions of 1,10‐phenanthroline and 2,2′‐bipyridine hydrochlorides, quater-
nary salts and metal chelates and related compounds. 1. Bacteriostatic
action on selected gram‐positive, gram‐negative and acid‐fast bacteria. Austr
J Exp Biol Med Sci. 1969;47(2):203–218.
23. Dwyer FP, Reid IK, Shulman A, Laycock GM, Dixson S. Biological activity
of complex ions. Nature. 1952;170(4318):190–191.
24. Gill MR, Thomas JA. Ruthenium(II) polypyridyl complexes and DNA‐from
structural probes to cellular imaging and therapeutics. Chem Soc Rev.
2012;41(8):3179–3192.
25. Bolhuis A, Hand L, Marshall JE, Richards AD, Rodger A, Aldrich‐Wright J.
Antimicrobial activity of ruthenium‐based intercalators. Eur J Pharm Scie.
2011;42(4):313–317.
26. Lei W, Zhou Q, Jiang G, Zhang B, Wang X. Photodynamic inactivation of
Escherichia coli by Ru(ii) complexes. Photochem Photobiol Sci.
2011;10(6):887–890.
27. Li F, Mulyana Y, Feterl M, Warner JM, Collins JG, Keene FR. The antimi-
crobial activity of inert oligonuclear polypyridylruthenium(ii) complexes
against pathogenic bacteria, including MRSA. Dalton Trans.
2011;40(18):5032–5038.
28. Li F, Feterl M, Warner JM, Keene FR, Grant CJ. Dinuclear
polypyridylruthenium(II) complexes: Flow cytometry studies of their accu-
mulation in bacteria and the effect on the bacterial membrane. J Antimicrob
Chemother. 2013;68(12):2825–2833.
29. Li F, Harry EJ, Bottomley AL, et al. Dinuclear ruthenium(ii) antimicro-
bial agents that selectively target polysomes in vivo. Chem Sci.
2014;5(2):685–693.
30. Li F, Harry EJ, Bottomley AL, et al. In vitro susceptibility and cellular uptake
for a new class of antimicrobial agents: Dinuclear ruthenium(II) complexes. J
Antimicrob Chemother. 2012;67(11):2686–2695.
31. Li F, Feterl M, Warner JM, Day AI, Keene FR, Collins JG. Protein binding by
dinuclear polypyridyl ruthenium(ii) complexes and the effect of
cucurbit[10]uril encapsulation. Dalton Trans. 2013;42(24):8868–8877.
32. Li X, Heimann K, Li F, Warner JM, Keene RF, Collins JG. Dinuclear
ruthenium(II) complexes containing one inert metal centre and one
coordinatively‐labile metal centre: Synthesis and biological activities. Dalton
Trans. 2016;45(9):4017–4029.
33. Li F, Collins JG, Keene FR. Ruthenium complexes as antimicrobial agents.
Chem Soc Rev. 2015;44(8):2529–2542.
34. Tan CP, Lai SS, Wu SH, et al. Nuclear permeable ruthenium(II)beta‐carboline
complexes induce autophagy to antagonize mitochondrial‐mediated apopto-
sis. J Med Chem. 2010;53(21):7613–7624.
35. Hiort C, Lincoln P, Nordén B. DNA binding of Δ‐ and Λ‐[Ru(phen) 2DPPZ]
2+. J Am Chem Soc. 1993;115(9):3448–3454.
36. Wilhelmsson LM, Esbjörner EK, Westerlund F, Nordén B. LincolnMeso ste-
reoisomer as a probe of enantioselective threading intercalation of semirigid
ruthenium complex [μ‐(11,11′‐bidppz)(phen)4Ru2]4+. J Phys Chem B.
2003;107(42):11784–11793.
37. Harrison JJ, Tremaroli V, Stan MA, et al. Chromosomal antioxidant genes
have metal ion‐specific roles as determinants of bacterial metal tolerance.
Environ Microbiol. 2009;11(10):2491–2509.
38. Henie EFP, Zaiton H, Suhaila M. Bacterial membrane disruption in food
pathogens by psidium guajava leaf extracts. Int Food Res J.
2009;16(3):297–311.
39. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Har-
bor Perspect Biol. 2010;2:a000414.
40. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin
Microbiol Rev. 2006;19(3):491–511.
720 MÅRTENSSON ET AL.41. Wu M, Hancock REW. Improved derivatives of bactenecin, a cyclic
dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother.
1999;43(5):1274–1276.
42. Vooturi SK, Cheung CM, Rybak MJ, Firestine SM. Design, synthesis, and
structure — Activity relationships of benzophenone‐based tetraamides as
novel antibacterial agents. J Med Chem. 2009;52(16):5020–5031.
43. Poole K. Stress responses as determinants of antimicrobial resistance in
Gram‐negative bacteria. Trends Microbiol. 2012;20(5):227–234.
44. Gefen O, Balaban NQ. The importance of being persistent: Heterogeneity of
bacterial populations under antibiotic stress: Review article. FEMS Microbiol
Rev. 2009;33(4):704–717.
45. Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357–372.
46. Chaires JB. Tris(phenanthroline)ruthenium(II) enantiomer interactions with
DNA: Mode and specificity of binding. Biochemistry. 1993;32(10):
2573–2584.
47. Eriksson M, Leijon M, Hiort C, Nordén B, Gräslund A. Binding of Δ‐ and
Λ‐[Ru(phen)3]2+ to [d(CGCGATCGCG)]2 studied by NMR. Biochemistry.
1994;33(17):5031–5040.
48. Haq I, Lincoln P, Suh D, Nordén B, Chowdhry BZ, Chaires JB. Interaction of
Δ‐ and Λ‐[Ru(phen)2DPPZ]2+ with DNA: A calorimetric and equilibrium
binding study. J Am Chem Soc. 1995;117(17):4788–4796.
49. Andersson J, Fornander LH, Abrahamsson M, Tuite E, Nordell P.
LincolnLifetime heterogeneity of DNA‐bound dppz complexes originatesfrom distinct intercalation geometries determined by complex‐complex inter-
actions. Inorgan Chem. 2013;52(2):1151–115.
50. McKinley AW, Lincoln P, Tuite EM. Environmental effects on the
photophysics of transition metal complexes with dipyrido 2,3‐a:3′,2′‐c phen-
azine (dppz) and related ligands. Coord Chem Rev. 2011;255(21–22):2676–
2692.
51. Kunst F et al. The complete genome sequence of the gram‐positive bacterium
Bacillus subtilis. Nature. 1997;390(6657):249–256.
52. Blattner FR, Plunkett G III, Bloch CA, et al. The complete genome sequence
of Escerichia coli K‐12. Science. 1997;277(5331):1453–1462.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in
the supporting information tab for this article.
How to cite this article: Mårtensson A. K. F.,
Bergentall M., Tremaroli V. and Lincoln P. Diastereo-
meric bactericidal effect of Ru(phenanthroline)
2dipyridophenazine, Chirality, 2016; 28, DOI:
10.1002/chir.22656 713‐720
Diastereomeric bactericidal effect of Ru(phenanthroline)2dipyridophenazine 
Anna K. F. Mårtensson*, Mattias Bergentall, Valentina Tremaroli and Per Lincoln 
Supporting Information 
Figure S1 Experimental setup of the metal susceptibility assay for antibiotic susceptibility testing. 
Figure S2 Total nucleotide leakage measured by UV absorption at 260 nm from B. subtilis (left) and E. coli (right) 
treated with ΔΔ- (black dots) and ΛΛbiRu-phen (red dots) (~300 μM). 3% SDS solution was used as comparison 
(gray triangles). Each point is the mean of six replicate cultures. Error bars show standard deviations (SD: 3σ); 
when not visible, these bars are as small as or smaller than the symbols plotted. 
 Figure S3 Confocal microscopy images of formaldehyde fixed B. subtilis cells incubated with Δ- (top row) and 
ΛRu-phen (middle row) overnight and then stained with Hoechst 33342. (a) fluorescence - Hoechst 33342 (Δ-
sample); (b) fluorescence - ΔRu-phen; (c) fluorescence - Hoechst 33342 (Λ-sample); (d) fluorescence - ΛRu-phen; 
(e) fluorescence - control sample B. subtilis stained with Hoechst 33342 (Bottom right: a black square for visual 
aid). Scale bar = 5 μm. 
 
 
